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 Today, we are implanting electrodes into many different parts of the peripheral 
and central nervous systems for the purpose of restoring function to people with nerve 
injury or disease. As technology and manufacturing continue to become more advanced, 
nerve electrodes are being developed to provide more selective access to multiple 
neurons simultaneously. With the advent of these technologies, it is important that in 
parallel, their potential clinical impact is investigated, so that both engineering and 
clinical outcomes can dictate future designs.  
 Three objectives were carried out to extend the applications of the Utah Slanted 
Electrode Array (USEAs) for use in the peripheral nervous system. The first objective 
was to investigate the capabilities and consequences of USEAs with four-fold higher 
electrode densities for use in smaller (≤ 1 mm) peripheral nerves. Chapters 2 and 3 of this 
dissertation cover recent work that showed USEAs with 25 electrodes/mm2 could be 
developed and implanted into peripheral nerves without causing global nerve injuries. 
Results from acute (up to 12 hr) and chronic (up to 2 mo) animal implantation studies are 
presented and discussed.  
 The second objective was to investigate the use of USEAs implanted into the 
pudendal nerve as a neural interface for the control of urinary function (Chapters 4-6). 
Utah Arrays were used to control excitation and inhibition of urinary muscles, and also to 
record and thereby detect, different genitourinary stimuli. Together, these results 





control and restoration of urinary function.  
 The final objective was to investigate the use of USEAs as a neural interface—
implanted into the human median and ulnar nerves—for bidirectional control of future 
generation prosthetic limbs in people with upper limb amputations. More than 80 
different sensory percepts could be evoked with electrical stimulation delivered to 
individual microelectrodes on a USEA implanted in the ulnar nerve. Recording neural 
activity during different perceived phantom finger movements, up to 13 different finger 
movements could be decoded offline. These results showed that, using USEAs, over 10 
times the amount of information could be transferred to and from the nervous system than 
had been previously published for other peripheral nerve electrodes.  
 In conclusion, we have fabricated and validated a new Utah Array for use in 
smaller neural structures, and in parallel we have begun investigation of the clinical 
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 Within these pages you will find a wide breadth of research, all of which utilized 
an array of microelectrodes, the Utah Electrode Array, originally developed at the 
University of Utah in the early 1990s for use in the nervous system. The major theme 
found throughout the chapters is the advancement of Utah Array technologies by 
combining aspects of both engineering and clinical medicine. Technologies, even if 
rudimentary in their design, can at times bring a better quality of life to the people with 
no or few treatment options, although there must remain a balance between pushing 
translational medicine when technologies are ready and protecting the patients from 
technologies that are not ready. We hope the collected work herein serves to inspire the 
neural engineering and clinical communities to make translational work a priority 
whenever possible.  
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 In this introduction, an overview is provided of the field of neuromodulation, 
peripheral nerve anatomy, the foreign body response to indwelling electrodes, as well as 
currently available peripheral nerve electrodes. The Utah Array and its structural 
variations are reviewed, as well as the clinical and experimental applications of these 
devices that were underway prior to the research presented herein. The limitations of the 
USEA geometry available prior to this research are also discussed, and a proposed new 
geometry for use in smaller nerves is introduced. Finally, two important clinical problems 
are discussed: loss of urinary and hand function following nerve injury and amputation, 
respectively. For each of these clinical problems, the potential for utilizing Utah Array 
technologies for the restoration of each respective function is introduced and an overview 
of the work we have done to begin realizing these potentials is reviewed. 
 This dissertation covers six different studies that have either been published, or 
are in press, in revisions or submitted for review. The scope of the collected work here is 
extensive, and therefore, the aim of this introduction is to provide a broad overview, 
while more detailed introductions are found at the beginning of each chapter. Finally, the 
dissertation concludes by focusing on the potential future of Utah Array interfaces both 
from engineering and clinical standpoints.  
 
1.2 Neuromodulation 
 Neuromodulation of the nervous system for the restoration of normal function has 
been used throughout history in different forms, such as the ancient eastern therapy of 




electricity was becoming more widespread.1 Today, neuromodulation is taking on new 
definitions, with clinical therapies that utilize many means of modulating neuronal 
activity in the Central (CNS) and Peripheral Nervous Systems (PNS) to achieve better 
function. Modulation techniques may include chemical, temperature, mechanical, 
genetic, electrical processes or even a combination of two or more techniques.2  
 Neuromodulation is among the newest and fastest growing areas of medicine with 
a projected mean market value that grew from under $1 billion to $3 billion (U.S.D.) in 
six years (from 2004 to 2010).2 It has been defined in different ways, and one definition 
is the ‘therapeutic alteration of activity in the central, peripheral or autonomic nervous 
systems, electrically or pharmacologically, by means of implanted or nonimplanted 
devices’.3 Several Food and Drug Administration (FDA) approved neuromodulation 
devices include electrodes implanted to deliver electrical stimulation to the basal ganglia 
for Parkinson’s disease; cochlea for profound deafness; retina for profound blindness; 
vagal nerve for depression; spinal cord for chronic pain; and the sacral roots for 
incontinence.2 
 The neuromodulation of interest to our research is the delivery of electrical 
stimulation to selective axons within a peripheral nerve in order to evoke a desired 
physiological response. Additionally, we are also interested in recording from selective 
axons within a peripheral nerve in order to decode activity that can tell us about people’s 
voluntary intentions (e.g., a hand amputee wants to move a finger) or different 
involuntary states (e.g., the bladder is now full). The ultimate goal is the combination of 
neural stimulation and recording for closed-loop control of fully implantable 




1.3 Peripheral nerves 
 Peripheral nerves are a collection of nerve axons that are made up of a protective 
outer layer called the epineurium (Fig 1.1). Within the epineurium are fascicles that 
contain neuronal axons.4 These fascicles or axons are the target for neuromodulation in 
the PNS, and different electrode designs are allowing for targeted delivery of electrical 
current to subsets of fascicles or neurons within a peripheral nerve.  
 As a nerve extends more distally, the fascicles may branch off into smaller nerves 
that eventually reach a targeted end muscle or organ.4,5 The fascicular structure of a 
peripheral nerve can vary between and along the length of nerves.5-9 There may also be 
variations in the fascicular organization of nerves in different species, such that a nerve in 
one species may be unifascicular, while it may be multifascicular in another. For 
example, the feline pudendal nerve trunk has been shown to have 6-10 fascicles10,11(Fig 
1.1A), while we found upwards of 40 fascicles in the porcine pudendal nerve (Fig 1.1B). 
Such anatomical differences are important to consider when designing neuromodulation 
studies and choosing neural electrodes, as the fascicular organization can alter the 
effectiveness by which selective electrical stimulation or recording can be conducted.  
 In order to assist research in effectively translating to human applications, it is 
important to consider an animal model that has anatomical similarities to the human. The 
human pudendal nerve trunk can have 4-6 fascicles that range from 0.5-2 mm in 
diameter.9 Therefore, from a purely anatomical standpoint, the feline should be 
considered a more appropriate animal model than the porcine for investigating 





1.4 The foreign body response to indwelling nerve electrodes 
 Any material intracorporally implanted evokes a Foreign Body Response (FBR) 
from both the immune and inflammatory systems.12 Strategies are being developed to 
contend with the FBR in order to increase the lifetime and effectiveness of neural 
electrodes. First, we will briefly review the FBR and then discuss some of these strategies 
as they pertain to Utah Arrays. 
 The FBR begins with the formation of a provisional matrix, which consists of 
adsorption of proteins, molecules and cells onto the surface of the material.13,14 During 
the acute phases, the adhesion and activation of platelets and complement lead to the 
release of cytokines, which then serve as chemoattractants for other 
immune/inflammatory cells. 
 As the FBR transitions from acute to chronic inflammation (days to weeks), it is 
marked by a decrease in neutrophils and an increase in monocytes.15 These new cells 
include macrophages and fibroblasts, which mediate chronic inflammation and 
encapsulation at the device-tissue interface, respectively. Macrophages can fuse together 
to form Foreign Body Giant Cells (FBGCs), which can mediate degradation of the device 
and tissue through production of reactive oxygen species/intermediates.13 However, 
macrophages can produce positive effects, as some phenotypes may help promote 
healing, and thus, regeneration of nerve axons.16 
 Inhibiting different phases of the FBR may help increase the longevity of 
indwelling electrodes. For example, devices may last longer if one can selectively inhibit 
the provisional matrix or chronic inflammation17-19 while also promoting neuronal 




pharmacological interventions or surface modifications. Pharmacological interventions, 
such as dexamethasone administration either systemically19 or locally coated onto 
electrodes,18 has been shown to decrease the FBR and neural loss in chronically 
implanted cortical electrodes. Additionally, minocycline has been shown to increase the 
quality (higher signal-to-noise ratios) and longevity of CNS implanted electrodes.20 
Surface modifications of the electrodes—such as decreasing surface area21 or adding a 
hydrogel matrix coating22—have also been shown to decrease the FBR to cortical 
electrodes. 
 It is important to note that much of the published work in this field has focused on 
CNS electrodes, and more studies are needed that focus efforts on investigating whether 
these and other strategies will translate in the PNS. However, it is clear that strategies for 
modifying the FBR to neural electrodes can help play a key role in the effective 
translation of indwelling neuromodulation devices for clinical applications. In the 
following chapters, various experimental designs were implemented in order to decrease 
the FBR to indwelling electrodes whenever possible. This included administration of 
systemic minocycline and dexamethasone in the chronic rat (Chapter 3) and human 
(Chapter 7) studies. Additionally, a new containment system was developed that 
incorporated an FDA approved nerve wrap to mitigate the immune response by 
decreasing the surface area of the containment system (Chapters 2 and 7).  
 
1.5 Neural electrodes 
 More advanced neural interfaces are being developed to assist in reaching new 




decades to provide researchers and clinicians with different design choices to meet their 
research or clinical goals. In order to determine which device to use for a given 
physiological experiment or clinical application, the neural interface must meet the needs 
of both the desired physiological outcome and the constraints applied by the targeted 
neuroanatomy.  
 Neuromodulation electrodes are generally characterized by low impedances for 
recording and/or safe charge injection for stimulation.23,24 Electrical stimulation of the 
nervous system initiates the flow of ionic current between two sources, such as an 
electrode and a reference wire return (monopolar configuration) or between two 
electrodes (bipolar configuration). Different electrode configurations can be used to steer 
current across targeted fascicles and thus, achieve more selective stimulation.25,26 Safe 
stimulation of the nervous system is characterized by the rate of charge injection (or 
charge density) and charge-balanced waveforms.24,27,28 The clinical usefulness of a 
neuromodulation electrode depends on its ability to deliver safe and effective stimulation 
levels. 
 Current peripheral nerve interfaces have different numbers, sizes and spacing of 
electrodes. Some electrodes are separated by hundreds of microns,29-31 while others by 
several millimeters.32-34 The majority of neural interfaces available for intrafascicular 
peripheral neuromodulation have a relatively low number of electrodes (< 10) compared 
to the number of axons (up to 8500 myelinated fibers in rat sciatic and 21,000 fibers in 
the cat sciatic6). Some examples include electrodes that are implanted: interfascicularly 
(e.g., Slowly Penetrating Interfascicular Electrode, SPINE35), intrafascicularly (e.g., 




Electrode, FINE34). These designs all take advantage of different methods by which to 
achieve excitation of different fascicles within a peripheral nerve. For example, FINE 
electrodes flatten a peripheral nerve such that activation of single fascicles is possible by 
delivering bipolar current across the individual fascicle or section of fascicle.36 
 One of the most important aspects of the field of neuromodulation is the ongoing 
improvement to nerve electrodes, such that that more selective information can be 
transferred to and from the nervous system. In order to achieve more selective access to 
the nervous system, one must consider modifying the size, number, and spacing of 
electrodes on a single device. The size of mammalian axons may range from 1-20 µm,37 
and one research goal is to modulate a subset of axons within a single fascicle. Thus, one 
can begin to appreciate that the size and spacing of the electrodes will directly impact the 
amount of information that can be selectively transferred to and from the peripheral 
nervous system.  
 In the early 1990s, Richard Normann’s research group recognized this need and 
pioneered a new type of nerve interface that greatly increased the number of electrodes 
per millimeter squared, while also decreasing the size of the active sites of the electrodes 
to less than 100 µm lengths.31 This new technology, known as the Utah Electrode Array 
(UEA), helped push the field to a new level: implantation of multiple microelectrodes (up 
to 100 electrodes/array) simultaneously to allow greater information transfer to and from 
the central nervous system. A different architecture of this array, known as the Utah 
Slanted Electrode Array (USEA), was later developed for the peripheral nervous system 
by grading the lengths of the electrodes in each row so as to achieve different tip 




1.6 Expanding applications of Utah Arrays: devices for smaller  
nerves  
 The UEA and USEA have 6.25 electrodes/mm2 with electrodes spaced by 400 µm 
and lengths from 0.5-1.5 mm. When our work began five years ago, UEAs were being 
used in many different cortical applications, including implantation into humans with 
paralysis for the control of remote computers or robotic devices.39-42 The USEA was 
being investigated as a neural interface for controlled fatigue-resistant stance in 
anesthetized felines43 and control of prosthetic devices in nonhuman primates.44 Although 
these were great strides for this device, many potential applications had not been pursued 
and many questions remained concerning the possible use of this device in peripheral 
nerves, especially for different sizes of nerves and chronic implantation studies. 
 The geometry of the USEA was appropriately designed for medium-sized 
peripheral nerve structures (2-4 mm wide nerves with ≥ 300 µm fascicular diameters), 
such as the feline sciatic nerve43 or rhesus macaque.44 However, implantation of this 
geometry device into either smaller (≤ 2 mm wide with average fascicle diameters of ≈ 
300 µm) or larger nerves (with diameters > 1 mm) would result in lower probabilities that 
the electrode tips would penetrate into targeted nerve fascicles. Thus, the functionality of 
USEAs implanted in smaller or larger nerves would become comparable to 
intrafascicular electrodes with smaller number of electrodes, such as LIFEs. For example, 
with USEA electrode lengths from 0.5 to 1.5 mm, only the fascicles within this range 
would be penetrated. Likewise, with electrode spacing of 400 µm, any fascicles with 
diameters smaller than 400 µm would potentially not be implanted intrafascicularly with 




smaller and larger neural structures, new USEA geometries were warranted. 
 One design feature of penetrating neural interfaces that can greatly impact their 
application is electrode density, or the number of electrodes per mm2. As researchers 
begin to investigate more chronic peripheral nerve USEA implants in animals, ideal 
animal models would be the lesser mammalian species, as they are more cost effective. 
 Although the UEA has been implanted in human cortex39 for > 2.7 years, the 
USEA has historically fallen behind not only in translation into human applications, but 
also in chronic peripheral nerve implantation times (longest published data = up to 7 
months45). The rat sciatic nerve has been well characterized anatomically,46 and this 
model would provide a cost effective method for studying the effects of chronic USEA 
implants; however, this nerve is 1 mm in diameter.46 Additionally, we were considering 
the feline as an animal model for studying USEA-based pudendal prosthesis for the 
control of genitourinary muscles; however, the fascicular organization of this nerve 
would necessitate shorter lengths and more closely spaced electrodes in order to provide 
high-count numbers (> 20) of intrafascicularly implanted electrode tips. Therefore, we 
began asking the question, could microelectrode arrays with greater number of electrodes 
per millimeter squared be developed for smaller nerves or nerves with more complex 
fascicular structure, and if so, would implantation of the devices cause nerve crush 
injuries that would negate their use?  
 Chapters 2 and 3 of this dissertation present and discuss the design, fabrication, 
and validation of High electrode Density USEAs (HD-USEAs) in acute11,47 and chronic 
(up to 2 months)48 animal models. HD-USEAs increase the number of electrodes per 




the older arrays to 25 electrodes/mm2). These two chapters cover physiological and 
histological assessment of acute implantation of HD-USEAs (Chapter 2) as wells as 
behavioral, physiological and histological analysis of chronic HD-USEA implants 
(Chapter 3). Collectively, these studies show that HD-USEAs do not cause global nerve 
injury that would negate their use in acute or chronic experimentation (up to the 2 mo 
investigated). As a consequence of the research endeavors covered in Chapters 2 and 3, 
we now have penetrating microelectrode arrays that can provide the highest degree of 
information transfer to and from the peripheral nervous system. 
 Finally, the studies covered in Chapter 3 were also designed to test a new 
containment system for Utah Arrays that was based on an organic material already FDA 
approved for human peripheral nerve injury studies.48 The success of this material in 
containing Utah arrays implanted chronically in actively behaving animals (rats with 
voluntary access to wheels) helped open the doors for the translational studies we then 
pursued in humans (Chapter 7).49  
 
1.7 Expanding applications of Utah Arrays: restoration of urination  
 Many urinary complications can arise from nervous system injury or disease, and 
may include overactive or underactive neuromuscular changes in the External Urethral 
Sphincter (EUS) and/or the detrusor bladder muscle.50-52 The neurophysiology of the 
urinary system involves both central and peripheral nervous systems, with voluntary 
urination (micturition) controlled by the CNS in adults.53 The urinary tract is innervated 
by three sets of peripheral nerves: sacral somatic nerves bilaterally (pudendal nerves 




thoracolumbar sympathetic (hypogastric plexus and sympathetic chain innervate the 
detrusor).53 Importantly, the urogenital system’s dependency on the CNS is rather unique 
compared to the other visceral organs (e.g., cardiac and gastrointestinal), which function 
in the absence of voluntary control. Thus, the genitourinary system is sensitive to 
interruption by CNS or PNS injury/disease.  
 Urinary function in adults requires pathways in the CNS and spinal cord that 
control the three nerves innervating the urinary system, such that either storage or voiding 
is activated. Voiding requires the simultaneous excitation of the detrusor (via increased 
pelvic nerve drive and decreased hypogastric drive) and inhibition of the EUS (decreased 
motor output in the pudendal).54 Urine storage can be switched to the urination phase by 
either voluntary mechanisms involving the CNS or involuntary mechanisms involving 
spinal reflexes. The involuntary voiding pathway is demonstrated in the infant53,55 or in 
some people with spinal cord injury,56 and involves reflex bladder-to-EUS pathways. 
During an involuntary void, a threshold volume is sensed by receptors in the bladder 
wall, which leads to activation of the pelvic-to-pudendal pathways to allow coordinated 
contraction of the bladder and relaxation of the EUS. When there is a loss of voluntary 
control over micturition in the adult, the potential issues can be classified by either 1) the 
failure to store (e.g., overactive bladder) or 2) the failure to void (e.g., detrusor-sphincter 
dyssynergia).53,56 
 The loss of urinary function can have a great impact on the patient’s quality of 
life, and the refractory cases are a challenging clinical problem with limited available 
options.57 One of the benefits to the emerging neuromodulation therapies for these cases 




carried out today are irreversible.  
 Sacral neural stimulation is an FDA approved therapy for patients with painful or 
dysmotility conditions such as neurogenic bladder, overactive bladder, or interstitial 
cystitis.58 Complications of sacral nerve stimulation may include lead wire migration 
(11.8%) or pain (15.3%) at the stimulation site.59 Refractory overactive bladder can also 
be treated via tibial nerve stimulation.60 Neuromodulation of the Pudendal Nerve (PN) is 
emerging as another potential therapeutic option for the restoration of urinary control.61-68 
To date, the neural interfaces that have been used to investigate neuromodulation of the 
PN in humans have included extraneurally placed electrodes66,68-72 or surface 
electrodes.69,72-74  
 Because there are multiple nerve pathways in the PN—including those that 
mediate reflex micturition,73-75 defecation,75,76 and erection76—a multipurpose PN 
stimulator would be able to selectively activate these different nerve pathways, depending 
on the clinical needs. Computer modeling studies have shown that whole-nerve cuff 
electrodes could be designed and electrical stimulation delivered such that selective 
access to the different fascicles within the PN may be possible.77,78 However, a closed-
loop device based on whole-nerve cuff electrodes would have false-positive detection of 
different bladder states during tactile stimulation of the genital region or bowel 
movement related stimulation.71,79  
 Therefore, we hypothesized that Utah Array-based pudendal nerve prostheses 
would be able to selectively activate the different neural pathways within the nerve trunk 
Chapters 4 and 6). Additionally, a Utah Array neuromodulation device should be able to 




the first two studies (Chapters 4 and 5), we demonstrated that Utah arrays implanted in 
the pudendal nerve trunk can be used to 1) deliver electrical stimulation that can 
selectively excite the urinary muscles (Chapters 4)); and 2) record neural activity that can 
differentiate between bladder states and tactile stimulation (Chapter 5). Finally, we 
extended those results by investigating whether intrafascicular electrode arrays could be 
used to deliver electrical stimulation to restore urinary function in three different clinical 
conditions: 1) to restore continence in an acute model of urinary incontinence, 2) to 
inhibit overactive detrusor contractions and 3) to excite detrusor contractions in 
underactive states (Chapter 6).  
 The results presented in Chapters 4-6 demonstrate that a future Utah Array-based 
pudendal neuroprosthesis could provide closed-loop detection of different genitourinary 
states, while also providing selective stimulation to allow for excitation or inhibition of 
different urinary muscles. An exciting avenue for future Utah Array-based pudendal 
research will be to investigate detection and control of the other pathways within this 
nerve: reflex erection and defecation (discussed in Chapter 8). 
 
1.8 Expanding applications of Utah Arrays: control of dexterous  
prostheses  
 Unidirectional (motor control only) prosthetic limbs are the current gold standard 
for people with upper-limb amputations and these devices can be myoelectrically or 
mechanically controlled.80 New generation prosthetic arms have been developed with 
more power and over 20 Degrees Of Freedom motion (DOF).81 One of the new goals of 




people with amputations such that they can control such high DOF prostheses. A 
concurrent goal of upper limb neuroprosthetic research is to establish bidirectional 
communication between the user and the limb, such that the device is under complete 
motor control81-83 by the user, and sensory feedback84-86 from the limb allows it to be 
perceived as an extension of the user.  
 Several neural interface strategies are being investigated for such bidirectional 
prosthetic limbs and include: surface,86 extraneural33 or intraneural38,84,87-89 electrodes. 
Another strategy is to implant electrodes directly into the transected peripheral nerves. To 
date, intraneural interfaces have successfully used a low number of electrodes (185,90; 691; 
1684; and 2089 electrodes) to establish bidirectional communication with the user’s 
nervous system. Motor intent has been decoded with up to two DOF online, and three 
DOF offline control has been achieved using modified LIFE electrodes.84 Sensory 
stimulation has also been delivered to the nerves of these amputees, and sensory percepts 
are evoked and perceived as arising from their phantom limb.84-86,90,92,93 Importantly and 
prior to our research, the highest number of movements decoded by a peripheral nerve 
interface was three DOF offline and the highest number of different percepts evoked by a 
single nerve implant was five.84  
 Therefore, the next step for advancing bidirectional prosthetic limbs was to 
increase the amount of information that could be transferred to and from the peripheral 
nervous system of people with amputations. We hypothesized that USEAs could be used 
to provide the necessary electrode-to-neuron ratios both to extract highly specific neural 
information related to phantom-limb movements, as well as to stimulate selective sets of 




 Chapter 7 presents the results of the first implantation of microelectrode arrays 
into the human median and ulnar nerves in two people that had undergone below-the-
elbow amputations 2 and 31 years prior to the study, respectively.49 Using action 
potentials recorded on the microelectrode arrays, the volunteers were able to 
independently and proportionally control the fingers of a virtual robotic hand, and up to 
13 DOF were decoded offline. By delivering stimulation to individual USEA electrodes, 
an average of 80 different percepts distributed over the hand were evoked by a single 
device. The results of the work presented in Chapter 7 demonstrate the feasibility of Utah 
Array-based prosthesis for providing proportional dexterous control of prosthetic fingers 





Figure 1.1. Peripheral nerve anatomy. Adult feline (A) and porcine (B) pudendal nerve 
trunks have similar overall anatomical structures that include an outer connective tissue 
layer called the epineurium. The inside of the nerve is made up of connective and adipose 
tissues that surround internal structures called fascicles. Within the fascicles are the 
neuronal axons that make up the nerve and include myelinated and unmyelinated fibers. 
Comparison of the feline (A) and porcine (B) pudendal nerve trunks demonstrates that 
the number and size of the fascicles may be significantly different between species. Such 
inter-species variations in nerve anatomy is essential to consider when deciding on what 
neural interface to use for a given neuromodulation goal. The nerve histology shown here 
was processed in collaboration with: Eduardo Fernandez, University of Alicante, Spain 
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2.1 Abstract  
 Among the currently available neural interface devices, there has been a need for a 
penetrating electrode array with a high electrode count and high electrode density (the 
number of electrodes/mm2) that can be used for electrophysiological studies of 
submillimeter neuroanatomical structures. We have developed such a penetrating 
microelectrode array with both a high electrode density (25 electrodes/mm2) and high 
electrode count (up to 96 electrodes) for small nervous system structures, based on the 
existing Utah Slanted Electrode Array (USEA). Such high electrode density arrays are 
expected to provide greater access to nerve fibers than the conventionally spaced USEA 
especially in small diameter nerves. One concern for such high density microelectrode 
arrays is that they may cause a nerve crush-type injury upon implantation. We evaluated 
this possibility during acute (< 10 h) in vivo experiments with electrode arrays implanted 
into small diameter peripheral nerves of anesthetized rats (sciatic nerve) and cats 
(pudendal nerve). Verification of successful intrafascicular implantation and of viable 
nerve function was made via microstimulation, single-unit recordings and histological 
analysis. Device fabrication quality was assessed by measuring the electrode impedances 
and by quantifying electrode dimensions. The results of these experiments show that such 
high density neural interfaces can be implanted acutely into neural tissue without causing 
a complete (neurotmesis) nerve crush injury, while mediating intrafascicular access to 
fibers in small diameter peripheral nerves. This new penetrating microelectrode array has 
characteristics unmatched by other neural interface devices currently available for 






 A variety of neural interfaces have been developed over the last few decades, 
which have provided researchers and clinicians with an ever-expanding repertoire of 
design choices to meet their research or clinical goals [1-7]. High-count microelectrode 
arrays have proven useful in basic physiology research [8], and for clinical applications 
such as the restoration of function in people with nervous system injury [9] or stroke [10]. 
In order to determine which device to use for a given physiological experiment or clinical 
application, the neural interface must meet the needs of both the desired physiological 
outcome and the constraints applied by the targeted neuroanatomy. Current peripheral 
nerve interfaces have electrodes that vary in their number of contacts, which can be 
separated by hundreds of microns [2, 4, 5, 11-13] or several millimeters [3, 7, 14]. Many 
of the devices have a low number of electrodes (<10) that are implanted interfascicularly 
(e.g., Slowly Penetrating Interfascicular Electrode, SPINE[6]), intrafascicularly (e.g., 
Longitudinal Intrafascicular Electrode, LIFE[15]), or epineurally (e.g., Flat Interface 
Nerve Electrode, FINE[7]). Recent penetrating neural interface applications are requiring 
a greater number of electrodes (>60) to achieve complex neuromodulation [9, 10, 16] or 
neurophysiological [8] goals.  
 One design feature of penetrating neural interfaces that greatly impacts their 
application is electrode density, or the number of electrodes per mm2. Some neural 
interface devices have been fabricated with high electrode densities; however, their 
designs have limited the use of these arrays to specific central nervous system structures, 
such as cortical grey matter (6.25 electrodes/mm2 [12, 13]; > 150 electrodes/mm2 [17, 18]  




include nonpenetrating electrode arrays [20], which will not be discussed herein. 
Currently, there is one high electrode density (6.25 electrodes/mm2), high electrode count 
(96 electrodes) penetrating device available for neuromodulation of large structures (> 
4mm) in the peripheral nervous system [1]. However, penetrating electrode arrays with 
higher densities have been needed to expand neurophysiology research and to investigate 
future clinical applications in submillimeter neuroanatomical structures, such as small 
diameter peripheral nerves or ganglia (e.g., the 1 mm cat pudendal nerve). Moreover, 
higher density microelectrode arrays would improve the access to closely spaced 
individual or subpopulations of neurons and/or nerve fibers in order to investigate the 
mechanisms underlying more complex spatial neural interactions. 
  We have recently developed a penetrating electrode array with a 25 
electrodes/mm2 density (called the High-Density Utah Slanted Electrode Array or HD-
USEA).  The grid of electrodes used in these studies had graded electrode lengths ranging 
from 300 to 800 µm with neighboring electrodes separated by 200 µm. We have shown 
that the production of a defined geometric surface area (GSA) of the electrode tips was 
possible using either an oxygen plasma etching technique [1, 21] or by excimer laser 
ablation [22]. This paper describes the fabrication techniques used for the production of 
these arrays as well as the results of in vitro and in vivo electrode characterizations.  
 One of the main concerns regarding the use of penetrating microelectrode arrays 
that have such high electrode densities is that a nerve crush injury may result from their 
implantation. Physiological and histological evaluations showed no evidence of 
neurotomesis (complete disruption of entire nerve trunk [23]) type of a crush injury after 




sciatic nerve fibers delivered via individual HD-USEA electrodes could selectively evoke 
hind limb muscle twitches. In the same rat preparations, we were also able to record 
afferent neuronal activity via individual electrodes that was evoked by tactile and 
proprioceptive stimuli. Histological analysis of the implantation sites verified that multiple 
HD-USEA electrodes penetrated into the individual fascicles (< 500 µm in diameter) of 
both the rat sciatic and feline pudendal nerves with little or no evidence of nerve fiber 
compression around the electrode tips. Collectively, these results show that HD-USEAs 
are safe and effective for acute neurophysiology studies (we have yet to investigate their 
use in chronic experimentation). The architecture of this device makes it a unique and 
useful addition to the neural interfaces currently available, as it provides unprecedented 
nerve fiber access in submillimeter structures outside the central nervous system. 
 
2.3 Methods 
2.3.1 Device Fabrication 
 High-density electrode arrays were fabricated using techniques that were 
previously described [13, 24-26]. In brief, fabrication of these devices proceeded in the 
following steps (described subsequently): back-side dicing, glassing, back-side 
metallization, front-side dicing, wet etching, dicing of individual arrays from the wafer, tip 
metallization, parylene-C deposition, tip deinsulation, and finally, wirebonding to a 
connector. The devices used in this study were fabricated from 2 mm thick boron-doped 
(p-type) single crystal silicon wafers (76.2 mm diameter) with high boron concentrations 
(resistivity of silicon wafers < 0.0025 Ω-cm). The fabrication procedures were designed to 




back-side dicing—to form a square grid of kerfs—was done using a Disco dicing saw 
(DAD - 3220) with a 50 µm thick resin blade (Semicon - FSN1600508). The resulting 
kerfs had a pitch of 200 µm and a depth of 500 µm. These kerfs were later filled with glass 
to electrically isolate the electrodes[25, 26]. Metalized bond pads for wirebonding to the 
electrodes were formed on the squares between the kerfs using standard photolithographic 
techniques. Bondpads were sputter deposited as individual layers of titanium (Ti), 
platinum (Pt), titanium tungsten (TiW), then Pt, with respective thicknesses of 
100/150/550/350 nm (1150 ± 100 nm total thickness).  
 The front side of the wafer was then diced in one direction to form sequences of 20 
steps. The steps were subsequently diced in two orthogonal directions to produce the high 
aspect-ratio columns that would become electrodes following the etching procedure.  This 
dicing step was also done using the Disco dicing saw, but with a 70 µm Ni bound blade 
with a 3 µm diamond mesh size (NBC-Z 1050). The postdicing dimensions of these 
columns were approximately 110×110 µm with lengths that ranged from 200 to 1500 µm 
in each 20 x 20 array. The wafer was then cut into quarters to facilitate etching. A two-
step wet acid etching process using a homogeneous mixture of 95% HNO3 and 5% HF 
was used to produce the final shape of the electrodes in the array. The first and second 
etching steps were performed on each quarter of the wafer for 3 min (in an agitated 
solution) and 3.45 min (in a nonagitated solution), respectively. The wafer was then diced 
into individual 20×20 arrays and prepared for tip metallization by pushing the electrode 
shanks through a thin square of aluminum foil (to protect the bottom of the electrode 
shanks from becoming metalized). One wafer yields approximately 20 arrays that do not 




using pulsed DC at a 10 mTorr process pressure and at a power of 90 and 100 W for the Ti 
and IrOx films, respectively. These Sputtered Ti and Iridium Oxide Films (SIROF) were 
deposited for 5 and 40 min, respectively, with gas flows of 150 sccm Ar for the Ti, then 
100 sccm each of Ar and O2 for the IrOx deposition. 
 Annealing of the metalized tips and parylene-C coating (6 µm thick) of the shanks 
was carried out as previously described [22]. Arrays were deinsulated with either an 
oxygen plasma etch of aluminum-foil-masked electrode shanks (March Plasmod, March 
Plasma Systems, Inc.; 150 W, 400 mTorr, n = three arrays) [13, 27] or with an excimer 
laser (200 pulses, 248 nm wavelength, 1440 mJ/cm2, n = one array) [22]. The carbon 
debris generated by the laser ablation was removed by a shorter (2 min) oxygen plasma 
etch using the parameters described above. The 20×20 electrode arrays were then custom 
diced and a subset of these electrode arrays were wirebonded using insulated wire (Isonel 
Au:Pd (with 2% Pd), Kanthal) to a Tucker-Davis Technologies (TDT) 96-pin ZIF-Clip 
connector. The final wired electrode arrays used herein consisted of 4 or 5 by 10 
electrodes with targeted lengths from 300 to 800 µm along the long axis of the array with 
2-4 electrodes wired as reference electrodes. This number of electrodes was chosen to best 
fit the dimensions of the peripheral nerves tested in this work, but up to 96 electrodes 
could be wirebonded for use in other nerve structures. An external reference wire (5 mm 
Pt, PTFE insulated) was also bonded to the TDT reference pads. 
 
2.3.2 In vitro and in vivo HD-USEA characterization 
 Impedance testing and Scanning Electron Microscopy (SEM) were used to 




tester as described previously [28]. In brief, the impedance of each electrode was 
measured with a 1 kHz, 10 mV sine wave [28]. Impedance tests were performed with the 
array, the driving electrode, and the sensing electrode placed in a dish of sterile 0.9% 
normal saline. Impedances were tested over the course of 2-3 days. In vivo impedance 
testing was also performed after implantation of the arrays. The Geometric Surface Area 
(GSA) of the electrode tips was calculated for the electrodes that were deinsulated via 
plasma etching and laser ablation. The surface area of the tips was approximated using the 
area of a cone [29], and the values for tip height and radius were determined from SEMs 
that included >15 tips/image. Tips without any insulation removed were excluded from the 
calculations (< 5 tips per image). The diameter of electrodes across 10 devices were 
determined via optical microscopy by measuring diameters at 20%, 50% and 90% of the 
electrode length measured from the electrode tip.  
 
2.3.3 Surgical and experimental procedures for in vivo  
validation of HD-USEA functionality 
 All procedures were approved by the Institutional Animal Care and Use 
Committee of the University of Utah. Sprague-Dawley rats (350-500 g) were used for the 
sciatic nerve preparations, and anesthesia was induced using either Isoflurane (2-5% gas in 
an induction chamber) or a cocktail of Xylazine (7.5 mg/kg IP) and Ketamine (65 mg/kg 
IP). Felines were used for the pudendal nerve preparations, and anesthesia was induced 
using Telazol (9-12 mg/kg IM) or Ketamine (10-20 mg/kg IM). Anesthesia was 
maintained with Isoflurane (1-2% gas) for both rats and felines, with the addition of α-




signs (heart rate, blood oxygen saturation, and rectal temperature) were monitored and 
recorded to assess the depth of anesthesia and condition of the animal. 
 The surgical procedures followed those previously described for exposing the 
sciatic [1, 30] and pudendal nerves [31]. The electrode arrays were inserted using a high-
velocity pneumatic pulse insertion technique [32]. Electrical currents were injected via 
HD-USEA electrodes using a custom-built 1100-channel stimulator [33].  Constant-
voltage, monophasic cathodic stimuli with varying amplitudes (-2 to -3 V) and pulse-
width durations (0.2 to 1024 µs) were used. A custom built program (MATLAB, 
MathWorks) was used to control stimulation via individual electrodes [34, 35]. 
Electromyography (EMG) wires (California Fine Wire Co., Model #M146240) were 
custom made as previously described [31]. Two EMG wires were inserted into each 
targeted muscle in the rat hind limb in order to record bipolar EMG responses to electrical 
stimulation. EMG responses were normalized to maximal muscle twitches evoked by 
either stimulating all electrodes simultaneously or by delivering stimulation through a 
single microelectrode. Electrodes that activated only flexor or extensor muscles at greater 
than 0.5 of the normalized EMG response were considered to be selective. Data collection 
was done using a Cerebus data acquisition system (Blackrock Microsystems, Inc.). In the 
rat preparations, recordings were taken from all wired electrodes while applying various 
mechanical stimuli to the lower limb. These stimuli included brushing areas of the foot 
and rotating the foot around the ankle joint. Signal-to-Noise Ratios (SNR) were 
determined by dividing the amplitude of the average waveform by two times the standard 





 Electrode arrays were acutely implanted (1-10 h) into small diameter peripheral 
nerves. Rat preparations were used for histology and physiology, while the feline 
preparations were used for histology only. After the animals were sacrificed, the exposed 
nerve containing the HD-USEA implant site was soaked in 4% paraformaldehyde for 30 
min, and the arrays were then explanted.  
 Nerves were excised from the animal and stored in 4% paraformaldehyde for 24 h, 
then rinsed and stored in 1% phosphate buffer solution with 0.01% sodium azide. Tissue 
was then stained with 1-2% OsO4 in a 0.1M sodium cacodylate buffer, dehydrated in 
graded concentrations of ethanol, cleared with propylene oxide, and embedded in Embed 
812 (Epon, Electron Microscopy Science). Serial 0.5-0.6 µm semithin sections (Ultracut 
EMUC6, Leica) were stained and examined with an Olympus AX70 Microscope. Scatic 
nerves were stained with toluidine blue and pudendal nerves were stained with thionin and 
acridine orange (Sigma-Aldrich). Sciatic nerve image fields were digitized using a high-
resolution Olympus DP12 camera. Pudendal nerve images were obtained using ImagePro 
Plus 4.0 (MediaCybernetics) and a color CCD camera (Photometrics) attached to a Nikon 
E600 microscope. The whole pudendal nerve images were obtained at 200x final 
magnification, while fascicle images were obtained at 1000x final magnification. For the 
pudendal nerve imaging, serial overlapping images were taken over the entire nerve or 
fascicle. Serial images were reconstructed to form a mosaic image using the photomerge 








2.4.1 Precision of HD-USEA device fabrication 
 Figure 2.1 shows a scanning electrode micrograph of the new HD-USEA device 
located next to a conventional USEA. The desired GSA of the exposed SIROF electrode 
tips was achieved by oxygen plasma etching and laser ablation techniques. The average 
GSA of electrode tips deinsulated with the oxygen plasma etching (Fig. 2.1b) and laser 
ablation (Fig. 2.1c) methods were 4543 ± 526 µm2 (mean ± sd; n = 17 tips from one 
device) and 473 ± 365 µm2  (n = 22 tips from one device), respectively. The in vitro mean 
tip impedances of the electrodes deinsulated by laser (n = one array) and plasma etching (n 
= three arrays) were 440 ± 340 and 179 ± 216 (mean ± sd) kΩ, respectively. The device 
deinsulated using the excimer laser technique had a large drop in mean tip impedance to 
232 ± 150 kΩ when measured in vivo. 
 The quality of the manufacturing techniques used was assessed by comparing the 
electrode dimensions [13] from ten different nonwirebonded HD-USEAs produced from 
the same silicon wafer (Fig. 2.2). The diameter of the electrodes along the length of each 
shaft was measured at three different points for each electrode and across 10 devices (Fig. 
2.2). The average lengths of the longest and shortest electrodes measured from these 10 
devices ranged from 884 ± 39 to 310 ± 60 µm, respectively. The quality and 








2.4.2 Selective recordings from afferent nerve fibers in rat sciatic nerve  
 In order to learn if such high electrode density arrays could be implanted into a 
nerve and subsequently used for neurophysiological research, we recorded the neuronal 
response to different tactile or proprioceptive stimuli in three rats with sciatic nerves 
acutely implanted with HD-USEAs. In each experiment, there were > 25 electrodes out of 
the 48 wired electrodes that were able to record either single unit or multiunit waveforms. 
In each preparation, there were neural units that fired spontaneously, and different neural 
units that could be selectively driven by tactile or proprioceptive stimuli. Figure 2.3 shows 
an example of two neural units that were recorded via two different HD-USEA 
microelectrodes on one implanted device and that were driven specifically by dorsiflexion 
(Fig. 2.3a, electrode 21) or by plantarflexion (Fig. 2.3b, electrode 14) of the ankle, 
respectively. The mean SNR for all three preparations across all recording channels was > 
4. 
 
2.4.3 Selective motor fiber activation achieved by electrical 
stimulation of rat sciatic nerve 
 Delivering voltage-controlled stimulation via individual electrodes on the 
implanted HD-USEA evoked selective muscle twitches in the ankle flexor and extensor 
muscles. In all three rat preparations, there were 15 ± 6 and 17 ± 8 (mean ± sd) electrodes 
that selectively evoked ankle flexion and extension, respectively. Figure 2.4 shows 
selective muscle activation using recruitment curves generated in the ankle flexor 
muscle—Tibialis Anterior (TA)—and the ankle extensor muscles—Lateral Gastrocnemius 




pulse-widths) delivered via two different HD-USEA microelectrodes on one implanted 
device. This selective activation of flexor versus extensor muscles was achieved by 
delivering stimulation via two catercornered electrodes with an approximate tip-to-tip 
separation of 208 µm. 
 
2.4.4 Histological evaluation of HD-USEA implants 
 A fixed sample of the rat sciatic nerve that was implanted with an HD-USEA is 
shown in Figure 2.5a-b. The suture in Fig 2.5a marks the distal portion of the nerve. The 
nerve was sectioned through the middle of the implant site.  A microscopic cross section 
of the 1.8 × 0.8 mm nerve shows penetration of the shorter HD-USEA microelectrodes (< 
400 µm in length) with preservation of the intrafascicular anatomy (epineurial, 
endoneurial, and perineurial) between electrode penetration tracks into the nerve (Fig. 
2.5c). Figures 2.5d-f show the microelectrode tracks of several HD-USEA electrodes. 
Sections taken through the center of an electrode track show no compression of the axons 
around the electrode tips (Fig. 2.5d-e). A section taken adjacent to the center of the 
electrode track shows no compression of axons around the electrode shank (Fig. 2.5f).   
 Figure 2.6a shows a cross-section of a feline pudendal nerve that was implanted 
with an HD-USEA. This section was taken from the portion of the nerve that was 
implanted with longer electrodes (> 400 µm in length). As with the sciatic nerve implant, 
there is preservation of the intrafascicular anatomy in the region between electrode tracks. 
One electrode was broken prior to implantation and does not penetrate into the fascicular 






2.5.1 Array fabrication 
 We have successfully fabricated 25 electrodes/mm2 penetrating microelectrode 
arrays with varying length electrodes designed to access nerve fibers that are found at 
different depths in small peripheral nerves. The electrode proportions, impedances, 
number of functionally distinct electrodes, and SNR of HD-USEAs are comparable to the 
conventionally spaced Utah electrode arrays. Implantation of the regularly spaced Utah 
arrays into submillimeter structures would result in neural interfaces that have a 
functionally low-count number of electrodes that could stimulate and record from nerve 
fibers. For example, implantation of a 5×10 conventional array (0.4 mm electrode spacing 
with lengths from 0.5 to 1.5 mm) into a 1 mm nerve would result in partial coverage with 
at most only two electrode rows penetrating into the nerve (20 electrodes). Additionally, 
the shortest electrode row (0.5 mm in length) would be too long to access fibers within the 
upper half of the nerve and the longest electrodes would pass through the nerve. Thus, as 
few as 6 electrodes of the conventionally spaced arrays might be functionally implanted 
into a 1 mm nerve. In contrast, implantation of a 5×10 HD-USEA would result in more 
complete coverage (from 0.2 to 1.0 mm) of the nerve and with a high-count number of 
electrodes (48 electrodes). For physiological testing of these arrays, we chose to wirebond 
two different grids: a 5×10 grid of electrodes to custom-fit the size of the rat sciatic nerve 
(1.2 mm in diameter [37]) and a 4×10 grid to custom-fit the feline pudendal nerve (1 mm 
in diameter [38]).  
 For the fabrication of these arrays, low resistivity silicon wafers were used to 




metalized tips and bond pads) and produce reliable contacts at lower annealing 
temperatures. The initial grid of electrodes was made bigger than the required grid to 
facilitate uniform acid etching of these columns in the middle regions of the 20×20 grid. 
The wet etching times were optimized to produce narrow shanks and rounded electrode 
tips. Wafers were cut into quarters for the wet etching steps in order to reduce the number 
of cuts made down from approximately 1000 to 250, which provides more uniform kerfs 
widths and depths. Analysis of the widths of the electrode shanks at different locations 
along their lengths across 10 electrodes on 10 different devices demonstrates the 
uniformity that was achieved during fabrication of these devices.  
 Electrode impedances were measured in vitro and in vivo to characterize the 
quality of the arrays. One concern in development of this device was whether we would 
have difficulty fabricating arrays with deinsulated tips and electrode impedances in the 
range needed for stimulation and recording (with SNRs > 4), while producing an overall 
electrode geometry that would meet our anatomical goals (penetrating into fascicles that 
are 50-200 µm diameter [37, 38]). Deinsulation of the HD-USEA microelectrode tips was 
carried out using two different methods and we assessed the ability of each to produce low 
and uniform GSAs. Deinsulation using the conventional plasma etching technique requires 
a foil mask to protect the rest of the array from becoming deinsulated. This process can be 
carried out on individual electrode arrays [13] or—for microelectrode arrays that have 
uniform electrode lengths—on the wafer scale [24]. Deinsulating HD-USEAs using the 
foil mask and oxygen plasma etching resulted in uniform GSAs (small distribution with 
standard deviation of 526 µm2), but relatively large areas (4543 µm2). Excimer laser 




electrode tips and thereby, increase the selectivity of neuronal recordings or evoked motor 
responses. In this work, we used a novel hybrid laser technique that included an additional 
plasma etching step. The mean GSAs obtained with the laser ablation deinsulation (473 ± 
365 µm2) were significantly lower (alpha = 0.05; p = 1.06 × 10-26; 2-tailed student t-test); 
however, this technique produced much less uniform tip exposures (larger distribution 
around the mean) likely due to the manual nature of the process. Deinsulation via laser 
ablation was done manually for each individual electrode; however, future work is aimed 
at developing an automated process.  
 The excimer laser ablation technique used in this work required the use of oxygen 
plasma etching to remove the carbon debris generated by the laser ablation. The carbon 
debris layer is thinner than the parylene-C layer [22], and thus, we hypothesized that the 
etching of the carbon debris could be carried out in 2 min without the need of a foil mask. 
The laser ablation technique (laser spot-size) was optimized for lower-density (6.25 
electrodes/mm2) microelectrode arrays, and more work is needed to optimize the 
parameters for performing laser ablation on higher-density neural interfaces. The mean 
GSAs for the laser deinsulated electrodes were well within the safe limits established for 
penetrating microelectrodes (GSA ≤ 2000 µm2) [29]; however, more work is needed to 
decrease the GSA of electrodes deinsulated using the foil mask technique. 
 
2.5.2 In vivo characterization of HD-USEAs 
 The conventionally spaced, lower density USEA can be implanted both acutely (< 
1 days) [1] and chronically (> 6 months) [40, 41] with insult to the epineurium or 




using the newly fabricated high-density arrays of electrodes is that the high-velocity 
pneumatic pulse insertion [32] of the device could cause a partial or complete nerve crush 
injury. We were able to record spontaneous and stimulus driven neuronal units on > 25 
electrodes with an average SNR > 4 in all animal preparations, indicating the nerve 
remained viable for at least the duration of these experiments (< 10 h). Importantly, 
histological analyses of the HD-USEA implant sites showed the nerve axons and fascicles 
appear to manifest no global damage. Tissue insult was limited to that which was 
produced by the penetrating electrode tips, similar to implantation of arrays that were four 
times less dense. If these arrays produced an acute nerve crush injury, rather than a limited 
penetrating injury, we would have expected to see evidence of traumatic injury to the 
anatomical structure of the nerve, which may have included the loss of myelinated axons 
surrounding the electrodes (neurapraxia); the loss of continuity of axons around the 
electrodes with preserved connective tissue between the electrode tracks (axonotmesis); or 
the complete transection of the nerve (neurotmesis) [23, 42]. The cross-sections of acutely 
implanted rat sciatic nerves (n = 2) and a feline pudendal nerve (n =1) showed no signs of 
these types of nerve injuries outside the tracks of the penetrating electrodes. Moreover, 
there was little compression of the nerve fibers around the tips and shanks of the HD-
USEA electrodes, as had been previously noted for the conventionally spaced USEAs [1]. 
Future studies will be needed to assess any chronic damage to the nerve and whether any 
such damage is followed by nerve regeneration, as in other nerve crush injury studies[42].  
 We also investigated the degree of selective motor fibers access in the rat sciatic 
nerve by delivering voltage-controlled stimulation via individual HD-USEA electrodes. In 




extensor muscles, and importantly, such selectivity could be achieved in electrodes with a 
tip-to-tip separation as low as 208 µm between electrodes. One advantage of the use of 
penetrating microelectrodes is that less current is needed to stimulate nerve fibers once the 
tips are inside the fascicle. Selective and complete recruitment of rat hind limb muscles 
was possible by delivering stimulation amplitudes of only -2 V with 50% recruitment of 
muscle twitches seen in some trials for pulse-widths < 100 µs. Lower voltages were not 
investigated, as this is the lowest limit of the 1100 channel stimulator used in these studies 
[33]. 
 The devices used in these experiments were designed, in part, to investigate the 
hypothesis that large numbers of electrodes with 200 µm spacing could penetrate 
intrafascicularly into peripheral nerves, and that such delicate electrodes would be not 
damaged (broken) by the epineurium and perineurium or vice versa. Further, experiments 
were designed to test the hypothesis that 200 µm spacing provided selective access both 
for stimulation and recording from small diameter neuroanatomical structures. In the rat 
preparation, selective activation of ankle flexor and extensor muscles was achieved by 
delivering stimulation via two neighboring electrodes in adjacent rows (≈ tip-to-tip 
separation of 208 µm). Another concern was that the shortest electrodes would not 
penetrate into the fascicles. Figure 2.5 shows that, in fact, the shortest electrodes were able 
to do so. In addition, we were able to record either single or multiunit waveforms from the 
300-µm-long-electrodes in one animal. We were also able to selectively stimulate flexor 
or extensor ankle muscles by delivering low amplitude (-2V, steps of increasing pulse-
width of 50 µs) stimulation to the 300 µm length electrodes. Together, these results 




nervous system structures where access to nerve fibers and/or cell bodies at depths of 200 
µm is needed, such as retinal ganglion cells [43], mitral cells of the rat olfactory bulb [44], 
or dorsal root ganglion neurons [45].  
 
2.6 Conclusion 
 We have developed a novel, high electrode density (25 electrodes/mm2), high 
electrode count (48-96 electrodes) penetrating neural interface, designed for use in 
stimulation and recording in submillimeter neuroanatomical structures, such as small 
diameter nerves (< 2mm) like the rat sciatic [37], feline pudendal [38], or feline/human 
cochlear nerves [46]. The results reported herein illustrate that such a delicate architecture 
can be fabricated consistently, and importantly, that implantation of such high-density 
electrode arrays does not cause nerve damage, at least on the acute time frame (<10 h) 
studied here. Furthermore, the HD-USEA provides selective access to the fibers of small 
diameter peripheral nerves. The high electrode density array described in this study adds a 
novel and useful architecture to currently available neural interfaces. Future studies will be 
needed to assess long-term efficacy and biocompatibility of these arrays for their potential 
use in clinical applications.  
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Figure 2.1 The High-Density Utah Slanted Electrode Array (HD-USEA). (a) A 
scanning electron microscopy (SEM) image of the conventionally spaced USEA (right) 
and the new HD-USEA (left) located atop a U. S. penny (scale bar = 3 mm). The inset 
SEM images were taken of HD-USEA tips that have the biocompatible parylene-C 
insulation removed using (b) an oxygen plasma etching technique (geometric surface 
area (GSA) = 4367 µm2; scale bar = 50 µm) and (c) a novel hybrid excimer laser and 








Figure 2.2 Structural variability of 10 HD-USEA devices. The diameters of 4 electrodes 
from 10 different HD-USEA devices was measured at 20%, 50%, and 90% the distance 
from the tip down the shaft of the electrode (from Rows 1, 4, 7 & 10; short to long 
electrodes). Diameters and electrode lengths are shown on the left and right ordinates, 










Figure 2.3 Neural units recorded from two HD-USEA electrodes on a single implanted 
array.  (a) 968 waveforms  show the summation of the responses from two units to 
dorsiflexion of the foot around the ankle joint recorded by electrode 21 (SNR = 5.9). (b) 
1416 waveforms show a unit recorded on electrode 14 that was driven by plantarflexion 
(SNR = 10.8). (c) The neural events recorded by electrodes 21 (top) and 14 (bottom) 
during both dorsiflexion and plantarflexion (shown below raster plot). Note that 
electrode 21 recorded neural responses only during dorsiflexion, while electrode 14 
recorded responses only during plantarflexion. 
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Figure 2.4 Selective ankle flexor and extensor muscle contractions. Normalized EMG 
peak amplitude was recorded in response to increasing stimulation amplitude (via 
increasing pulsewidth) delivered via single electrodes on HD-USEA. (a) Stimulation 
delivered via HD-USEA electrode 19 evoked selective contractions in the ankle flexor 
muscle, tibialis anterior (TA). (b) Similarly, stimulation delivered via electrode 23 
evoked selective contractions in the ankle extensor muscles: lateral gastrocnemius (LG), 



























































Figure 2.5 Evaluation of implant site. (a-b) HD-USEA electrode tracks are visible on 
macroscopic inspection of the nerve (a, scale bar = 2 mm; b, scale bar = 0.5 mm). (c) 
Microscopic cross section of the nerve shows penetration of a row of shorter length 
electrodes into the top portion of the rat sciatic nerve fascicles (scale bar = 200 µm).  (d-
f) show a close up of the tips of the short electrodes penetrating into a fascicle. (f) shows 
a section taken adjacent to an electrode shank. Notice there is no axonal compression 
around the tips (d-e) of the electrodes or around the shanks (f) of the electrodes  (d-f, 














Figure 2.6 Cross-section of cat pudendal nerve implanted with HD-USEA for <10 h. (a) 
Low-resolution image showing penetration of four electrodes into the nerve, three of 
which penetrated the fascicular space. The far right track (arrowhead) is from an 
electrode that was broken prior to implantation. The three tracks that penetrate into the 
endoneurium extend approximately 450-500 µm from the edge of the epineurium to the 
electrode tips (scale bars = 200 µm). (b) Close up view of an electrode track from (a) 
(denoted by arrow) showing penetration of the electrode through the epineurium and 
perineurium into the endoneurial space (scale bars = 100 µm). While substantial loss of 
fibers in the electrode track is observed, fibers immediately surrounding the track show 
minimal signs of acute damage. Additionally, no evidence of complete crush injury 
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3.1 Abstract  
 Before peripheral nerve electrodes can be used for the restoration of sensory and 
motor functions in patients with neurological disorders, the behavioral and histological 
consequences of these devices must be investigated. These indices of biocompatibility 
can be defined in terms of desired functional outcomes; for example, a device may be 
considered for use as a therapeutic intervention if the implanted subject retains functional 
neurons postimplantation even in the presence of a foreign body response. The 
consequences of an indwelling device may remain localized to cellular responses at the 
device-tissue interface, such as fibrotic encapsulation of the device, or they may affect 
the animal more globally, such as impacting behavioral or sensorimotor functions. Here 
we investigate the overall consequences of high-electrode count intrafascicular peripheral 
nerve arrays, High Density Utah Slanted Electrode Arrays (HD-USEAs; 25 
electrodes/mm2), that were implanted in rat sciatic nerve for one- and two-month periods. 
We monitored wheel running, noxious sensory paw withdrawal reflexes, footprints, nerve 
morphology, and macrophage presence at the tissue-device interface. In addition, we used 
a novel approach to contain the arrays in actively behaving animals that consisted of an 
organic nerve wrap. A total of 500 electrodes were implanted across all 10 animals. The 
results demonstrated that chronic implantation (≤8 weeks) of HD-USEAs into peripheral 
nerves can evoke behavioral deficits that recover over time. Morphology of the nerve 
distal to the implantation site showed variable signs of nerve fiber degeneration and 
regeneration. Cytology adjacent to the device-tissue interface also showed a variable 
response, with some electrodes having many macrophages surrounding the electrodes, 





along the length of the electrodes. Axons remained within the proximity of the electrode 
tips at the distances required for theoretically effective stimulation and recording 
(≤100µm). We conclude from these studies that HD-USEAs do not cause overall global 
effects on the animals, at least up to the two-month period investigated here. These 
results demonstrate for the first time that the consequences of high-electrode count 
intrafascicular arrays compare with other peripheral nerve electrodes currently available 
for clinical or investigational neuromodulation. 
 
3.2 Introduction 
 The use of peripheral nerve electrodes offers new therapeutic approaches for the 
restoration of sensory and motor function following nerve injury or disease [1]. 
Assessment of the behavioral and histological consequences of implantation of such 
neural interfaces is an important milestone in the development of this technology as it 
progresses from acute animal experimentation to clinical applications. For a device to be 
considered for use as a potential therapeutic intervention, it must meet a predetermined 
set of criteria after implantation into living tissue.  
 Nerve electrode arrays have recently been developed that contain a large number 
of electrodes, allowing for more information to be transferred to and received from the 
nervous system for neuromodulation studies and applications [2]. To date, larger 
peripheral nerves (>3 mm diameter) have been implanted with devices that have between 
16 [3] and 96 [4] electrodes. For smaller peripheral nerves (≤1 mm), three different 
multielectrode neural interfaces have been manufactured and chronically implanted (≤3 





27 electrodes [6]), Transverse Intrafascicular Multichannel Electrodes (TIMEs; 5 
electrodes [7]), and thin-film Longitudinal Intrafascicular Electrodes (tfLIFEs; 8 
electrodes [8]). The behavioral and cellular consequences of chronic implantation of 
these devices have been investigated [6-8]. However, no studies have been carried out 
that investigate the consequences of chronically implanted peripheral nerve high-
electrode count penetrating microelectrode arrays. 
 A new high electrode count neural interface, the High Density Utah Slanted 
Electrode Array (HD-USEA; 25 electrodes/mm2), has recently been fabricated and tested 
in acute experiments (<12 hr) for its use in small peripheral nerves (<2 mm) [2,9]. The 
motivation for developing such a high electrode count array was to increase the selective 
intrafascicular access to nerve fibers in millimeter and submillimeter nervous system 
structures. In order to expand application of HD-USEAs to chronic preparations, we 
assessed the behavioral outcomes and cytology at the tissue-device interface in rats that 
had nonwired HD-USEAs implanted into their sciatic nerves. This study was motivated 
by the concern that implantation of such a high spatial density of penetrating 
microelectrodes could severely damage or crush the nerve, negating their use in short-
term chronic experimentation. The behavioral and histological criteria we used in this 
study to assess the use of such high-electrode density arrays in chronic experimentation 
included: 1) that the devices must have remained implanted in actively behaving animals, 
2) that the devices did not permanently interfere with overall animal behavior, and 3) that 
axons remained within 100 µm of the electrode tips. Nonwired devices were used in this 
study in order to assess the effects of the implanted electrodes alone, without 





 The rat model was chosen for these studies as it has frequently been used in 
chronic peripheral nerve injury models [10-12], and for standard histological [13-16] and 
behavioral [10,15,17-20] quantification studies. Because functional recovery in the rat 
has been observed within three to four weeks after nerve crush injury and within six to 
eight weeks after nerve transection repair, we implanted two cohorts of rats for durations 
of four and eight weeks to focus on assessing damage and recovery during these early 
phases of nerve injury [10,20]. 
 We found that HD-USEAs caused mild behavioral changes that recovered within 
days to weeks postimplantation and that there was a mild chronic inflammatory response 
characterized by a nonuniform distribution of macrophages surrounding the tissue-device 
interface. The novel containment system (an organic nerve wrap) that was used in these 
studies successfully protected the arrays, and nine of the arrays remained completely 
implanted in the nerve at the end of the two study periods. Morphology of the nerves was 
assessed both proximally and distally to the implant site, and signs of degeneration and 
regeneration were seen. Quantification of these sections showed no significant difference 
in the myelin thickness, while there was a significant difference the area and diameter of 
the nerve fibers or axons. Morphology was also assessed at the device tissue interface, 
and axons remained in close proximity (≤ 100µm) to the tips of the intrafascicular 
electrodes in both study cohorts. Future studies are now warranted to assess the 
capabilities of HD-USEAs that are implanted for > eight weeks and for devices that are 







3.3 Materials and methods 
3.3.1 Animal groups and behavioral protocols 
 All studies were approved by the University of Utah Institutional Animal Care 
and Use Committee. Ten Wistar-Kyoto rats (Charles-River Laboratories International, 
Inc., USA) were randomly assigned to either four- or eight-week implant cohorts (n = 5 
for each cohort). Wistar-Kyoto rats were chosen as they have been shown to have 
increased voluntary wheel running over other rat strains [21]. Rats (age ≈ 40 days 
postnatal at the start of the study) were placed in separate cages each night and provided 
with food, water, and an exercise wheel ad libitum. Each wheel was equipped with a 
cyclometer that measured running distance (km), maximum speed (km/hr), average speed 
(km/hr), and total elapsed running time. Rats were returned to shared housing (3-4 
rats/cage) with the same litter mates each morning. All rats were allowed to run 
voluntarily for nine weeks prior to implantation of HD-USEAs in order to establish 
preimplant peak and average running distances [22]. The distances ran nightly were 
averaged for a weekly distance. For statistical analysis, average weekly distances were 
compared using t-test statistics for nine weeks of preimplant data and for either four or 
eight weeks of postimplant data. Data analysis was carried out using MATLAB (The 
MathWorks, Inc., MA, USA) and Microsoft Excel (Microsoft, WA, USA). 
 
3.3.2 Surgical procedures 
 Unwired HD-USEAs were cut to form a 5x10 grid of electrodes (lengths ranged 
from 200 to 800 µm with 200 µm spacing) and then coated in paralyene-C [2]. Prior to 





left sciatic nerve using previously described methodology [2,9]. In brief, anesthesia was 
induced and maintained with Isoflurane (5.0% and 0.2% gas, respectively) and vital signs 
were monitored. The sciatic nerves were exposed and HD-USEAs were pneumatically 
implanted [23]. The implantation site was then wrapped with a commercially available 
nerve wrap (AxoGen Inc., Alachua, FL). Nerve wraps were trimmed to fit around the 
nerves and arrays, with approximately 5 mm of wrap extending both proximally and 
distally from the HD-USEA. The wraps were closed with sutures (8-0 Nylon, Ethicon) to 
minimize gaps between the wrap and the nerve. The ends of the wraps were then sutured 
to the epineurium in order to prevent slippage of the wrap along the length of the nerve. 
Rats were given minocycline (100 mg/L) dissolved in water ad libitum for two days 
before and for five days after implantation of the HD-USEAs [24]. Dexamethasone (200 
µg/kg) was administered by a subcutaneous injection on the day of surgery [25]. 
 
3.3.3 Assessment of sensorimotor reflexes 
 Assessment was evaluated using the paw Withdrawal Reflex Latency (WRL) test, 
defined as the time it took for the animals to withdraw their paw from a hot plate set to ≈ 
50°C (with a cut-off time of 12 sec) [10,19]. Tests were performed with rest intervals > 1 
min to prevent sensitization and average weekly WRLs were calculated from > 3 tests on 
each hindlimb [10]. Our methodology differed from previous methods only in that we 
tested the WRL for both hindlimbs in order to control for any small differences in hot 
plate temperature that may have occurred between testing times. The ratio of WRLs for 
implanted and control hindlimbs were calculated and expressed as percentages 





week before surgery, but not weekly during the control period when peak running 
distances were obtained. Footprint analysis was carried out using the ratio of the toe-
spread length from the first to the fifth digit in the implanted versus the control limb, 
which has been shown to be an efficient and sensitive test for footprint deficits [18]. 
Briefly, the rats were placed in a box with a clear bottom and photographs were taken of 
the standing rats. In order to decrease the chance of any postural tone which could affect 
footprint stance, the testing room was free of startling noises and the animals were 
allowed to acclimate in the box before photos were taken [18].  
 
3.3.4 Histological procedures 
 Animals were sacrificed by injection of pentobarbital and perfused with 4% 
paraformaldehyde. The nerves around the implant site and nerve wrap were excised, the 
nerve wrap was dissected from the nerve, and the HD-USEAs were explanted under a 
dissecting microscope. The nerves were then transferred to 0.01 M phosphate buffer 
solution (PBS) with 0.1% sodium azide. Each rat nerve was assigned to a morphological 
and/or immunohistochemistry processing group, which included light microscopy cross- 
and longitudinal sections through the implanted array site; light microscopy cross-
sections proximal and distal to the implanted array site; and cross- and longitudinal 
sections of the array site for immunohistochemical assessment of macrophages. The light 
microscopy designated samples were incubated for 1 h in 2% OsO4 and further processed 
for embedding in Epon 812 resin. Semithin sections (0.5 µm thick) were stained with 
toluidine blue and examined by light microscopy. Images of the whole sciatic nerve were 





resolution digital camera (Olympus DP-11).  
 Images were analyzed using the Image J software (National Institutes of Health, 
Bethesda, MD) and a custom-modified version of software designed to study axonal 
morphometry (Cavalieri 3.0 macros by G. MacDonald, Virginia Merrill Bloedel Hearing 
Research Center, University of Washington, Seattle, WA). Morphometrical evaluation 
was performed in sets of images chosen by systematic random sampling of squares 
representing at least 20-30% of the nerve cross-sectional area. Because it was difficult to 
automatically select the boundary between the nerve fibers and the surrounding 
background for small axons and thinly-myelinated fibers using standard image analysis 
techniques, each digitized image was analyzed using a semiautomatic method. The 
axonal contour and the external contour of the myelin sheath (fiber contour) were 
manually traced on enlarged images. A set of custom macros allowed the calculation of 
the lengths of the major and minor axes of the best fitting ellipse and the cross-sectional 
area. Fiber diameters and axonal diameters were deduced from the fiber and axonal 
perimeters assuming a cylindrical shape of axons. These data were used to derive the 
form factor, roundness of fiber, and myelin sheath thickness. Fibers were defined as the 
outer diameter of the neuron including the myelin. Axons were defined as the inner 
diameter of a neuron, not including the myelin. These diameters were calculated from the 
area of each assuming a circular geometry. Because many of the fibers had elliptical 
geometry, the form factor, roundness and mean diameter (major axis diameter + minor 
axis diameter/2) were calculated to quantify differences that could be due to changes in 
elongation. The ratio of the axon diameter to the fiber diameter (g-ratio) was calculated 





fiber, assuming circular geometry, and 2) using the mean diameter of the major and 
minor axes. 
 Samples designated for immunohistochemical processing were washed in PBS, 
cryoprotected in 30% sucrose at 4ºC and mounted in optimal cutting temperature 
compound (OCT). Longitudinal and traversal sections were cut at 16 µm with a minus 
20ºC cryostat (Micron HM505E) and mounted directly onto Superfrost Plus (Thermo 
Fisher Scientific) slides. Slides were removed from the cryostat, air-dried, blocked for 30 
min (0.1M PBS, 10% normal donkey serum, and 0.5% Triton X-100) and incubated 
overnight at room temperature in the following primary antibodies (in 0.1 M PBS, pH 
7.4, plus 0.5% Triton X-100): mouse antirat monocytes/macrophages clone ectodermal 
dysplasia-1 (ED1; Millipore 1:100); and rabbit antirat neurofilament-200 (NF-200; Sigma 
1:300). After three 10 min washes in PBS, the corresponding secondary antibodies to IgG 
(Invitrogen) conjugated to Alexa Fluor 488 (green), 555 (red), 633 (far red) or 647 (far 
red) were applied at a 1:100 dilution for 1 h at room temperature. Finally slides were 
washed three times (10 min each) in PBS before being cover-slipped in fluorescent 
mounting medium. All fluorescent images were captured with a confocal laser-scanning 
microscope (TCS SPE, Leica Microsystems, Wetzlar, Germany). Mosaic images were 
created using Photoshop (Adobe Photoshop CS5, Adobe Systems Inc., USA). 
 
3.4 Results 
3.4.1 Behavioral assessment of rats implanted with HD-USEAs 
 Rat toe-spread lengths were measured for each hindlimb between the first and 





shown in Figure 1a (rat #7, eight-week cohort). This rat showed a decreased toe-spread 
postimplantation (middle photograph; star indicates implanted side).  By the third week 
after surgery there was a full recovery of the 1-5 toe-spread length. For the four- (Fig 
3.1b) and eight-week (Fig 3.1c) cohorts, a total of four rats manifested no decreases in 
their 1-5 toe-spread lengths for the duration of their implants. The remaining six rats had 
decreased initial toe-spread lengths in their implanted hindlimbs, but these returned to 
normal lengths compared to the contralateral foot (mean time for full recovery = three 
weeks; range = one to four weeks).  
 Paw WRLs were measured weekly for each rat beginning the week prior to 
surgery and weekly thereafter. The presurgical value for the WRL manifests no 
differences in the latency times between left and right hindlimbs as they reflexively 
withdrew from the hot plate.  Figures 3.1d-e show the mean value (computed from three 
measurements) of the ratio of WRLs in the implanted versus the control leg for the four 
and eight-week cohorts. A total of three rats had WRL ratios that increased above 
baseline within the first week after HD-USEA implantation, with latencies returning to 
normal by the second week. Two rats had increases in WRL times in their implanted leg 
3-4 weeks after surgery, with times returning to baseline within 1-2 weeks. The mean 
recovery time for the five rats with increased WRL in their implanted leg was 1.5 weeks.  
 Average distances in kilometers ran per night over the course of one week were 
plotted for rats that had no significant (Fig 3.2a; two-tailed t-test; p > 0.05 for each rat) 
and significant (Fig 3.2b; two-tailed t-test; p < 0.05 for each rat) differences in running 
distances before and after HD-USEA implantation. Note that here the rats have been 





not by implanted time periods. For the rats that had significant changes in running 
distances after surgery, two of these rats had decreased weekly running distances (rat #8, 
8-wk group, preimplant average = 7.44 km/night, postimplant average = 4.45 km/night, p 
= 0.0294; rat #4, 4-wk group, preimplant average = 7.64 km/night, postimplant average = 
2.87 km/night, p << 0.0005), while one rat had increased average nightly distances ran 
(rat #9, preimplant average = 4.94 km/night, postimplant average = 8.73 km/night, p = 
0.0005). There were no significant differences (p = 0.70; two-tailed t-test;) in the mean 
and standard deviations of the weekly distances ran across all rats when comparing 
preimplantation (6.24 ± 2.3 km/night; mean ± std) and postimplantation (6.07 ± 2.45 
km/night) groups (Fig 3.2c).  
 
3.4.2 Tissue assessment of rats implanted with HD-USEAs 
 Nerves were dissected in postperfused animals and the organic nerve wraps were 
subjectively assessed for the quality of the nerve tissue and the extent of fibrotic 
encapsulation surrounding the implant site. A representative example of a control nerve 
and the contralateral implanted nerve is shown in Figure 3.3a. In all of the rats, the 
organic nerve wraps remained in place and each of the nonwired arrays were still 
contained within the organic material at the end of the study period. Furthermore, no 
major adhesions between the wrap and the epineurium were formed. Each HD-USEA 
implantation was dissected under a microscope and assessed for the extent by which the 
arrays remained implanted in the sciatic nerve. Figures 3.3b-c show two nerves with the 
HD-USEA exposed for the qualitative assessment of the extent of end-point implantation. 





immediately adjacent to the epineurium (Fig 3.3b). Implants were characterized as 
‘partial’ if the substrate had backed away from the nerve with any portion of the electrode 
shanks visible outside the epineurium (Fig 3.3c). Nine rats were found to have devices 
that were completely implanted post sacrifice. After removal of the HD-USEAs, a waffle-
like pattern produced by the electrodes was visible (third photograph Fig 3.3b-c). One rat 
had an HD-USEA that had partially migrated out of the nerve (Fig 3.3c; rat 4; four-week 
cohort). Note the waffle-like pattern from this device appeared to have an enhanced 
fibrotic response with suspected hemosiderin-laden macrophages or erythrocytes causing 
pigmentation on the epineurium. None of the implants had electrode arrays that had 
completely migrated out of the nerve. Scanning electrode microscopy (SEM) images 
were taken of several HD-USEAs after explantation and organic material adhering to the 
surface of the device was evident (Fig 3.3d).  
 Representative proximal and distal nerve cross-sections are shown in Figure 3.4 
for a rat in each of the implant cohorts. For each of the samples processed for proximal 
and distal morphology (n= seven rats; four-week cohort rat#s 1-4; eight-week cohort 
rat#s 6, 7 & 10), the distal nerve showed more signs of nerve degeneration and 
regeneration, consistent with local damage to the axons at the implant site. Such axonal 
degeneration was characterized by encroachment of axoplasm, redundant myelin 
(including collapse of the myelin into the axoplasm; thick arrowheads Fig 3.4d & h), and 
presumptive presence of phagocytic immune cells (thin arrowheads Fig 3.4d &h). These 
injuries left the endoneurium and perineurial tubes intact, which presumably facilitated 
the regeneration of damaged axons. In the nerve distal to the implant, regenerating axons 





the organic nerve wrap material used to contain the arrays can be seen in the light 
microscopy images for each rat (double headed arrow Figs 3.4a & g).  
 Nerve morphology was assessed in nerve sections taken proximal and distal to the 
HD-USEA implant site for two rats representative of each group (number of fibers: four-
week proximal = 534, distal = 483; eight-week proximal = 520, distal = 499). There was 
no significant difference (two-tailed homoscedastic t-test) found in the thickness of 
myelin (prat 1 = 0.64; prat 10 = 0.17) or the g-ratio (Fig 3.5.a & c; prat 1 = 0.24; prat 10 = 0.25) 
between proximal and distal sections for both rats. We calculated g-ratios using two 
different methods to obtain the fiber and axon diameters. The first method used diameter 
measurements derived from the fiber and axon areas, assuming a circular geometry, and 
there was no significant difference in the g-ratios for both rats (Fig 3.5.a & c; prat 1 = 0.24; 
prat 10 = 0.25). The second method used diameter measurements derived by measuring the 
mean diameter from both the major and minor axes for a given fiber and axon, and there 
was a significant different in the g-ratio of the distal tissue for the eight-week implant (p 
= 0.02; proximal = 0.62 ± 0.07; distal = 0.63 ± 0.08), but there was no significant 
different for the four-week implant (p = 0.63; proximal = 0.61 ± 0.07; distal = 0.60 ± 
0.10). 
  In the tissue implanted for four weeks, no significant difference between the 
proximal and distal morphology was found for axon diameter (Fig.5b; p = 0.18; proximal 
= 5.25 ± 1.39; distal = 5.11 ± 1.86 µm), fiber area (p = 0.47; proximal = 65 ± 26, distal = 
64 ± 37 µm2; mean ± std) or axon area (p = 0.94; proximal = 23 ± 12; distal = 23 ± 17 
µm2). In the tissue implanted for eight weeks, there were significant differences in the 





area (p < 0.005; proximal = 70 ± 24; distal = 62 ± 26 µm2), axon area (p < 0.005; 
proximal = 27 ± 13; distal = 24 ± 12 µm2), and fiber diameter (p < 0.005; proximal = 9.3 
± 1.56; distal 8.68 ± 1.85 µm). Morphometric parameters with significant differences in 
proximal and distal segments for tissue implanted for four or eight weeks included form 
factor (increased for both groups indicating elongation; p << 0.001), mean fiber and axon 
diameter (decreased for both fiber and axon measurements in both groups indicating 
smaller fibers; p < 0.05), and roundness of the fiber (decreased for both groups; p << 
0.001). 
 Figure 3.6a shows a representative cross-section through a row of electrodes from 
a rat that was implanted for four weeks (rat #1). Magnification of the electrode tracks 
shows myelin-stained axons that were still intact and within 50 µm of the electrode tracks 
(Fig 3.6b). Antibodies were used to identify the presence of ED1 positive macrophages at 
the device-tissue interface. Macrophages and neurons were found along the electrode 
tracks (Fig 3.6c; ED1 positive cells = green; Neurofilament positive cells = red; rat #8; 
eight-week cohort). Figure 3.6d-e shows a longitudinal section taken from the same rat 
shown in Figs 3.6a-b (rat #1) and the osmium-stained myelin again shows that many of 
the axons are within 100 µm of the electrode tips. A longitudinal section that was 
exposed to antibodies for ED1 positive macrophages demonstrates again the presence of 
macrophages at the electrodetissue interface (Fig 3.6f; rat #7; eight-week cohort). The 
presence of macrophages around the electrode shafts was found to be nonuniform, with 







3.4.3 Overall assessment of the functional and histological consequences 
of implanted HD-USEAs 
 Table 3.1 summarizes the overall results for each implanted rat. Grades were 
given for the following categories: sensorimotor tests (‘Sensorimotor’), running distance 
(‘Running’), macroscopic assessment of the depth of implantation of the electrode arrays 
at the end of the study period (‘Implant’), and an assessment of the proximity of axons to 
electrode tracks (‘Axons’). None of the rats had deficits across all of the categories. 
Overall scores were given with one point for each severity of deficit so that a total of 
seven points would indicate major deficits in each category (major biocompatibility 
issues) and a score of zero indicated no deficits across all the categories (no 
biocompatibility issues). The mean scores were 1.2 and 1.8 for the four- and eight-week 
cohorts, respectively.  
 
3.5 Discussion 
3.5.1 Effect on animal behavior 
 In order to quantify animal behavior and sensorimotor changes that may result as 
a consequence of electrode array implantation, we chose standard tests that have been 
previously reported to accurately reflect nerve crush or transection injuries (WRL and 
standing 1-5 toe-spread). In addition, we also measured nightly running behavior in each 
rat in order to obtain a quantification of the more global effects the devices may have had 
on animal behavior. The results of these studies suggest each of the tests utilized here 






 The peak times of the deficits in the WRL and 1-5 toe-spread lengths did not 
correlate in time across all of the rats. One of the two rats in the four-week cohort (rat #1) 
and one in the eight-week cohort (rat #7) that showed impaired toe-spreads on their 
implanted side also had impaired WRL times in this limb. However, the times 
corresponding to each deficit did not overlap, suggesting that the sensorimotor fibers 
needed for stance were damaged or inhibited first, while impairment of the sensorimotor 
fibers needed for noxious withdrawal reflexes occurred subsequently. However, this trend 
was not consistent for rat 9, where both WRL and toe-spreads showed deficits within the 
first week postimplantation. The different assessment sensitivities of the WRL and toe-
spread ratio suggest these two methods for assessing sensorimotor function are specific to 
different types of nerve injury. We speculate that the 1-5 toe-spread ratio reflects acute 
nerve injury resulting from HD-USEA implantation, as all deficits revealed by this test 
were seen immediately following implantation. However, the WRL test showed deficits 
that appeared at varying times throughout the study period, which could be reflective of 
different stages of inflammation, nerve compression or injury. 
 The two rats that had decreased weekly running distances (rat #8, eight-week 
cohort; rat #4, four-week cohort) did not show any major deficits in their sensorimotor 
tests towards the end of the study periods. Rat #8 had transient deficits in both its toe-
spread and WRL, but both sensorimotor tests returned to normal while its average weekly 
distances continued to decline. Finally, the rat (#4) with the HD-USEA that had partially 
migrated out of the nerve by the end of the study also had decreased weekly running 
distances, but did not have deficits in the other sensorimotor tests.  





AAALAC holding cages and had wire walls to encourage rat-climbing activity. These 
enrichment cages allowed for substantially more activity both on the exercise wheel and 
during wall climbing than standard cages. One motivation for using these cages was to 
increase the possible mechanical stress on or around the implant system and to provide a 
challenging environment in which to test the ability of HD-USEAs to remain implanted 
in peripheral nerves, especially while using the novel organic nerve wrap containment 
system. However, forced treadmill running in rats has been shown to increase healing 
after peripheral nerve injury [26], and therefore, the time required by nerves to recover 
following HD-USEA implantation may be shortened in our rats compared to more 
sedentary animals.  
 
3.5.2 Containment of the HD-USEAs using an organic nerve wrap 
 In previous studies using a lower electrode density version of the HD-USEA (the 
USEA with 6.25 electrodes/mm2), chronic feline sciatic nerve implants were contained 
using a three-step containment system: silicone elastomer cuffs were wrapped around the 
implant and nerve, surrounded by a gold screen (to minimize EMG interference), and 
then the entire system was coated with surgical-grade adhesive [27,28]. In order to 
investigate a new containment system that would have less foreign material surrounding 
the implant, and thus, a potentially decreased foreign body response, we used a 
decellularized organic nerve wrap that has been approved for use in human nerve repair 
or protection surgeries [29]. Because few or no adhesions between the organic nerve 
wrap and the epineurium were formed, the wrapping material could easily be dissected 





system for HD-USEAs would be important for applications in semichronic human 
experiments where the implanted arrays would need to be explanted from the nerve at the 
end of the study.  
 
3.5.3 Morphology and cytology at the tissue-device interface  
 Tissue damage after implantation and/or the formation of a large fibrotic scar can 
effectively displace the indwelling electrodes from the nerve axons, negating their use in 
chronic studies [7,30-33]. Fibrotic scarring can also increase the distance from the tip of 
the electrodes to active neural tissue, potentially placing the electrode outside its effective 
recording distance (150 µm) [34]. Also, an extensive fibrotic or granulation response 
surrounding the device could require higher stimulation currents in order to evoke a given 
response over time, and thus, may lead to stimulation levels that would no longer be safe 
for the electrodes or the surrounding neural tissue [35]. The results of this study showed 
that the tips of the electrodes remained within distances that would be useful for 
stimulating and recording from these fibers on the time scales investigated herein. 
Although axons were found within such useful ranges, it is unknown whether these axons 
were functional; however, Rushton pointed out that g-ratios (of peripheral nerves) close 
to 0.6 provide fiber geometries that allow for the optimal spread of current between nodes 
of Ranvier [36]. The g-ratios reported herein were all between 0.59-0.63, and thus, we 
hypothesize these axons would be functional for electrophysiological recording or 
stimulation studies, and future studies using wired HD-USEA are warranted to 
investigate this hypothesis. 





historically been carried out for neural interfaces with either a low number of electrodes, 
such as long intrafascicular electrodes, or with many electrodes along a single plane, such 
as the Michigan probe [37]. However, the electrode arrays here differed in that many 
electrodes are distributed along multiple planes. Our results—and other previous results 
from conventionally spaced Utah Arrays implanted in the peripheral and central nervous 
systems [28,38]—indicate that much variability of the tissue adjacent to the electrode 
tracks is observed in both light microscopy and immunohistochemical samples. A total of 
500 electrodes were implanted across 10 animals in this study, and the tips of some of 
these electrodes penetrate into fascicular space, while others penetrate into endoneural 
space. This results in variability in the number of axons within distances needed for 
recording or stimulation, as well as variability in the number of macrophages at the 
electrodetissue interface (both between electrodes and along the length of a single 
electrode). Some electrodes had many macrophages surrounding the shaft/tip of the 
electrode, while other electrodes had few or no macrophages present. With such 
variability, it was difficult to obtain quantification of the morphology or immunology that 
would be representative of all of the 500 implanted electrodes.  
 As with the immunohistochemistry, there was variability in the morphology of the 
distal nerve sections, depending on which section of the nerve was magnified. Some 
areas within the fascicles had nerve morphology that showed little to no signs of 
degenerating/regenerating fibers, while others showed marked differences. In Figure 4 we 
did our best to show regions of the nerve that had the most marked signs of 
degeneration/regeneration, although we note that other areas of the nerve remained free 





implanted devices supported such variability, with significant differences seen for some 
parameters (such as increases in form factor and decreases in mean axon diameters in the 
distal tissue), while there were no significant differences in other factors (such as the 
thickness of the myelin). Thus, the quantified morphometric data did not support overall 
degeneration/regeneration throughout the entire section of the distal nerve.  
 The g-ratio has been traditionally used as a method for quantifying nerve 
morphology and is defined as the ratio of the axon to the fiber (axon and myelin) 
diameters [39]. Many of the axons in the proximal tissue closely approximated circular 
geometries, whereas many regenerating axons in the distal tissue approximated more 
elliptical geometries. When we calculated the g-ratio using diameters back-calculated by 
the area of the fiber/axon, assuming circular geometry, we did not find significant 
differences in the proximal and distal g-ratios for rats implanted for 4 or 8 weeks. 
However, when we calculated the g-ratio using mean diameters by measuring the major 
and minor axes, we found a significant difference in the g-ratio of the distal tissue (8-
week implant). Future studies that utilize the g-ratio as a metric for quantification of 
nerve morphology following nerve injury or implantation of nerve electrodes should 
consider calculation of g-ratios using the mean of major and minor axes, which may 
better reflect geometric changes in regenerating axons. 
 Immunohistochemistry was performed to obtain additional information about the 
distribution of macrophages surrounding the device. The tissue reaction to HD-USEA 
implantation was characterized by a mild to moderate inflammatory response localized 
mainly around the device-tissue interface, an observation consistent with previously 





[32,38,40,41] nervous systems. Macrophages were nonuniformly distributed at the 
device-tissue interface, a finding that may reflect localized impalement of blood vessels 
in the nerve. Macrophages are known to differentiate into different subsets that are either 
inflammatory (referred to as M1 cells) or reparative (referred to as M2 cells) [42] and 
future studies are warranted to assess which subtype is found at the device-tissue 
interface and whether the subtype changes over different postimplantation times.  
 The variability seen in the immunohistochemistry and the morphometric analysis 
of the nerves is in agreement with previous studies that were carried out using Utah 
Arrays with 400µm electrode spacing implanted for various time periods in the cat sciatic 
nerve [28]. Future studies are warranted to determine what causes this variability among 
arrays of electrodes (possibly a result of localized blood vessel impalement or positioning 
of the electrodes within the nerves either intrafascicularly or interfascicularly). Methods 
for automating such quantification for high electrode count devices across three-
dimensional space within the nerves would facilitate studying this question. 
 
3.5.4 Overall assessment of the histological consequences of HD-USEAs 
 In this study, an overall subjective evaluation was made across the data collected 
using behavioral assays, assessment of the extent that the devices remained 
intrafascicularly implanted, and the distance of nerve axons from the electrode tips. 
Compilation of the data in Table 3.1 resulted in an overall rating for the consequences of 
chronic implantation of HD-USEAs for four and eight weeks, and for each cohort, these 
devices were considered to have minor consequences. Future studies need to investigate 





connector for electrophysiological studies. Such wired electrode arrays may produce 
additional tethering forces that could exacerbate the immune response as seen for tethered 
devices in the central nervous system [32]. There may also be increased mechanical strain 
on the implant site for wired devices, which may result in differences in tissue damage 
and/or explantation of the devices. 
 
3.5.5 Modifying the cellular response at device-tissue interface 
 Previous research has shown that the cellular response to chronically implanted 
brain electrodes can be attenuated by systemic or local delivery of antiinflammatory 
drugs [24,25,43]. The rats in this study were given both oral minocycline and injected 
dexamethasone, and although it was not the aim of this study to investigate the effects of 
these drugs, the administration of these drugs was carried out to potentially provide a 
more neuroprotective environment in the face of indwelling HD-USEAs. Future studies 
are warranted to assess whether administration of these drugs can help modify the 
sensorimotor and/or cellular responses to chronically implanted peripheral nerve 
electrodes. Additionally, modifications to the surface chemistry [43-45] or surface area 
[37] of HD-USEAs could assist in altering the host response to these devices.  
 
3.6 Conclusion 
 The present study was aimed at evaluating the consequences of HD-USEA 
implantations in actively behaving animals in terms of overall animal behavior and 
cytology at the tissue-device interface. Using a combination of behavioral assessment 





normal within days to weeks. Cytological analysis showed that although macrophages 
were present at the device-tissue interface, nerve axons remained within distances needed 
for neural recording or stimulation. Signs of axonal damage were observed in all animals, 
with the distal nerve showing signs of regenerating neurons. Our results indicate that 
unwired high count (25 electrodes/mm2) microelectrode arrays passed the 
biocompatibility criteria defined for this study. Future studies are now warranted to 
investigate longer duration implants, devices that are wired to a connector, and 
histological analysis of the variability in morphometric and immune cell changes 
throughout the nerve and along the device-tissue interface.  
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Figure 3.1. Functional assessment of sensorimotor pathways in rats with HD-USEAs 
chronically implanted into their sciatic nerves. (a) Footprint analysis of a rat (#7, eight-
week cohort) before and after HD-USEA implantation. The preimplant photograph shows 
an example of the 1-5 toe-spread length measurement taken from a standing rat. The left 
sciatic nerve was implanted with an HD-USEA (indicated by a star in postimplant 
photographs). In this rat, the 1-5 toe-spread length decreased in the implanted leg for two 
weeks, then returned to control lengths. (b-c) The 1-5 toe-spread lengths are plotted for 
rats implanted for four (b) and eight weeks (c). Six rats had decreased 1-5 toe-spread 
lengths that returned to normal lengths within 2-4 weeks. (d-e) The sensorimotor reflexes 
were assessed in rats implanted with HD-USEAs for (d) four and (e) eight weeks by 
measuring the paw withdrawal reflex latency (WRL) times. Five rats had transient 
increases in WRL times in their implanted hindlimb, which recovered within three weeks 
(mean = 1.5 weeks). Across all rats, there was no correlation between decreased toe-







Figure 3.2. Voluntary running in rats implanted with HD-USEAs. Average nightly 
distance ran per week for (a) rats that had no significant changes (p > 0.05) and (b) rats 
with significant changes (p < 0.05) in the distances ran after implantation of HD-USEAs. 
Rat identifications are shown in the legends. Note for the rats in the four-week cohort, the 
last data points are four-weeks post surgery. (c) No significant differences  (p = 0.70; 
two-tailed t-test) were seen in the distribution of nightly distances ran by all the rats (both 
time period groups combined) for four weeks before (preimplant; white bars; mean ± std 
= 6.24 ± 2.3 km/night) and four weeks after (postimplant; grey bars; 6.07 ± 2.45 
km/night) HD-USEA implantation. Note that both groups are included in this distribution 














Figure 3.3. Macroscopic assessment of chronic HD-USEA implantations. (a) After 4-8 
weeks of implantation in actively behaving animals, HD-USEAs all remained within the 
confines of the organic nerve wrap containment system (left image = control nerve; right 
image = implanted nerve). Black suture can be seen in the image, which was used to 
close the wrap around the implant site and to tack the wrap to the epineurium. The distal 
ends of the nerves are on the right sides of the images. (b-c) Dissection of each implant 
site allowed for a qualitative characterization of implants as either: complete; partial; or 
explanted. Nerve wraps were completely dissected away from the nerve for the examples 
shown. (b) Example of an HD-USEA that remained completed implanted into the nerve 
(rat 2; four-week implant). The last image shows the waffle-like pattern seen after array 
explantation. Nine rats had implants characterized as complete at the end of the study 
period. (c) One rat had a partially implanted HD-USEA at the end of the study period and 
the waffle pattern after array explantation on these devices showed marked increases in 
fibrosis (rat 4; four-week cohort). (d) Scanning electron microscopy (SEM) image for an 
HD-USEA device that was implanted for eight weeks (top image). The image on the 
bottom shows a close up of one of the electrode tips with sparse organic material 
adhering to the surface of the device. None of the electrodes were broken across all 10 








Figure 3.4. Nerve morphology of the tissue proximal and distal to the HD-USEA implant 
site. Assessment of the whole-nerve shows intact epineurium and perineurium adjacent to 
(< 5mm) the site of device implantation (4-week implant a & c; 8-week implant e & g). 
These rats were chosen as representative samples that included some deficits in their 
sensorimotor testing. The organic nerve wrap used to contain the HD-USEAs can be seen 
as multiple layers surrounding the nerve (a & g; double-headed arrows). Magnification of 
the neuronal fibers (proximal- b & f; distal- d & h) within the largest fascicle showed an 
overall decrease in fiber packing in the distal section (rat 1distal= 723 & rat 10distal= 951 
fibers/mm2) compared to the proximal sections (rat 1proximal= 1357 & rat 10proximal= 1146 
fibers/mm2). (b & f) The proximal nerve had normal myelinated fibers (arrows) and 
presumptive regenerating/degenerating fibers indicated by dilation of the Schmidt-
Lanterman incisures and/or myelin collapse (arrowheads). (d & h) The distal nerve 
showed normal myelinated axons, presumptive regenerating axons (thinly myelinated; 
arrows), degenerating axons (myelin collapse; thick arrowheads) and phagocytic 










Figure 3.5. Quantification of the nerve morphology of the tissue proximal and distal to 
the HD-USEA implant site. The top two graphs represent data from a 4-week implant (rat 
1; a-b) and the bottom graphs represent data from an 8-week implant (rat 10; c-d). (a, c) 
The g-ratios (back-calculated from area, assuming circular geometry) are plotted against 
the axon diameters measured in nerve sections proximal and distal to the implants. No 
significant difference in the g-ratio was measured (p > 0.2 both rats; rat 1proximal = 0.59 ± 
0.08; rat1distal = 0.59 ± 0.1; rat 10proximal = 0.61 ± 0.07; rat10distal = 0.62 ± 0.08; mean ± 
std). There was a significant difference (p = 0.02) in the g-ratios for rat 10 when they 
were calculated from mean major and minor axes. (b) There was no significant difference 
in the proximal and distal axon diameters (p = 0.18; proximal = 5.25 ± 1.39; distal = 5.11 
± 1.86) in rat 1, although there was a significant difference in axon diameters for rat 10 (p 
< 0.005; proximal =5.73 ± 1.31; distal = 5.38 ± 1.33). The smaller diameter axons seen in 
rat 10 may reflect more regenerating axons in an 8-week nerve. Note these are the same 












Figure 3.6. Morphometric and immunological assessment of the tissue adjacent to the 
electrode tracks. Transverse (a-b) and longitudinal sections (d-e) of the implant sites were 
stained for myelin and show axons within 25 µm of the electrode tracks (rat #1; 4-week 
cohort). (c) An electrode track from a rat implanted for eight weeks (rat #8) was stained 
for macrophages (ED1 = green) and neurons (NF200 = red). The macrophages lined 
some of the electrode tracks (as shown in this example); however, despite the presence of 
these immune cells, axons were still found within 50 µm of the electrode tip, with some 
axons as close as 25 µm. (f) A representative longitudinal section was stained for 
macrophages (ED1 = green) of a rat sciatic nerve that was implanted for eight weeks (rat 
#7). The distribution of macrophages around the HD-USEA microelectrodes varied 
across the electrode tracks, and in this image two rows of electrodes are shown that each 
have varying degrees of macrophage infiltration. Note that electrode diameters differ 
along the length of an electrode, such that near the tip the diameter is smaller (smaller 
holes in the tissue) while closer to the substrate the diameters are larger. Scale bars are as 










Table 3.1: Overall assessment of rats chronically implanted with electrode arrays 
 
 
Animal #      Sensorimotor   Running    Implant Axons Overall 
4-week cohort: 
1  ++ - - - 2 
2 + - - - 1 
3 - - - - 0 
4 - + + N/A 2 
5 + - - - 1 
     Mean = 1.2 
8-week cohort: 
6 + - - - 1 
7 ++ - - - 2 
8 ++ + - N/A 3 
9 ++ * - - 2 
10 + - - - 1 




- No damage 
+ Transient deficit on one test 
++ Transient deficit on both tests 
+++ Permanent deficit on ≥ one test 
Sensorimotor tests = WRL & Toe-spread length 
 
Running Behavior Grade: ! No change in running 
* Increased running 
+ Decreased running 
 
Array Implant Grade: ! Array base adjacent to the nerve 
+ Array base partially explanted 
++ Array completely explanted  
Axon Grade: ! Axons ≤ 100μm of electrode tips 
+ Axons > 100μm of electrode tips 
 
Overall Grade: 
One point was given for each ‘+’  
0 = no consequences overall 
7 = major behavioral & neuronal consequences 
 
Abbreviations:  
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 To investigate the hypothesis that intrafascicular stimulation of the Pudendal 
Nerve (PN) can be used to selectively activate the detrusor bladder muscle and the 
External Urethral Sphincter (EUS). Nine anesthetized male canines were used in this 
study. Muscle activations were measured via bladder catheter pressure transducers and 
EUS Electromyography (EMG) wires. The PNs were exposed via dissection of the 
ischioanal fossa and implanted with Utah Slanted Electrode Arrays (USEAs). USEAs 
consist of 100, 0.5-1.5 mm long microelectrodes that project out from a 4x4 mm 
substrate. Intrafascicular stimulation was delivered via individual USEA microelectrodes 
in order to map the ability of each electrode to selectively or nonselectively evoke 
detrusor and/or EUS contractions. We were able to selectively activate the detrusor using 
33 Hz stimulation of PN axons with an average of 4.57 ± 3.82 (mean ± sd) USEA 
electrodes per animal tested. Electrically-evoked and distention-evoked bladder 
contractions had similar kinetics. Sustained bladder contractions were evoked via 60 s of 
intrafascicular stimulation.  The EUS was activated using 33 Hz stimulation via an 
average of 26.14 ± 19.45 electrodes per animal tested. High frequency (>2 kHz) 
stimulation delivered via EUS selective electrodes produced nonselective block of PN 
axons. Examples of how this selective axonal access could be used to restore continence 
and activate micturition were demonstrated in two animals. We report herein the first 
study demonstrating selective detrusor and EUS activation via microelectrodes implanted 
intrafascicularly in the PN. Such selective activation enables new therapeutic possibilities 







 Bladder dysfunction—or neurogenic bladder—may include hesitancy, 
incontinence or urinary retention and can arise from neurological injuries, diseases, or 
disorders [1,2]. Current treatments for neurogenic bladder include catheterization, 
pharmaceuticals, urinary tract reconstruction, or electrical stimulation of sacral nerves 
[3,4]. Due to limitations and complications related to these therapies, new treatments for 
neurogenic bladder are warranted for refractory patients.  
 Functional electrical stimulation of various parts of the urogenital system is one 
approach that has been successful [3,5]. Recently, the pudendal nerve (PN) has been 
targeted for electrical stimulation therapy to restore urinary function [6-11] and fecal 
continence [12]. Electrical stimulation of the PN can either relax the detrusor to promote 
continence or excite the detrusor to promote micturition, depending on the frequency of 
stimulation [13]. Stimulation of PN afferent axons excites the pudendal-to-bladder 
reflexive micturition pathway [14]. Previous studies have evoked detrusor muscle 
contractions via low frequency PN stimulation (33 Hz) delivered using whole-nerve cuff 
electrodes [7,8]. In addition, High Frequency Alternating Current (HFAC) (>1 kHz) 
delivered to the PN using cuff electrodes has been shown to produce conduction block of 
orthodromic action potentials, resulting in relaxation of the external urethral sphincter 
(EUS) [15].  
 Intrafascicular stimulation can provide highly selective activation of axons in 
peripheral nerves. Utah Slanted Electrode Arrays (USEAs) implanted in feline sciatic 
nerves have been shown to selectively activate hind-limb muscles in acute [16,17] and 





USEAs can selectively block activation of targeted hind-limb muscles [19]. To date, no 
study has investigated whether intrafascicular stimulation of the PN can selectively 
activate the efferent and afferent pathways involved in micturition. We report herein the 
first results of intrafascicular stimulation of the PN in nine anesthetized canines. This 
study demonstrates the capacity of USEAs to selectively evoke contractions of either the 
EUS or the detrusor. Additionally, we describe preliminary results of two applications of 
intrafascicular stimulation of the PN: restoration of continence in one animal and limited 
activation of micturition in another. These results show that the selectivity provided by 
intrafascicular microelectrodes may allow for more flexible control of targeted muscles 
involved in micturition. 
 
4.3 Materials and methods 
 Nine adult male mongrel dogs (ranging from 17-31 kg) were used in these acute 
studies. All animal procedures were approved by the University of Utah Institutional 
Animal Care and Use Committee. Anesthesia was initiated with Telazol (9-12 mg/kg IM; 
Animal Health, Fort Dodge, Iowa) and general anesthesia was maintained by Isoflurane 
(1.0-2.5%) for surgical procedures. α-Chloralose (5-65 mg/kg IV; Sigma-Aldrich and 
Alpha-Aesar) was used during electrophysiological mapping and data collection as this 
anesthetic has been shown to maintain the spinal reflexes necessary to activate the 
pudendal-to-bladder reflex [7,8]. α-Chloralose solutions (1%) were prepared within 24 
hrs of use by dissolving α-chloralose in sterile 0.9% w/v NaCl at 50-60 ºC and storing at 
40 ºC [20]. Artificial respiration (10-15 breaths/min) and body temperature (39 ºC) were 





Ringer’s solution was administered intravenously at 10 mL/kg/hr during surgical 
procedures, then at 2mL/kg/hr during experimental procedures to limit urine production. 
A warm water blanket maintained normal body temperature.  
 A ventral midline incision was made to expose the bladder and EUS. Catheters (7 
Fr) were inserted directly into the bladder and secured with purse-string sutures. One 
catheter was used to fill the bladder with 0.9% w/v NaCl using a syringe pump (New Era 
Pump Systems, Inc., Model NE-1000). The other suprapubic catheter was filled with 
0.9% w/v NaCl and connected to a pressure transducer (Deltran DPT-100, Utah 
Medical Products, Salt Lake City, UT) to record bladder pressure increases due to 
detrusor contractions. Bladders were filled at 2-15 mL/min. Electrical stimulation trials 
were carried out when the bladder volume was approximately 78% of the bladder 
capacity. The EUS was instrumented with 1-2 pairs of 0.051 cm bifilar electromyography 
(EMG) wires (California Fine Wire Co., Model #: M146240) in seven animals. 
Approximately 2 mm of insulation was removed from the end of each EMG wire and the 
tips of the wires were bent at a 45º angle for insertion into the muscle. The ventral 
midline preparation was sutured in layers.  
 The PN was exposed by dissection of the ischioanal fossa and a USEA was 
implanted proximal to any branching points using high-speed pneumatic insertion [21]. In 
some animals, bilateral PNs were exposed in order to assure the larger PN (if applicable) 
was chosen for USEA implantation.  
 The USEA is a 10x10 array of silicon microelectrodes that vary in length from 0.5 
mm to 1.5 mm [22]. The median tip impedances for the four USEAs used in these studies 





was mapped to an evoked response—detrusor and/or EUS contractions. Electrodes were 
stimulated with cathodic monophasic stimulation at amplitudes of 0.8-9.0 V with 100-
300 µs pulse-widths at 30-33 Hz for 5-10 s duration. After experiments were terminated, 
USEAs were cleaned in a stirring solution of ~1% Enzol Enzematic Detergent (Advanced 
Sterilization Products, division of Ethicon, Inc., USA), washed with distilled water, and 
electrodes were inspected for damage under a microscope. USEA impedances were 
verified between experiments using a custom-built impedance testing system [23]. 
Stimuli were delivered via voltage-controlled stimulators (Grass Technologies, SD9; 
West Warwick, Rhode Island, USA). HFAC waveforms were generated with a PC 
running a custom MATLAB (The MathWorks, Inc., Natick, MA) program and delivered 
to USEA microelectrodes by a National Instruments DAC card (NI6711) [19]. Animals 
were grounded using a 22-guage needle placed under the skin. Reflexive detrusor bladder 
muscle contractions were evoked by filling the bladder with saline [24], and here we refer 
to these contractions as ‘distension evoked contractions.’  Analog data from our 
stimulator, pressure transducers, and EMG wires were sampled at 10 kSamples/s and 
stored on a hard disk using a Cerebus data acquisition system (Blackrock Microsystems, 
Inc., Salt Lake City, UT). Voided urine weight was collected through urethral catheters 
and continuously monitored with a force transducer.  
 Data analysis was carried out using MATLAB. USEA electrodes that, upon 
stimulation, evoked only EUS or detrusor contractions were classified as ‘selective.’ 
Electrodes that evoked contractions in both muscles were classified as ‘nonselective.’ We 
interpreted any bladder pressure increases above baseline—excluding increases seen as a 





H2O). For EUS EMG activity, we also interpreted any increases above the normally 
recorded sphincter tone as electrical activation of efferent EUS fibers from USEA 
stimulation. In two animals, EMG of the EUS was not recorded, and therefore, these 
trials were classified as nonselective (Table 4.1; animals 1 and 2). The electrode counts 
from these animals were labeled as ‘not applicable’ (n/a) and were excluded from the 
statistical analysis.  We determined the threshold voltages needed to evoke detrusor or 
EUS contractions in five animals by stimulating via individual electrodes with 33 Hz 
starting at 0 V and increasing in steps of 0.1 -0.5 V. 
 
4.4 Results 
 Distention of the bladder from passive filling evoked reflexive detrusor 
contractions in all animals tested. During distention evoked detrusor contractions, voids 
ranged from 8-120 mL, bladder pressure increases ranged from 15-100 cm H2O, and the 
mean bladder capacity was 125.17 ± 43.91 mL (range of 80-225 mL) for all nine animals. 
Distention evoked contractions were followed by a reflexive reconstriction of the urethral 
sphincter (measured by EMG).  
 In all nine animals, we were able to selectively and nonselectively activate the 
detrusor bladder muscle via brief (3-5 s) low frequency (33 Hz) stimulation of afferent 
PN axons with 4.57 ± 3.82 and 5.56 ± 8.00 (mean ± sd) electrodes per animal, 
respectively (Table 4.1). In three animals we measured threshold voltages of 4.10  ± 1.54 
V (n = 15 electrodes) for selectively activating the detrusor using intrafascicular 
stimulation. Figure 4.1A shows five consecutive detrusor contractions evoked by 





100 µs pulse-width at 33 Hz). The kinetics and amplitudes of these increases in bladder 
pressure, evoked by selective stimulation of the PN, were similar to the kinetics and 
amplitude of distention evoked contractions. As with distention evoked contractions, 
intrafascicularly evoked contractions resulted in reconstriction of the urethral sphincter 
(Fig. 4.1A; top trace).  We also observed that 1 min of 33 Hz stimulation produced a 
prolonged detrusor contraction that persisted as long as stimulation was delivered (Fig. 
4.1B).  
 In the seven animals in which EUS EMG was measured, an average of 26.14 ± 
19.45 and 2.43 ± 1.99 (mean ± sd) USEA microelectrodes evoked selective and 
nonselective contractions of the EUS, respectively (Table 4.1). In five animals the 
threshold voltage for selectively activating the EUS using USEAs was 3.61  ± 2.01 V (n 
= 40 electrodes). Nonselective electrodes (n =7) were found to have threshold activations 
of 5.00  ± 1.31 V for the detrusor and 6.85 ± 2.10 V for the EUS. For the arrays where 
threshold voltages were recorded, there was no apparent trend between threshold voltage 
and array impedance [Array 1, median tip = 100.00 kOhm, mean Vthreshold = 3.09; Array 
2, median tip = 23.80 kOhm, mean Vthreshold = 5.06; Array 4, median tip = 23.00 kOhm, 
Vthreshold = 0.50]. Selective activation of the EUS by intrafascicular stimulation is shown 
in Figure 4.2, where stimulation delivered via two USEA electrodes evoked EUS 
contractions only. Figure 4.2 also shows a neighboring electrode that did not evoke a 
response in the EUS or detrusor.  
 The distributions of USEA electrodes that activated either the detrusor and/or the 
EUS suggested a functional organization of the PN. Electrodes that excited the EUS 





The geometric centers of the electrodes that excited the detrusor and those that excited 
the EUS were determined for each animal.  In the seven experiments where mapping was 
attempted for both detrusor and EUS, the average separation of the geometric centers was 
1.11 ± 0.69 mm (mean ± sd). 
 We investigated the possibility of restoring continence using intrafascicular 
stimulation of EUS efferent axons. Stress urinary incontinence was modeled in one 
animal after unilateral PN crush (Fig. 4.3a). The detrusor could be filled to pressures 
between 20-30 cm H2O before leaking occurred. The black bar indicates continued 
bladder filling, that began after the bladder was filled to just below the leak point pressure 
(20 cm H2O). Episodes of urine leakage were free of detrusor contractions. Two periods 
of 35-40 s duration, 33 Hz stimuli were delivered via a USEA electrode that selectively 
activated the EUS. Urine leakage completely stopped during stimulation. During such 
stimulation periods the rate of urine flow went from 17.4 to 0 mL/min.  
 In a separate experiment, USEA microelectrodes that targeted the detrusor and 
EUS were used to deliver stimulation via two USEA electrodes simultaneously in order 
to activate voiding (Fig. 4.3b). Four consecutive trials were conducted in which low 
frequency stimulation (7 V with 200 µs pulse-width at 30 Hz) was delivered for 1 min via 
a detrusor selective electrode. Because the EUS was presumably constricted, this 
stimulus produced only a small transient flow of urine at the onset and offset of 
stimulation (0.2 mL/s; Fig. 4.3b).  In three of the trials, we were able to transiently 
increase urine flow (0.7 mL/s) by also delivering an HFAC blocking stimulus (4 V peak-
to-peak for 10 s duration at 1 kHz) via a EUS selective electrode (trials 1, 2 & 4; Fig. 





min of detrusor stimulation, and no transient increase in urine flow was observed. The 
HFAC stimulation appeared not only to produce a block of efferent axons, but HFAC 
also appeared to block afferent activity causing bladder pressure to fall to prestimulation 
levels (Fig. 4.3b; bottom trace). Upon cessation of HFAC, bladder pressure increased, 
due to the ongoing low frequency stimulation via the electrode activating the pudendal-
to-detrusor reflexive pathway. 
 
4.5 Discussion  
 The results described herein validate the hypothesis that microelectrode arrays, 
intrafascicularly implanted in the PN, can provide selective access to the afferent and 
efferent neural pathways involved in the control of micturition. In all nine animals, 
selective activation of both the detrusor and EUS was possible by stimulating via 
individual USEA electrodes. In all seven animals where both detrusor and EUS 
contractions were measured, we were able to evoke selective contractions of each muscle 
with different USEA electrodes. Because such selective access was achieved, we also 
investigated if targeted axonal stimulation could form the basis for new therapeutic 
approaches to problems of micturition. The two examples demonstrated in this work, 
restoration of continence and controlled, but limited micturition, were not intended as 
definitive studies, but only as indicators of research areas based upon intrafascicular 
stimulation that are likely to be fruitful when more focused work has been done.   
 Figure 4.1 and Table 4.1 illustrate that individual microelectrodes in an array of 
electrodes implanted intrafascicularly in the PN can be identified that selectively excite 





and amplitudes of the pressure waveforms evoked via these electrodes were virtually 
identical to the distension evoked contraction waveforms. Further, when prolonged low-
frequency intrafascicular stimulation was used, bladder pressure increases persisted as 
long as the stimulation was delivered (Figs. 4.1b and 4.3b).  
 We were able to selectively evoke detrusor contractions using a small number of 
USEA electrodes (mean = 4.57) compared to the number of electrodes that selectively 
evoked EUS activity (mean = 26.14). This finding suggests that the canine PN may 
contain a smaller number of afferent fibers than efferent fibers. Another explanation 
would be potential differences in thresholds of activation between afferent and efferent 
fibers; however, no significant difference between threshold voltages was found for 
selective (n = 55; p > 0.3; two-tailed paired t-test) or nonselective (n = 7; p > 0.09; two-
tailed paired t-test) electrodes. An additional explanation for this discrepancy may be due 
to effects of α-chloralose on the pudendal-to-bladder micturition reflex.  
 A similar functional PN organization was observed for the seven animals in which 
both detrusor and EUS contractions were monitored, suggesting that afferent and efferent 
axons in the PN may be localized to separate fascicles in the canine. Another possibility 
is that the canine PN, unlike the feline [25] or the human [26], contains one or a few 
larger fascicle(s). If the afferent detrusor and the efferent EUS fibers coursed through the 
same fascicle, the geometric centers of these subsets of electrodes would be expected to 
overlap. However, for the seven experiments where mapping was attempted, the 
geometric centers were separated by an average of 1.11 ± 0.69 mm (mean ± sd). This 
separation between geometric centers suggests that in the canine model the afferent fibers 





course through separate fascicles or one large fascicle but be segregated spatially. 
Histological evaluation of the canine PN will help shed light on these questions. 
 Stimuli delivered using intrafascicularly implanted microelectrodes were able to 
selectively excite the EUS. This observation suggests an approach to restore continence 
in individuals who have lost this function due to loss of EUS tone or decreased 
innervation. In one animal, we were able to model stress urinary incontinence by 
unilateral crushing of the PN [27,28]. The crush injury was carried out on the PN 
contralateral to the USEA implant. Bladder pressure increases above 20-30 cm H2O 
resulted in leaking. Low frequency stimulation via an electrode implanted in the PN that 
selectively excited the EUS was able to eliminate this leakage for the two 35-40 s periods 
that stimulation was delivered. Although this demonstration is encouraging, a major 
concern about the use of intrafascicular stimulation to restore continence is that 
stimulation must be provided for multiple hours, and such sustained prolonged 
stimulation could cause adverse effects on the tissues being stimulated or on the 
electrodes used for stimulation. One advantage of using multielectrode arrays to interface 
with the PN is that many electrodes excite axons that innervate the EUS (an average of 
26.14/animal in this report). The overall stimulation amplitude delivered via each 
electrode may be reduced by interleaving stimulation among multiple USEA electrodes. 
Additionally, interleaved stimulation has been shown to result in more fatigue-resistant 
muscle activation [29], and such stimulation paradigms may result in fatigue-resistant 
contraction of the EUS for multiple hours of restored continence. Additional longitudinal 
studies will be required for this to be established conclusively.  





the EUS simultaneously relaxes.  Although the example of controlled voiding shown in 
Figure 4.3B is only from one experiment, these results have shown this hypothesis to be 
worth investigating in more focused studies. Future work will be aimed at optimizing 
stimulation parameters in order to investigate the extent to which intrafascicular 
stimulation of the PN using USEAs can produce controlled voiding. Additionally, HFAC 
stimulation delivered to an electrode that selectively activated the EUS at low frequencies 
of stimulation produced a nonselective block at high frequencies, which lead to relaxation 
of the detrusor. Such stimulation paradigms may also be used to inhibit the detrusor in 
patients with overactive bladder. Future work is needed to investigate to what extent 
HFAC stimulation can selectively block axons within a single fascicle or whether such 
stimulation produces only nonselective block of an entire fascicle. 
 We were able to elicit distention evoked detrusor contractions in all nine animals 
by methods previously reported for feline models [24]; however, we were unable to do so 
reproducibly over the course of each experiment. We hypothesize that α-chloralose may 
depress the pudendal-to-bladder micturition reflex in canines, as it has been shown to do 
in felines [7], [27]. Yoo et al. were able to demonstrate that electrical stimulation of the 
PN drives excitation of the pudendal-to-bladder reflex, which overcomes any inhibition 
caused by α-chloralose in the feline model [8]. Delivering stimulation via multiple USEA 
electrodes may improve selective detrusor activation electrode counts by increasing 
activity in the reflexive micturition pathway.  
 The studies reported herein were conducted in the large canine model in order to 
work with a PN that has a size more consistent with the human PN. However, in the 





spontaneous muscle activity. There are several reports in the literature that indicate α-
chloralose has: (1) dose-dependent effects on the nervous system [30], and (2) varying 
effects across different species [31]. The species-dependent effects of α-chloralose are 
still not well understood, and may account for the effects we observed during these 
studies. In future experiments, the USEA will be redesigned such that it will be custom-
fit for the smaller size and fascicular organization [25] of the feline PN, as no side effects 
have been reported for felines anesthetized with α-chloralose. 
 
4.6 Conclusion 
 We have demonstrated that intrafascicular stimulation of the PN can selectively 
activate the detrusor bladder muscle and EUS using individual microelectrodes in an 
implanted USEA. The two examples using selective afferent and efferent activation 
demonstrate that intrafascicular electrodes may allow for targeted control of the muscles 
mediating micturition.  
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Figure 4.1: Selective activation of detrusor bladder muscle by intrafascicular stimulation. 
(A) Examples of 5 consecutive detrusor contractions (pressure trace) after stimulating 
USEA electrode 92 with 5-8 V, 100 µs pulse-width at 33 Hz (bottom bars). Each epoch is 
followed by sphincter reconstriction (top trace). At 8V stimulation, current began to 
spread to EUS efferent nerve fibers, which evoked EUS contractions. (B) Prolonged 
detrusor contraction was evoked by 1 min of stimulating a USEA electrode that 
selectively activated the detrusor with 4V, 100 µs pulse-width at 33 Hz (bottom bar). 







Figure 4.2. Selective activation of the EUS by intrafascicular stimulation. Suprathreshold 
stimulation (9V, 33 Hz; bottom bars) via three different USEA electrodes (electrode 17, 
18, and then 19) in the same animal whose responses were shown in Figure 4.1A. USEA 
microelectrodes 17 and 19 evoked selective EUS contractions as measured by EMG, 
while electrode 18 did not evoke any muscle responses (bladder pressure did not increase 






Figure 4.3. Applications of intrafascicular stimulation of the PN. (A) Restoration of 
continence. Trace shows voided urine volume in an animal made incontinent by 
unilateral PN crush injury. Gray bars show stimulation of the contralateral PN delivered 
via a single USEA electrode that selectively constricted the EUS. Continence was 
completely restored during stimulation. (B) Activation of micturition. Voiding was 
evoked (voiding rate; top traces) by 60 s of low frequency stimulation (33 Hz, black bar) 
via a detrusor-selective USEA electrode while a 10 s high frequency stimulation (2 kHz, 
gray bar) was delivered via another USEA electrode that was EUS-selective. In trial 3 
(filled triangles, black line), a control was performed in which no HFAC was delivered 
and the voiding rate did not increase as in the other trials. Bottom trace shows detrusor 
pressure in response to one of the trials from Fig. 3B in which both low and high 













Table 4.1: Number of USEA microelectrodes that
evoked selective or nonselective muscle activity
Animal Det EUS Det EUS
1 n/a n/a 7 n/a
2 n/a n/a 26 n/a
3 4 21 3 3
4 2 26 3 3
5 2 26 1 1
6 3 68 6 6
7 10 14 3 3
8 10 9 1 1
9 1 19 0 0
Mean 4.6 26.1 5.6 2.4
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5.1 Abstract  
 To investigate the use of a microelectrode array with a high spatial density of 
penetrating intrafascicular electrodes for selective recording of pudendal nerve activity 
evoked by a variety of genitourinary stimuli. Felines were anesthetized with alpha-
chloralose and High Density Utah Slanted Electrode Arrays (HD-USEAs; 48 
microelectrodes; 200 µm spacing) were implanted into the pudendal nerve for acute 
experimentation. Neural activity was recorded during bladder filling, spontaneous 
reflexive Distention Evoked bladder Contractions (DECs), and tactile somatosensory 
stimulation. The intrafascicularly implanted pudendal nerve electrodes were able to 
selectively record neural activity that corresponded to various genitourinary stimuli. 
Across all seven experimental animals, a total of 10 microelectrodes recorded neural 
units that were selectively driven by bladder filling or DECs.  Twenty-two electrodes 
were selectively driven by tactile stimulation. Microelectrode arrays implanted 
intrafascicularly into the pudendal nerve can be used to selectively record the neural 
responses that reflect bladder status and urogenital tactile stimulation. This work sets the 
stage for developing future implantable closed-loop neuroprosthetic devices for 







The work described herein is focused on investigating a critical element in 
achieving closed-loop control of genitourinary function: the selective monitoring of 
urogenital status via pudendal nerve single-unit recordings. Previous research has shown 
that whole-nerve cuff electrodes can record pudendal nerve activity that corresponds to 
genital stimulation1 or bladder contractions2, but this method records the overall evoked 
nerve activity (not the selective activity from individual axons) and, thus, suffers from 
false-positive detection of bladder fullness produced by tactile stimulation. Therefore, a 
neural interface that can selectively detect and differentiate different genitourinary 
functions could improve the accuracy of bladder monitoring and the effectiveness of such 
a closed-loop system.  
 Here we investigated the use of penetrating microelectrode arrays implanted 
intrafascicularly into the pudendal nerve of anesthetized felines as a means for selectively 
monitoring various genitourinary states. The arrays3 contained 48 wired microelectrodes 
of varying lengths and were used to record neuronal activity at multiple sites across the 
cross-section of the pudendal nerve evoked by bladder filling, Distension-Evoked bladder 
Contractions (DECs), and by tactile stimulation. Further, because the tips of the 
implanted electrodes sample neural activity at discrete loci across the cross section of the 
nerve, we also show that such recordings can be used to determine the distribution of 
afferent and efferent fibers within the pudendal nerve. This study demonstrates that an 
intrafascicularly-based pudendal neural interface could provide an important component 






5.3 Materials and methods 
 All acute (< 30 h) experimental procedures were approved by the University of 
Utah’s Institutional Animal Care and Use Committee. Male felines (n = 7 animals; 3-5 
kg; intact sexual organs) were induced with Telazol (9-12 mg/kg; IM) and surgical 
anesthesia was maintained with isoflurane (0.25-2.0% gas). Alpha-chloralose (10-65 
mg/kg IV; as needed) anesthesia was used during experimental procedures. Vital signs 
were monitored every 15 min throughout the experimentation to ensure maintenance of a 
stable anesthetic plane. 
 A dual-lumen suprapubic catheter (12 French, Cook Medical, Inc., Bloomington, 
IN, USA) was purse-string sutured into the bladder for filling and measuring bladder 
pressure. A syringe infusion pump was used to fill the bladder at constant rates (0.5-8 
ml/min). These rates have been used in previous bladder physiology studies2,4,5 and are 
within the ranges induced by diuretics6. In two animals, the ureters were ligated, 
transected proximal to the ligation, and drained internally. DECs were stimulated by 
filling the bladder with room temperature sterile saline to resting pressures of 5-15 cm-
H2O (infusion volumes ranged from approximately 5-20 ml)4,7. Felines were positioned 
either prone or laterally.  
 The pudendal nerve was exposed by dissection of the ischioanal fossa and the 
pudendal nerve trunk was identified via anatomical branching patterns. The nerve trunk 
and branches were further verified via whole nerve stimulation while resulting muscle 
contractions were monitored visually (penile, anal or both). In most animals, the gluteal 
muscle groups were reflected in order to gain access to the pudendal nerve trunk for the 





platform was placed under the nerve trunk and then an HD-USEA was implanted using a 
hand-held pneumatic insertion technique8.  After implantation, the nerve and HD-USEA 
were wrapped in low-density polyethylene wrap to keep the nerve hydrated and to 
contain the implanted electrode array. To investigate the origin of the recorded responses, 
the pudendal nerve in one animal was crushed proximal to the implant site. The HD-
USEAs had 48, 300-800 µm long, wired electrodes arranged in a 5×10 grid (200 µm 
spacing, with the four corner electrodes used as reference electrodes)3. The ~50 µm long 
deinsulated and metalized electrode tips formed the active surfaces. This architecture was 
chosen to custom-fit the anatomy of the feline pudendal nerve9.  
 Recordings were taken from all wired electrodes while filling and emptying the 
bladder or brushing the skin near the anus, scrotum or penis. Neural units were detected 
using a threshold initially set at six times the Root Mean Squared (RMS) of the 
continuously recorded signal on each electrode and thresholds were further adjusted 
during the experiments. Units were then screened subjectively and categorized as either: 
1) multimodal - defined as a unit that was driven by multiple forms of stimulation or a 
unit that fired spontaneously, or 2) selective – defined as units that were driven only by 
tactile stimulation, or by changes in bladder pressure produced either via filling or by 
bladder DECs. For units with activity that correlated with DECs, unit firing rates 
(calculated as the number of neuronal events in 100 ms bins) were smoothed with a 0.5 
Hz fourth-order low-pass Butterworth filter. Recorded suprapubic pressure was regressed 
against the firing rates for one trial, and the regression coefficients were used in 
subsequent trials to predict the bladder pressure. Finally, the coefficient of determination 





Square Errors (RMSE) of the estimated bladder pressures were calculated with respect to 
the recorded pressures. 
 All data were collected using a Cerebus Data Acquisition System (Blackrock 
Microsystems, Salt Lake City, UT, USA). Neural data were bandpass filtered (750-7,500 
Hz) and sampled at 30 kHz. Bladder pressure recordings were sampled either at 10 kHz 
or 30 kHz. Data analysis was performed using Offline Sorter (Plexon, Inc., Dallas, TX, 
USA), MATLAB (The MathWorks, Inc., Natick, MA, USA) and Microsoft Excel 
(Microsoft, Redmond, WA, USA). 
 After one animal was sacrificed, the exposed nerve containing the HD-USEA 
implant site was soaked in 4% paraformaldehyde phosphate buffer solution (PBS) for 30 
min. The array was explanted and the nerve was excised and stored in 4% 
paraformaldehyde PBS for 24 h, then rinsed and stored in 1% PBS with 0.01% sodium 
azide. Tissue was then stained with 1-2% OsO4 in a 0.1M sodium cacodylate buffer, 
dehydrated in graded concentrations of ethanol, cleared with propylene oxide, and 
embedded in Embed 812 (Epon, Electron Microscopy Science, Hatfield, PA, USA). 
Serial 0.5-0.6 µm semithin sections were stained and examined using a color CCD 
camera attached to a Nikon E600 microscope.  Serial overlapping images were captured 
over the entire nerve (at 60x magnification) and then reconstructed to form a mosaic 
image (Adobe Photoshop CS, Adobe Systems Inc., San Jose, CA, USA). 
 
5.4 Results 
 The mean electrode impedance of the four HD-USEAs used in this study was 130 





included in the mean impedance calculation. The mean number of functional electrodes 
was 45 + 2 (mean + standard deviation) in each of the seven experiments. 
 The drawings of Figures 5.1A and B illustrate that a 5×10 HD-USEA implanted 
into the feline pudendal nerve provides uniform electrical access across its cross-section. 
A cross-section of the feline pudendal nerve that was implanted with an HD-USEA for 10 
h is shown in Figures 5.1C, D, and E. The base of the array was located at the top portion 
of the nerve and the tracks made by the extracted electrodes are evident. At the implant 
site shown in this figure, the feline pudendal nerve trunk is 39% neuronal tissue (Fig. 
5.1D with fascicular areas filled in) and 61% nonneuronal tissue (connective, vascular, 
adipose, etc). 
 In the 7 feline experiments performed, 48 of the 336 wired electrodes recorded 
single unit activity.  In 2 of the experiments, an average of 23% of the implanted 
electrodes recorded single unit activity. Table 5.1 summarizes the stimuli that evoked 
selective and nonselective neuronal activity for each animal. In 4 of the 7 preparations, 
we recorded at least one neuronal unit that selectively responded only to bladder pressure 
changes due to bladder filling or DECs. In 2 of these 4 preparations, we additionally 
recorded at least one additional neuronal unit that selectively responded to tactile 
stimulation only. In each animal, there was at least one neuronal unit recorded that was 
exclusively driven by tactile stimulation, by bladder filling, or by DECs. In two animals, 
nonselective, multimodal units were recorded (1 unit/animal) that were driven by both 
tactile stimulation and bladder filling. In 3 animals, we recorded spontaneous neural 
activity that could not be associated with either tactile stimulation or any bladder states. 





genital tactile stimulation alone and 10 electrodes recorded single unit activity that was 
driven by changing the bladder pressure due to filling or due to DECs. The temporal 
profiles of the action potentials of these 10 units varied: bladder filling produced a 
monotonic increase in firing over the duration of filling, while DECs produced bursts of 
firing.  
 Figures 5.2A and B show examples of single unit waveforms that were evoked in 
one animal by stroking the scrotum. A raster of spiking events recorded by each electrode 
evoked by periodic tactile stimulation was plotted (Fig. 5.2C), and 12 electrodes recorded 
neural activity driven by the stimulus (scrotal stroking).  The map of electrodes that 
recorded single unit activity (Fig. 5.2D) indicates that the afferent fibers responding to 
scrotal stimulation were distributed across the entire cross-section of the nerve. 
 Figure 5.3 shows an example of bladder filling along with the spiking data 
recorded on two HD-USEA electrodes. These electrodes recorded increases in the firing 
rates of nearby axons as the bladder began to fill. For example, in 10-second windows 
before and after filling, the number of spikes recorded by electrode 39 increased from 5 
to 47 spikes. These firing rates either remained with constant volume (20 mL) in the 
bladder or decreased upon emptying of the bladder.  The neural activity map (Fig. 5.3B) 
suggests that the afferent fibers encoding tactile or bladder fullness may be somewhat 
segregated in the pudendal nerve. The two electrodes that recorded activity correlated 
with bladder fullness were located to one side of the nerve and the seven electrodes 
recording activity that correlated with tactile stimulation were localized on the opposite 
side of the nerve. 





5.4A, top trace). This figure also shows the spiking data from four electrodes during this 
experiment. Electrodes 6-8 recorded transiently increased firing from neurons in response 
to bladder contractions, while electrode 5 recorded only spontaneous activity. The 
histogram (Fig. 5.4A, bottom trace) shows the summed spiking events recorded across 
electrodes 6-8 and these events were correlated with bladder contractions (R2 = 0.60; 
normalized RMSE = 0.42 cm-H2O). The neural activity from these four electrodes was 
also recorded during 10 periods of tactile genital stimulation (Fig. 5.4B, upper trace). 
Neural activity recorded on electrode 5 was driven by genital stimulation (the binned 
spiking events on electrode 5 are shown in the bottom histogram), but the neural activity 
recorded on electrodes 6-8 was not driven by such stimuli.  In order to identify if this 
recorded activity arose from afferent or efferent pathways, the pudendal nerve of this 
animal was crushed proximal to the implanted HD-USEA, resulting in the loss of activity 
selectively driven by bladder filling and DECs.  The neural activity map (Fig. 5.4C) 
supports the fiber segregation seen in Figure 5.3B, but in this experiment the fibers with 
activity that correlated with bladder fullness were localized to the upper region of the 
nerve, and the electrodes responding to tactile stimulation were localized to one side of 
the nerve.  
 
5.5 Discussion 
 Neurogenic bladder can result from many different central or peripheral nerve 
injuries or diseases, such as spinal cord injury or spina bifida. Patients for whom 
pharmacological or surgical interventions are not effective are being considered for 





locations that is being investigated for the development of a neuromodulation system to 
restore genitourinary function in people with problems such as neurogenic bladder11. 
Animal studies have shown that whole-nerve (cuff electrode) stimulation of pudendal 
afferent fibers can be used to drive the micturition reflex (20-40 Hz) or inhibit bladder 
contractions (10-20 Hz)12,13, while very high frequency stimulation (1-20 kHz)14 can be 
used to block efferent EUS motor fibers and produce sphincter relaxation.  
 A pudendal nerve closed-loop control system would presumably achieve 
improved control of urogenital function. However, such an approach would require the 
monitoring of detrusor muscle status (via reflexive circuitry reflecting different bladder 
states) and the use of this information to provide electrical stimulation to subsets of nerve 
fibers that modulate detrusor and/or external urethral sphincter activity. Whole-nerve cuff 
electrodes have been used to record pudendal nerve activity corresponding to genital 
stimulation1,2 or bladder contractions2; however, such recordings are unable to 
differentiate activity evoked by these different stimuli. Thus, a closed-loop 
neuroprosthetic device based on whole-nerve cuff electrodes for the treatment of bladder 
dysfunction would likely suffer from false-positive detection of bladder fullness due to 
unrelated genital tactile stimulation2.  
 Intrafascicular penetrating peripheral nerve electrodes have been developed for 
large (3-4 mm)15 and small (≤1 mm)3 diameter neuronal structures. Using the nonslanted 
version of these microelectrode arrays, Bruns et al. have  achieved selective detection of 
bladder-driven units by recording neurons in sacral dorsal root ganglia, another potential 
site for a closed-loop neuroprosthesis for bladder control4. We previously demonstrated 





small subsets of nerve fibers, allowing for the selective activation of the detrusor and 
EUS muscles16. Here we have expanded upon that work and investigated whether 
recording of pudendal nerve neural activity could be used to selectively detect various 
genitourinary stimuli, and thus, provide an important component in the future 
development of a single implant site for a closed-loop neuroprosthetic device for the 
control of human urinary function. 
 HD-USEAs have a slanted architecture, allowing the tips of the electrodes to 
penetrate into various depths of the nerve, thereby providing access to nerve fibers in 
different regions of most of the nerve fascicles. However, as shown in the pudendal nerve 
cross-section (Figs. 5.1D), much of the nerve is nonfascicular tissue (61%), causing many 
electrodes to reside in nonneural regions of the nerve. However, many of these electrodes 
could be used for stimulation of the nerve fibers, but with less selectivity than electrodes 
located within fascicles.  We have also used HD-USEAs to investigate the distribution of 
afferent fibers within this small diameter nerve (electrode activity maps of Figs. 5.2, 5.3 
and 5.4). Despite observed differences, likely due to variations in nerve orientation, these 
activity maps support previously published histology work describing the fascicular 
organization of the pudendal nerve in felines9.   
 Bladder filling, reflexive DECs and tactile stimulation evoked neural activity that 
was selectively and nonselectively recorded via different HD-USEA microelectrodes. Of 
all successfully recording electrodes across all animals, only two electrodes were found 
to record multimodal activity that could not distinguish between tactile stimulation and 
different bladder states. Thus, microelectrode arrays may be expected to have few 





tactile stimulation.  
 The temporal profile of firing evoked by bladder filling or DECs differed; 
contractions evoked transient activity and filling evoked monotonic increases in firing. 
Therefore, a closed-loop system for monitoring bladder status will likely need to 
incorporate an algorithm that detects different bladder states based on the temporal 
signature of neuronal firing. Additionally, these studies were carried out using bladder 
infusion rates within ranges induced by diuretics (0.5-8 mL/min)6 and future studies need 
to investigate whether pudendal nerve activity differs during lower urine flow rates (0.5-
1.4 mL/hr). In one animal, the pudendal nerve was crushed proximally to the implanted 
HD-USEA in order to investigate whether signals in the pudendal nerve corresponding to 
bladder filling/DECs were being recorded from afferent or efferent pudendal fibers. The 
loss of all neural signals postneuronal crushing suggests that these units were reflexively 
activated, and therefore, a pudendal neural interface for detection of bladder status may 
necessitate intact reflexive arcs.  
 Over the course of an experiment, many of the electrodes drifted in and out of 
their ability to record neural activity. This may be a result of micromovements at the 
device-nerve interface causing the electrode tips to move in and out of the listening radius 
of individual nerve fibers, a problem that may be mitigated in chronically implanted HD-
USEAs where tissue encapsulation would tend to stabilize the electrodenerve interface. It 
is likely that implantation of the HD-USEA also causes minor nerve damage that leads to 
a loss in neuronal signals over time. However, previous research has shown that these 
devices can be implanted without major nerve damage for acute electrophysiology 





would not expect to have regained the ability to record the signals that were lost at earlier 
times. Future chronic studies in feline pudendal nerves are warranted to investigate the 
long-term recording capabilities and anatomical consequences of HD-USEA 
implantations, and various containment systems that may better serve to decrease 
possible movement at the device-nerve interface. 
 The experiments described in this report were performed in the small diameter 
feline pudendal nerve, and it is expected that this approach may be more effective in the 
larger human pudendal nerve18 where implantation of larger electrode arrays with more 
electrodes could allow even greater numbers of single unit recordings of neural activity 
that correlate with bladder fullness.  Further, pairs of electrode arrays could be implanted 




 In order to develop a clinically useful neuroprosthesis for the restoration of 
genitourinary functions—such as inhibition of overactive bladder or the restoration of 
controlled micturition—a fully implantable system must be able to both detect various 
genitourinary states and then send the appropriate electrical stimulation to drive the 
desired physiological response (e.g., control the states of the external urethral sphincter 
and the detrusor muscle). The results presented herein provide evidence that an array of 
microelectrodes inserted intrafascicularly into the pudendal nerve could be used as a 
neural interface for the selective monitoring of various genitourinary stimuli, such as 





could form the basis for an implantable system that provides closed-loop control of 
genitourinary functions without suffering from false-positive detection of different 
bladder states due to unrelated genital tactile stimulation. 
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Table 5.1: Number of electrodes that recorded neural activity for various stimuli 
Nonselective Selective 
Animal 
Multimodal Spontaneous Tactile Bladder 
1 - 3 - 1 
2 - - 1 - 
3 - - 12 - 
4 1 - 7 2 
5 1 - 1 6 
6 - 4 1 - 
7 - 7 - 1 









Figure 5.1. Side and end-on perspective diagrams of a High-Density Utah Slanted 
Electrode Array (HD-USEA) implanted into the feline pudendal nerve (fascicles 
indicated with shaded cylinders). (A-B) The 200 µm spacing of the HD-USEA electrodes 
was based upon feline pudendal nerve dimensions. The location and sizes of the pudendal 
nerve fascicles were estimated from the cross-sectional image shown in C. The diagrams 
show the tips of electrodes accessing fibers distributed throughout the nerve. C. Cross-
section of the pudendal nerve after an acute (10 h) HD-USEA implantation. The base of 
the array was located on the top surface of the imaged nerve and evidence of the 
electrode tracks penetrating into the nerve can be seen (histological processing produced 
curvature in the electrode tracts in this image). D. Same cross-section as in C but with the 
fascicles outlined and numbered. At the site of this implantation, the fascicular area made 
up 39% of the total cross sectional area of the pudendal nerve. E. Distribution of 
electrode tips (represented as circles) throughout cross section of nerve.  In this image, 
the electrode tips of 18-24 of the 48 implanted electrodes appear to be located within 
fascicles #1-4, such that the axons inside these fascicles are within ≈ 100 µm of an 







Figure 5.2. Selective detection of genital tactile stimulation. Tactile stimulation evoked 
neural activity that could be recorded via individual microelectrodes on an HD-USEA 
implanted into the feline pudendal nerve. Neural activity was evoked during stroking of 
the scrotum and various neural units could be recorded from different electrodes, such as 
electrode 21 (A) and electrode 23 (B).  C. A raster plot of the spikes recorded on each 
microelectrode were plotted during ten scrotal stroking events (top bar, marked ‘STIM’) 
and only the electrodes that were within the listening radius of fibers associated with the 
tactile stimulation showed increased firing during each event. D. Electrode array activity 
map showing the location and identifying numbers of electrodes in the implanted HD-
USEA. Electrodes that recorded increased neural activity when the scrotum was stroked 































R 41 26 21 16 11 6
46 42 37 27 22 17 12 7
38 33 28 23 18 8 3
48 44 39 29 19 9 4
















Figure 5.3. Selective detection of bladder fullness. A. The top trace shows the volume of 
saline infused into the bladder (20 mL) over 150 seconds. The dashed lines mark the 
beginning and end of the filling episode. The bottom four traces show raster plots and 
firing rates (100 ms bins) of the neurons recorded with two different electrodes during 
this filling epoch. Note the constant increase in spike firing for each unit over the course 
of filling. B. Electrode array map showing the location and identifying numbers of 
electrodes in the implanted HD-USEA. Electrodes that recorded increased neural activity 
during the filling epoch are identified with cross-hatched tiles, suggesting that these 
afferent fibers were distributed along on one side and deep within the nerve. Data shown 
were collected from cat #4. 
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Figure 5.4. Selective discrimination of various urogenital stimulation-associated nerve 
activity. A. The bladder was filled to 5 mL, a volume that evoked reflexive DECs (top 
trace). Spike data recorded with four HD-USEA microelectrodes are shown in the middle 
traces. Electrodes 6-8 showed increased neural activity during DECs while electrode 5 
showed no consistent change in neural activity. The bottom trace shows the combined 
firing rate (100 ms bins) for spike events recorded on electrodes 6-8. Increased neural 
activity in electrodes 6-8 correlated with bladder contractions. B. Neural activity recorded 
from the same four electrodes shown in A. have different patterns of evoked activity 
during periodic genital stimulation (top bar, marked ‘STIM’). Electrode 5 was 
specifically driven by tactile stimulation (the firing rate, 100 ms bins are plotted the on 
bottom), whereas electrodes 6-8 were not modulated by tactile stimulation. C. Electrode 
array map showing the location and identifying numbers of electrodes in the implanted 
HD-USEA.  The map indicates that these bladder activated afferent fibers were located 
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 To investigate intrafascicular pudendal nerve stimulation in felines as a means to 
restore urinary function in acute models of urinary incontinence, and in overactive and 
underactive bladder states. Felines were anesthetized and high-electrode count (48 
electrodes; 25 electrodes/mm2) intrafascicular electrode arrays were implanted into the 
pudendal nerve trunk. Electrodes were mapped for their ability to selectively or 
nonselectively excite the external anal sphincter, external urethral sphincter and the 
detrusor bladder muscle. Multielectrode arrays implanted into the pudendal nerve trunk 
were able to selectively and nonselectively excite genitourinary muscles. After inducing 
urinary incontinence with bilateral pudendal nerve transections (proximal to the 
implants), electrical stimulation delivered using HD-USEA electrodes was able to 
eliminate leaking. Electrical stimulation on detrusor selective electrodes was able to 
inhibit overactive detrusor states or excite contractions, depending on the stimulation 
frequency. Multielectrode arrays implanted intrafascicularly into the pudendal nerve 
trunk may provide a promising new clinical neuromodulation therapy for the restoration 
of urinary function.  
 
6.2 Introduction 
 Many urinary complications can arise from nervous system injury or disease, and 
may include a variety of changes in the activity of the External Urethral Sphincter (EUS) 
and/or the detrusor bladder muscle. Neuromodulation of the Pudendal Nerve (PN) is 
emerging as a potential therapeutic option for the restoration of urinary control1. To date, 





humans have included extraneurally placed electrodes1-3, intraurethral electrodes4 or 
surface electrodes5,6.  
 Because there are multiple nerve pathways in the PN—including those that 
mediate reflex micturition4,7, defecation8, and erection9—a multipurpose PN stimulator 
would be able to selectively activate these different nerve pathways, depending on 
clinical needs. Computer modeling studies have shown that whole-nerve cuff electrodes 
could be designed and electrical stimulation delivered such that selective access to the 
different fascicles within the PN may be possible10. In addition, the frequency of 
electrical stimulation delivered to different PN branches can also differentially activate or 
inhibit neural pathways7,11.  
 Intrafascicularly implanted microelectrode arrays have emerged as a neural 
interface that can provide high degrees of information transfer to and from the nervous 
system using a high-count (48-96) number of microelectrodes12-14. Utah Slanted 
Electrode Arrays (USEAs, with 6.25electrodes/mm2) have been implanted 
Intrafascicularly into the canine PN and were used to selectively activate the muscles of 
micturition15.  
 Here we extend those results by investigating whether intrafascicular electrode 
arrays could be used to deliver electrical stimulation to restore urinary function in three 
different clinical conditions: 1) to restore continence in an acute model of urinary 
incontinence, 2) to inhibit overactive detrusor contractions and 3) to excite detrusor 
contractions in underactive states. The results presented herein provide evidence that an 
intrafascicular PN neuroprosthesis could be used for the restoration of detrusor or EUS 





6.3 Materials and methods 
 All experiments were approved by the Institutional Animal Care and Use 
Committee of the University of Utah. Adult male felines (13 animals; 3-5kg) were 
anesthetized with Telazol (9-12mg/kg; IM) and anesthesia was maintained with 
isoflurane (0.25-2.0%) and alpha-chloralose (5-30mg/kg IV; every 1.5 h or as needed) 
during surgical and experimental procedures, respectively. Two animals (cat #s: 11 & 12) 
were used to investigate effects of Telazol on reflex bladder contractions the induction of 
anesthesia was done with isoflurane (2-4%). Alpha-chloralose solutions (1% solutions) 
were prepared as needed on the day of the experiment by dissolving alpha-chloralose  
(Alpha-Aesar) in sterile 0.9% w/v NaCl at 40-55ºC stirring on a hot plate. Solutions were 
maintained at 40-55ºC18. Lactated Ringer’s solution was administered intravenously at 
≤2mL/hr to hydrate the animal but to minimize urine production. Ureters were ligated 
near the bladder, transected proximally and allowed to drain internally in cat #s 7-9. Vital 
signs were monitored throughout the experiment. 
 A dual-lumen suprapubic catheter (12Fr, Cook Medical, Inc., Bloomington, IN, 
USA) was purse-string sutured into the bladder for filling and measuring bladder 
pressure. A syringe infusion pump (Yale Apparatus, Wantagh, NY, USA) was used to fill 
the bladder at constant rates (2-8ml/min). An intraurethral catheter (3.5Fr, Utah Medical 
Products, Midvale, UT, USA) was used to measure urethral pressure at the location of the 
EUS (located by performing a urethral pressure profile). Both the intraurethral and 
bladder pressures were measured using pressure transducers (Deltran-DPT-100, Utah 
Medical Products, Midvale, UT, USA) that were calibrated on each experimental day. 





Wire, Model #: M146240) or by visual inspection. 
 Nerve trunks were exposed through dissection of the ischioanal fossa and 
reflection of the gluteal muscles15. A nerve platform was placed under the nerve and then 
a High electrode Density USEA (HD-USEA; 25 electrodes/mm2: 48 electrodes in a 5×10 
grid with 200 µm spacing; 300 to 800µm lengths)12 was pneumatically implanted19.  
After implantation, the nerve and HD-USEA were wrapped in low-density polyethylene 
plastic wrap to keep the nerve exposure hydrated and assist in containment of the 
implanted electrode array20.  
 Reflexive voiding was investigated in eight animals and measurements were taken 
of the volumes voided (V) and retained (R) in the bladder in order to calculate the 
voiding efficiency (VE = [V/(R+V)]*100). Periods of voiding were recorded with a foot 
switch. Three to five voiding trials were completed with 10min rest intervals between 
trials for each group: control, unilateral and bilateral nerve transection.  
 After implantation, each HD-USEA microelectrode was mapped to an evoked 
muscle response: detrusor bladder, EUS and/or external anal sphincter (EAS) 
contractions. Electrodes were stimulated with cathodic monophasic stimulation at 
amplitudes of 0.1-4.0V (steps of 0.25 – 0.5V) with 200µs pulse-widths at 30-33Hz for 5-
30s durations. Stimuli were delivered via voltage-controlled stimulators (SD9, Grass 
Technologies, West Warwick, Rhode Island, USA). The mean electrode tip impedance 
was 73±54 (median = 36; n = 7 HD-USEAs; impedances >1000kOhms were considered 
nonworking electrodes and were excluded from the analysis). All data were collected at a 
30kHz or 10kHz sampling frequency (Cerebus, Blackrock Microsystems, UT, USA), and 





WA, USA).  
 
6.4 Results 
6.4.1 Somatotopic and musculotopic maps of the feline pudendal nerve 
 Figure 6.1 shows two example maps that were generated by delivering electrical 
stimulation (monopolar cathodic, 30Hz, 100-200µs pulse-widths, mapped to thresholds 
between 0.1-2V) via individual electrodes on the HD-USEAs. The numbers of selective 
and nonselective electrodes were different for each implant. In one animal, selective 
activation of the EUS and EAS muscles could be achieved with individual electrodes 
(Fig.6.1A, cat #8), while the electrodes that were able to drive bladder contractions 
simultaneously evoked EUS and/or EAS contractions. In a different preparation 
(Fig.6.1B, cat #12), electrodes were found that when used to deliver stimulation could 
selectively activate all three of the muscles studied herein. Each implantation was done 
with the row of long electrodes located proximally along the nerve. Reference electrodes 
were wired to two of the electrodes for recording purposes not investigated in this study, 
and instead, an extraneural reference wire was used as the current return path for 
monopolar and some multipolar electrode configurations. 
 
6.4.2 Reflexive detrusor contractions 
 Reflexive detrusor contractions (defined as >10cm-H2O in amplitude) were 
evoked in six animals (Table 6.1; cat #s marked with ‘y’) by infusing saline into the 
bladder at 2mL/min and contractions were observed at 5-15cm-H2O above resting 





using any of the following strategies: constant fill rates 0.5-8mL/min; 1-3mL bolus/min; 
and at different time periods prior to or following alpha-chloralose dosing. 
 
6.4.3 Reflexive voiding 
 Reflexive voiding was investigated in eight of the preparations (#’s: 6-13) by 
measuring the voiding patterns and volumes evoked by filling the bladder (2mL/min) 
with saline. When bilateral PNs were intact, voiding was observed in an intermittent 
pattern following the initial leak point, indicative of normal reflexive voiding patterns 
(Fig. 6.2A; cat #7). Five of the eight animal preparations (see Table 6.1) had evoked 
reflexive voiding during filling, and in these animals, the average leak point pressure was 
14±14 cm-H2O (mean ± std; range 3-45cm-H2O) and the VE was 47 ± 24% (range 9-
79%).  
 Unilateral PN transection did not result in a significant change to urinary function 
compared to controls (VE p = 0.94; leak point pressure p = 0.82; two-tailed 
heteroscedastic t-test). Following unilateral PN transection, average leak point pressure 
was 12±20cm-H2O (range 4-57cm-H2O) and average VE was 46 ± 29% (range 6-76%). 
Bilateral PN transection, however, resulted in constant leaking following the initial leak 
point in 5 of 8 cats (Table 6.1). Note that the three cats (#s 9-11) that did not have 
incontinence induced after bilateral nerve transections were the same three that did not 
have reflexive detrusor contractions or voiding. Figure 6.2B shows an example of 
constant leaking after the initial leak point in cat #7 after bilateral nerve transections. The 
average leak point pressure during filling trials for the five cats with induced 





3-33cm-H2O), while the average VE was significantly increased (p = 0.01; 69±20%; 
range 41-87%).   
 
6.4.4 Restoration of continence  
 Following induction of incontinence in bilaterally transected animals, electrical 
stimulation was delivered via HD-USEA electrodes that either selectively or 
nonselectively evoked contractions of the EUS. When no stimulation was applied (Fig. 
6.2B), a constant voiding pattern (grey bar) occurred after the leak point and until filling 
stopped (right arrowhead). However, voiding stopped and continence was restored during 
the periods when stimulation was being delivered intrafascicularly to the PN (solid bars 
in Fig. 6.2C and 6.D). When stimulation was delivered over multiple 30s periods during 
voiding, the VE significantly decreased (p = 0.008; 46±18%) compared to no stimulation. 
Stimulation delivered via electrodes that selectively activated the bladder or the EAS 
were unable to eliminate leaking.  
 
6.4.5 Inhibition of overactive bladder  
 In two animals (cat #s: 8 & 12) we investigated whether low frequency 
stimulation (10 Hz) could inhibit pudendal-to-bladder reflexes and lead to inhibition of 
reflexive detrusor contractions evoked after filling. Bladders were filled to threshold 
volumes needed to evoke the overactive bladder model, but under volumes that would 
evoke reflexive voiding. In each experiment, 10Hz stimulation (200µs pulse-widths, 0.4-
2V, single or multielectrode stimulation via detrusor selective electrodes) was able to 





of stimulation. Some of the trials showed longer lasting inhibition that continued after the 
stimulation was turned off (Fig. 6.3B). In cat #8, stimulation delivered via one electrode 
(electrode #20; 10Hz, 1V, 200µs pulse-widths) was able to inhibit reflexive detrusor 
contractions. In cat #12, inhibition was achieved by delivering stimulation via two 
electrodes simultaneously (electrodes 38 & 42, 10Hz, 2V, 200µs pulse-widths), while 
stimulation via each electrode individually did not result in detrusor inhibition. These 
were neighboring electrodes separated by a row and a column (≈203µm tip-to-tip 
separation; compare electrode locations in Fig.6.1B).  
 
6.4.6 Excitation of underactive bladder 
 Robust and sustained bladder contractions (defined as >10cm-H2O for >10s) were 
electrically evoked using intrafascicular PN stimulation (n = 5 successful preparations; 
Table 6.1). During these stimulation trials, bladders were filled to 5-15 cm-H2O above 
resting pressure and below reflexive voiding volumes. Monopolar cathodic stimulation 
delivered via single microelectrodes resulted in robust contractions of the detrusor in cat 
#7 and #12 (Fig. 6.4A; cat #12; 30Hz, 1V, 200µs pulse-widths). In two preparations 
where reflexive detrusor contractions were unable to be evoked by filling, electrical 
stimulation was able to drive detrusor contractions (Figs. 6.4B-E). In three felines (#s: 1, 
5 & 8), long duration (5-30s) monopolar cathodic stimulation delivered via detrusor-
selective electrodes evoked only small amplitude and transient detrusor contractions 
(Figs. 6.4C and E; <15cm-H2O for <5s). Increasing the amplitude of the monopolar 
stimulation did not increase the amplitude of the contractions. In cat #8, no robust bladder 





achieved in the other two cats using multipolar (Fig. 6.4B) or bipolar (Figs. 6.4D) 
electrode configurations. For multielectrode stimulation, each electrode was used to 
deliver cathodic stimulation with the return electrode placed extraneurally. For this 
experiment, each of the four electrodes was stimulated individually, then in groups of 
two, three or four for approximately 20s durations. Increasing the number of electrodes 
used to deliver the stimulation resulted in an increase in the amplitude of the evoked 
bladder contractions for each trial (compare Figs. 6.4B and 6.C). The amplitudes of the 
bladder contractions were significantly (p<0.001; student t-test; heteroscedastic) higher 
when evoked by four electrodes (19±4cm-H2O; mean ± std; n = 19 trials) than by just one 
electrode (8±1cm-H2O; n = 12 trials). 
 For bipolar electrode configuration trials, electrodes on the HD-USEA were used 
to deliver cathodic stimulation and as the return of anodic current. Figure 6.4D shows an 
example of a detrusor contraction evoked by a bipolar electrode configuration with the 
cathodic (electrode #18) and anodic (electrode #23) electrodes aligned in parallel with the 
nerve. Figure 6.4C shows the transient detrusor responses evoked by monopolar 
stimulation alone (electrode #18 as the cathode). Stimulation parameters were fixed for 
all electrode configurations (4V, 30Hz, 100µs pulse-width, for 15-20s durations; a 
suprathreshold voltage was used). Controlling longitudinal current distribution along 
axons using bipolar electrode configurations resulted in mean pressure increases of 
25cm-H2O for 16s durations (n = 3 different bipolar configurations used). Point source 
current delivered via monopolar electrodes produced mean bladder pressure increases of 







6.5.1 Using HD-USEAs to map neural pathways 
 Somatotopic and musculotopic mapping of the PN implants showed that many 
different electrodes could be used to stimulate different genitourinary muscles, either 
selectively or nonselectively. No two implants produced maps that were the same, which 
was expected considering the orientation of nerve fibers and fascicles change along and 
between nerves21,23. Using different single or multielectrode configurations, different 
subsets of nerve fibers could be activated. Future studies are warranted to assess the 
ability of multielectrode arrays to also provide modulation of reflexive defecation and 
erection pathways. 
 
6.5.2 Intrafascicular stimulation to restore continence 
 PN injury has been used as a model for urinary incontinence in female rats24 and 
cats25. To our knowledge, this is the first study that evaluated PN transection as an acute 
model of incontinence in male felines. Bilateral transection resulted in significantly 
increased voiding efficiencies following the initial leak point. Clinical applications for 
pudendal neuromodulation may also include the restoration from urinary incontinence via 
selective stimulation of the motor fibers innervating the EUS; however, future 
experiments are needed to test the success of intrafascicular stimulation for the 








6.5.3 Intrafascicular stimulation to control overactive or underactive bladder 
 Whole-nerve stimulation of the PN at different frequencies can excite or inhibit 
the pudendal-to-bladder reflexes7,11. Here for the first time we have shown that 
intrafascicularly implanted electrodes can also activate or inhibit pudendal-to-bladder 
reflexes in a frequency dependent manner. Using multielectrode arrays, it was possible to 
use different electrodes or subsets of electrodes to drive these pathways independently.  
 We hypothesized that varying the current distribution along axons or subsets of 
axons within a fascicule using multipolar configurations may activate PN pathways 
differentially. Such current steering techniques presumptively increased the likelihood 
that adjacent Nodes of Ranvier on nearby axons experienced the voltage gradients needed 
to initiate action potentials26. Interestingly, detrusor contractions evoked by longitudinal 
current fields had activation latencies approximately 3sec longer than those evoked by 
monopolar stimulation. This may suggest that different underlying nerve pathways are 
involved with monopolar and bipolar electrode stimulation of pudendal-to-bladder 
reflexes.  
 
6.5.4 Effects of anesthetics  
 In order to activate the bladder by stimulation of pudendal afferents in 
anesthetized animal models, alpha-chloralose is commonly used as the anesthetic 
agent7,17. However, alpha-chloralose has been shown to alter autonomic functions of the 
urinary system, including decreasing VE compared to decerebrate felines27. Despite these 
results, researchers have indicated this is a useful agent for studying electrical stimulation 





previous findings, we observed 46% success rates for evoking reflex detrusor 
contractions via filling. However, we observed lower success rates for evoking detrusor 
contractions via electrical stimulation (38%). These results suggest alpha-chloralose 
anesthetized, spinal intact animals may be an appropriate model for investigating 
pudendal-to-bladder reflexes as driven by electrical stimulation, but the success rates can 
be variable.  
 Telazol is a combination of a dissociative agent (tiletamine HCl) that should leave 
spinal reflexes intact and a muscle relaxant agent (zolazepam HCl). It may be possible 
that the detrusor muscle remains impacted by this agent and thus, inhibition of bladder 
contractile states may occur. However, the effects of this agent usually wear off < 1hr and 
the experiments performed herein lasted for up to 30hrs. In the two animals induced 
without Telazol, reflexive detrusor contractions were observed, but we were unable to 
electrically excite the detrusor in one animal. The small numbers of animals that did not 
receive Telazol are insufficient to draw conclusions on the effects of this drug on 
pudendal-to-bladder and/or detrusor states, and future studies are warranted. Chronic 
implantation of HD-USEAs into the PNs of spinalized felines may help shed light on this 
issue as trials could be carried out in awake animals without the potentially confounding 
effects of alpha-chloralose and/or Telazol.  
 
6.5.6 Effects of HD-USEA implantation  
 Other factors that may contribute to our low success rate for electrically driving 
detrusor contractions may include damage to the nerve fibers following HD-USEA 





decrease in nerve compound action potentials following implantation of HD-USEAs into 
rat sciatic nerve, with a 12% chance in the loss of entire signals20. Thus, this nerve 
damage may be a factor when using HD-USEAs to investigate intrafascicular stimulation 
of the PN in acute studies. In chronic studies, HD-USEAs have been shown to cause 
transient sensorimotor deficits in rats implanted for 8 weeks; however, viable neurons 
(normal & presumptive regenerating) were found within proximities of the electrode tips 
that would be needed for stimulation and recording28.  
 
6.5.7 Potential for translational use 
 The access to the human PN has been well characterized and the branching 
patterns are indicative of a common PN trunk found near the level of the sacrotuberuous 
ligament23. Therefore, it should be possible to implant intrafascicular microelectrode 
arrays with longer electrodes14 into the human PN trunk. In recent work, we were able to 
show that HD-USEAs were able to selectively detect different genitourinary stimuli, such 
as bladder fullness, bladder contractions, and tactile stimulation29. Future multielectrode 
PN devices should be able to combine the ability to selectively detect different states, and 
then activate different stimulation paradigms to excite or inhibit different genitourinary 




 The results of this study demonstrate that intrafascicular electrode arrays 





acute models of incontinence, overactive bladder and underactive bladder. 
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1 n y -
2 y n -
3 y n -
4 n n -
5 n y -
6 n n y
7 y y y
8 y y y
9 n n n
10 n n n
11 n n n
12 y y y
13 y n y
Result 
Totals: 6 5 5
Percent 
Success: 46 38 63
Table 6.1: Summary of feline experimental results
y = yes, experiments succesfull in evoking given response
n = no, experiments not succesful in evoking given response






Figure 6.1. Intrafascicular microelectrodes selectively and nonselectively activated direct 
and reflexive nerve pathways in the PN trunk. After implantation of an HD-USEA into a 
PN, electrical stimulation was delivered via individual electrodes in order to map the 
genitourinary response(s) evoked by each electrode. Example maps are shown for two 
different implants (A- cat #8; B- cat #12) that evoked selective and nonselective muscle 
contractions including: the external anal sphincter (EAS, horizontal lines), external 
urethral sphincter (EUS, vertical lines) or detrusor bladder (grey boxes). Arrays were 
implanted such that the longest electrodes were located proximally along the nerve. The 
wire bundle came off of the array substrate parallel to the nerve and on the short electrode 











Figure 6.2. Modeling of incontinence and restoration of continence due to overactive 
bladder. (A) Infusion of saline (2 mL/min) into the bladder (black arrow labeled ‘Fill’) 
evoked reflexive contractions of the bladder once a threshold volume was reached (data 
from cat #7; leak point volume = 4.8 mL). In five animal preparations, these contractions 
caused leaking of the bladder (grey rectangles labeled ‘Void’) and this state was used as a 
model of incontinence due to overactive bladder. The mean VE across all animals with 
intact PNs was 47 ± 24%. (B) After bilateral PN transection, the voiding pattern changed 
from intermittent leaking to constant leaking (data from cat #7). Across all animals, the 
VE significantly increased (p =0.011; mean = 69±20%) compared to animals with 
bilateral nerves intact. (C) Delivery of electrical stimulation to motor fibers in the PN 
(black bars; 30 Hz, 3V, 200 µs pulse-width durations) via a nonselective HD-USEA 
electrode (#9) resulted in contraction of the EUS and eliminated voiding for the duration 
of stimulation (data from cat #12). (D) Magnification of the first two stimulation periods 







Figure 6.3.  Selective inhibition of detrusor contractions in a model of overactive 
bladder. (A) Lower frequency stimulation (10 Hz, 1V, 200 µs pulse-width cathodic; black 
bars) delivered via two HD-USEA electrodes simultaneously (electrode #’s 38 & 42) 
during distension-evoked bladder contractions was able to inhibit contractions for the 
duration of stimulation and for varying periods after stimulation was turned off. (B) 
Magnification of the third stimulation period shown in (A). Oscillations in the pressure 
trace when no detrusor contractions were occurring (during stimulation) were due to 









Figure 6.4.  Selective excitation of the detrusor during underactive bladder states. 
Electrical stimulation (30 Hz) was able to drive detrusor contractions depending on the 
frequency of stimulation and the type of current delivered to the nerves.  The electrode 
configuration needed to evoke more robust bladder contractions (>15 cm-H2O) changed 
for different implants. (A) Monopolar stimulation (1 V with 200 µs pulse-widths) was 
able to evoke detrusor contractions for the duration of stimulation (cat #12). (B) 
Stimulation (3.5 V with 200 µs pulse-widths) delivered simultaneously using four HD-
USEA electrodes (#’s: 6, 7, 12, 13) was able to evoke robust contractions for the duration 
of stimulation (cat #5). (C) However, when those same electrodes were stimulated in 
groups of three, two or single electrodes, the amplitude of the evoked detrusor 
contraction was decreased. Increasing the amplitude of stimulation on a single electrode 
did not drive robust bladder contractions that were comparable to multielectrode 
stimulation (cat #5). (D) Bipolar electrode configurations were used to deliver stimulation 
that evoked detrusor contraction. (cat #1). (E) However, in this same preparation 
monopolar stimulation (4V with 100 µs pulse-widths) was unable to evoke detrusor 
contractions for the duration of stimulation or that were as robust in amplitude. 
Stimulation train durations are marked with black bars. Oscillations in the pressure trace 
are due to mechanical ventilation of the animal. Before stimulation was delivered, 
bladders where filled with saline to 5-10 cm-H2O above resting pressure or before any 
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7.1 Abstract 
 Modern prosthetic arms/hands have been developed, which are capable of greater 
than 20 Degree Of Freedom (DOF) movements. An important goal of neuroprosthetic 
research is to establish bidirectional communication between the user and high-DOF 
prosthetic limbs. Having intuitive neural control of, and sensory feedback from, high-
DOF prosthetic limbs is critical to their effective utilization. One strategy for achieving 
this goal is to interface the prosthetic limb directly with efferent and afferent fibres in the 
peripheral nervous system using an array of intrafascicular microelectrodes. A high 
electrode count microelectrode array may provide the large number of sufficiently 
independent neural signals needed to control a high-DOF prosthetic limb. A high 
electrode count microelectrode array may also enable the selective stimulation of afferent 
fibres needed to evoke discrete sensory percepts across the phantom-limb. Here we report 
the initial results of the first one-month implantations of microelectrode arrays into the 
median or ulnar nerves in two subjects that had undergone transradial amputations thirty-
one and one-and-a-half years prior to the study, respectively. Using a Kalman filter to 
decode neural activity recorded by the microelectrode arrays that was correlated with 
volitional phantom finger movements, the subjects were able to proportionally control the 





delivered via individual electrodes, sensory percepts of varying sizes and qualities were 
perceived as originating from loci distributed over the phantom hand. Modulating the 
stimulation parameters altered the quality of the percepts, and simple patterns of percepts 
could be evoked when electrical stimulation was simultaneously delivered via multiple 
electrodes. This study demonstrated that a high-count intrafascicular microelectrode array 
can be subchronically implanted into the human peripheral nervous system and provide 
intuitive and dexterous control of an artificial limb with sensory feedback. 
 
7.2 Introduction 
 The volitional control of movement involves a complex hierarchy of motor and 
sensory neural systems. Our understanding of these complex systems has been facilitated 
with arrays of microelectrodes that have been implanted at various levels in this hierarchy 
to record the spatiotemporal patterns of neural activity that correlate with motor 
behaviours. Early efforts to obtain volitional control signals from the cortex were 
conducted in nonhuman primates, where the control of external devices has been 
achieved by decoding neural activity patterns recorded with microelectrodes implanted in 
the motor cortex of nonhuman primates [1-6]. Researchers have begun translating these 
efforts to human subjects, and electrode arrays implanted into the motor cortex of people 
with paralysis have provided the unidirectional communication needed for the volitional 
control of external devices such as the two-dimensional movements of computer cursors 
[7-9] and the manipulation of objects in three-dimensional space with robotics [10]. 
Although the central nervous system is an effective implantation site for people with 





peripheral nerve targeted reinnervation [11, 12] or peripheral nerve electrode 
implantation [13-19]. 
The current gold standard for people with upper-limb amputations are 
mechanically or myoelectrically controlled prosthetic arms with few DOF that do not 
provide sensory feedback [20]. Next generation prosthetic arms are being developed with 
upwards of 26 DOF [21, 22] and with embedded sensors capable of providing sensory 
feedback to the user [13, 19, 23]. Several strategies are being investigated for providing 
sensory feedback from these new prosthetic limbs including surface vibrators [23], and 
extraneural [17, 18, 24, 25] or intraneural [19, 26-29] electrodes. Motor intent has been 
decoded online and offline [13, 19, 30] with achievement of up to three DOF of control 
[13], and sensory feedback has been provided via electrical stimulation [13, 14, 16, 19, 
23] with the evocation of up to nine different percepts [19]. To date, neural interfaces 
have successfully used one electrode [13, 16], six electrodes [30], sixteen electrodes [19], 
and twenty electrodes [28] to established bidirectional communication with a subject’s 
peripheral nervous system. In order to provide intuitive dexterous control of modern 
high-DOF prosthetic arms and hands it is likely that a high number of electrodes (i.e., 
more electrodes than the DOF being controlled) capable of conveying sufficiently 
independent control and feedback signals will be required. 
We report herein an approach for the control of prosthetic limbs using a high-
electrode count intrafascicular array, the Utah Slanted Electrode Array (USEA) [27]. This 
work was conducted in two subjects who had previously undergone transradial 
amputations. The subjects each had a microelectrode array implanted in either their 





small groups of motor and sensory fibres within the distal end of their transected 
peripheral nerve. Selective spatiotemporal neural activity patterns were recorded when 
subjects were asked to make volitional movements of their phantom fingers. Closed-loop 
neural control of multiple cursors or virtual robotic fingers was achieved in each subject 
with two DOF control achieved online for both subjects, and up to 13 DOF control 
achieved offline using the data from Subject 2. Electrical stimulation delivered via 
individual electrodes evoked distinct sensory percepts that were distributed over the 
subjects’ phantom hands. The subjective quality of these sensory percepts could be 
altered through modulation of the parameters of electrical stimulation. This work 
demonstrated that an array of microelectrodes implanted into residual nerves of patients 
with a forearm amputation allows for selective access of both sensory and motor nerve 
fibres. These results further suggest that intuitive and dexterous control of prosthetic 
fingers and sensory feedback for future bidirectional prosthetic limbs can be provided 
using a high-electrode count intrafascicular array of microelectrodes. 
 
7.3 Materials and methods 
 This study was approved by the University of Utah Institutional Review Board 
and the Salt Lake City Veterans Affairs Hospital Research and Development Service 
Center. 
 
7.3.1 Prestudy enrolment period 
 Potential volunteers were evaluated for the extent by which they perceived that 





phantom limb sensations, including pain, were documented with the duration, frequency, 
and intensity (scale of 1-10, 10 being most intense phantom sensation ever perceived). 
Such documentation continued for the duration of the study and again at a 3-month 
postexplantation follow-up. Multiple movements mediated by median and ulnar nerve 
activity were evaluated in each volunteer and the extent of their ability to move their 
fingers was noted from their descriptions (e.g., Subject 1 had ‘a very fluid hand’ but 
Subject 2’s phantom fingers were often ‘clenched tight’). Volunteers were then given a 
mirror box and specific exercises to perform in order to strengthen their perceived ability 
to move the digits on their phantom hands. Study personnel contacted the volunteers to 
document any changes in the perceived control of their phantom hand, and if any 
decreased control or unpleasant sensation was experienced, the volunteers would have 
been asked to discontinue use of the mirror box. Prior to enrolment, volunteers underwent 
a psychosocial evaluation in order to determine if any underlying psychological disorders 
were present which would have excluded them from the study. 
 
7.3.2 Nerve electrode arrays 
 The USEA (Blackrock Microsystems, Salt Lake City, UT, USA) has been 
described elsewhere [27] and consists of ninety-six electrodes with lengths ranging from 
0.5 to 1.5 mm that project out from a 4 x 4 x 0.3 mm substrate. Lead wire lengths from 
the connector (ZIF Clip Connector, Tucker Davis Technologies, Inc., Alachua, FL) to the 
array were configured for implantation into the upper limb nerves at a transradial location 
and included 1) 96 electrode lead wires to the 96 electrodes used for recording (9 cm 





were available as backup references but were not used for amplification 3) two low 
impedance platinum reference wires tied to one reference channel, which were used for 
amplification (≈8.5 cm long) and 4) two low-impedance platinum ground wires tied to 
the same ground (≈7.5 cm long). Approximately 10 mm of the distal ends of the 
reference and ground wires were twisted, looped back, the ends were secured onto the 
proximal reference or ground wires with silicone (MED-4211, NuSil Technology LLC, 
Carpinteria, CA, USA), and then the loops were deinsulated to make them low-
impedance. The length of the reference and ground wires was measured from the base of 
the connector to the end of the distal loop. The reference and ground wires were placed 
inside the nerve wrap (see section 2.3 surgical procedures) near the electrode array. 
Before implantation, the electrodes on each device had an average (mean ± std) 
impedance of 75 ± 57 kΩ (Subject 1, median nerve) and 90 ± 28 kΩ (Subject 2, ulnar 
nerve). 
 
7.3.3 Surgical procedures 
 The two volunteers with previous transradial amputations underwent implantation 
for one month with a USEA into their median (Subject 1, 31 yrs postamputation) and 
ulnar (Subject 2, 1.5 yrs postamputation) nerves. The distal nerve end was exposed and 
the implant site was selected such that it was distal to any branching points and proximal 
to the transitional zone adjacent to the neuroma (approximately 5-10 mm from the 
neuroma). The USEA was then passed transcutaneously via a trocar (7-8 mm diameter) 
down to the exposed implantation site. A metal platform was placed underneath the 





(AxoGuard Nerve Wrap, AxoGen Inc., Alachua, FL). The lead wires were then sutured 
(8-0 nylon) to the epineurium (≈5 mm from the base of the electrode array) and then the 
USEAs were inserted with a pneumatic insertion device [31] hand-held by the surgeon. 
The implanted USEA, reference wires, ground wires, and nerve were contained within 
the organic nerve wrap, which was closed snuggly around the implant site with titanium 
vascular clips (Figure 7.1(a-b)). The organic nerve wrap was sutured (8-0 nylon) to the 
epineurium proximal and distal to the array site to prevent movement of the wrap along 
the nerve. 
The percutaneous site was dressed with an antibacterial patch (1” diameter 
Biopatch, clorohexadine, Ethicon Inc., Johnson & Johnson). In Subject 2, the connector 
was sutured down to the skin to prevent stress on the lead wires due to movement of the 
connector. The entire percutaneous site was layered with gauze and covered with a 
breathable and waterproof transparent dressing (Tegaderm, 3M Healthcare). The gauze 
and film dressing was changed during each experimental session and antibacterial 
patches were replaced every 7-10 days. To decrease the inflammatory process and 
potentially assist in enhanced signal quality over time, subjects were given 
dexamethasone (0.1 mg/kg IV, intraoperatively after removal of the tourniquet) and 
minocycline  (100 mg BID, 2 days prior and for 5 days after surgery) [31, 32]. 
Both subjects underwent explantation of the USEAs under general anesthesia at 
the end of one month. The percutaneous connector was cut at the level of the skin and the 
entire limb was then prepared for surgery. Implant sites were exposed, the lead, reference 
and ground wires were cut just prior to their entry into the organic nerve wrap 





was excised and placed in 4% Paraformaldehyde for subsequent histological analysis. 
The new nerve end was then sutured deep in the surrounding musculature according to 
standard surgical procedures for neuroma excisions. 
 
7.3.4 Data acquisition and analysis 
 Two-hour experimental sessions were performed on an average of three times a 
week. The time was limited by the availability of the subjects or their willingness to 
continue testing (Subject 1 underwent 12 total experimental sessions: 6 
electrophysiological recording sessions and 8 microstimulation sessions; Subject 2 
underwent 14 total experimental sessions: 13 electrophysiological recording sessions and 
8 microstimulation sessions). All experimental sessions were recorded by video camera, 
which was time-stamped to the neural recording or stimulation data. Neural signals were 
amplified and recorded using active head-stage cables (ZIF-Clip 96 channels, Tucker 
Davis Technologies, Inc., Alachua, FL) that connected to a custom-built board used to 
interface the TDT-connector with a Neuroport data acquisition system (Blackrock 
Microsystems, Salt Lake City, UT, USA). Data were collected using Cerebus Software 
(Blackrock Microsystems, Salt Lake City, UT, USA). The continuous neural signals were 
band-pass filtered with cutoff frequencies of 0.3 Hz (1st order high-pass Butterworth 
filter) and 7500 Hz (3rd order low-pass Butterworth filter) and sampled at 30 kHz. Online 
multiunit activity was extracted from high-pass filtered data (250 Hz 4th order 
Butterworth filter) by setting a threshold using the auto threshold setting in the Cerebus 
data acquisition software (multiplier = 3, threshold = multiplier × noise estimate of the 





box-car average of 300 ms with an update period of 33 ms. Offline action potentials were 
isolated from the high-pass filtered data using commercially available software (Offline 
Sorter version 3, Plexon Inc., Texas, USA). Signal-to-noise ratios (SNR) were calculated 
by dividing the peak-to-peak action potential amplitude by two times the standard 
deviation of the noise. 
 
7.3.5 Neural decodes 
 A standard Kalman filter was implemented to perform the continuous neural 
decodes [33]. This algorithm assumes a linear relationship between the kinematics (finger 
movements) and the neural data. For this study, it was used to provide continuous 
estimates of finger position based on the firing rates of multiple neurons. Sessions began 
by cueing the subjects to perform multiple flexions, extensions or abductions of their 
individual phantom fingers. A total of 4 movements were performed for Subject 1 
(Thumb-Flex, Index-Flex, Middle-Flex, and Ring-Flex) and 13 movements for Subject 2 
(Thumb-Flex, Thumb-Extend, Index-Flex, Index-Extend, Index-Abduct, Middle-Flex, 
Middle-Extend, Ring-Flex, Ring-Extend, Ring-Abduct, Little-Flex, Little-Extend, Little-
Abduct). These movements are given acronyms based on the first one or two letters of 
each word, which are used in subsequent figures (e.g., Thumb-Flex = TF). The subjects 
were instructed to make finger movements by either a computer controlled display of 
indicators  (Subject 1) or by movement of virtual robotic fingers [34] (Subject 2). Subject 
1 held a small manipulandum consisting of individual, movable pads that could be 
depressed by each finger with his intact hand. He was asked to mirror the movements 





fingers. The instructed finger position (instruction variable) for Subject 1 was measured 
as the continuous analogue voltage signal from pressure sensors on the pads of the 
manipulandum. Subject 2 was instructed to duplicate the movements of the virtual 
prosthetic hand using her phantom hand. The instructed finger position (instruction 
variable) for Subject 2 was taken as the software generated position of the virtual 
prosthetic finger. The positions of the virtual prosthetic fingers were generated using a 
cosine function, which was normalized from -1 (full extension/adduction) to +1 (full 
flexion/abduction). Multiunit firing rates from selected electrodes and the movement 
instruction variables were then used to train and test the decode algorithm for both online 
and offline control. 
For online decoding, electrodes were selected based on their ability to record 
movement correlated action potentials. This selection process was made using two 
methods: 1) the experimenters viewed a map of correlation coefficients between the 
instruction variables and the firing rates on each electrode and 2) the experimenters’ 
subjective observations of the high-pass filtered neural data on each electrode during the 
cued movements. Following electrode selection, the decode algorithm was trained on a 
set of 10 trials for each movement type. For testing, subjects were asked to control a 
computer display of indicators (Subject 1) or virtual prosthetic fingers (Subject 2) and 
acquire targets in a trial-based format. During these testing trials, subjects were presented 
with a target of varying size and distance from a starting point. Subjects began a trial by 
moving the fingers of their phantom hand to a neutral at rest position, which moved the 
indicators or virtual prosthetic fingers to a start position. Once all fingers were at the start 





were to move their finger(s). In order to correctly complete a trial, the subjects had to 
acquire and hold the target(s) while maintaining the fingers that were not being instructed 
to move at the start position. Start and target hold periods varied from 300 to 5000 msec. 
This task format assessed the ability of subjects to move the virtual fingers/cursors 
independently. Targets were placed at various distances to assess the ability of the 
subjects to proportionally control the indicators or virtual fingers. 
For offline decoding, an average of 22 (13-37) trials of each movement type 
recorded during a typical experimental session were analyzed. Electrodes were chosen 
based on the results of a Wilcoxon signed-rank test. First, a ‘baseline period’ was defined 
as 2 sec prior to the onset of the movement cue, while a ‘movement period’ was defined 
as the 2 sec after the onset of the cue. Then, the difference in median firing rates was 
calculated between the ‘movement period’ and the ‘baseline period’ for all movement 
types recorded on each electrode. This was repeated for all movement trials across all 
electrodes. The null hypothesis was that the data came from a continuous, symmetric 
distribution with a median equal to zero (i.e., no electrode recorded increased firing rates 
in the movement period compared to the baseline period). All electrodes for which the 
null hypothesis was rejected (p<0.001) with a positive median difference from baseline 
were kept. These electrodes were then sorted in order of increasing median difference and 
the top 90% of electrodes were used in the offline decode. After electrode selection, the 
decode algorithm was trained on the first 10 trials for each movement and tested on the 
remaining trials. A Pearson’s correlation coefficient between the instruction variable and 






7.3.6 Neural stimulation, percept mapping, and analysis 
 Current-controlled, biphasic, cathodic-first (without anodic bias) stimulation [35] 
(IZ2, 128-Channel Tucker-Davis Technologies Stimulator, Inc., Alachua, FL) was 
delivered to individual or subsets of electrodes using custom LabVIEW software 
(National Instruments Corp., Austin, TX). The stimulator battery had a compliance 
voltage of ± 15V (LZ48-400, Tucker-Davis Technologies Stimulator, Inc., Alachua, FL). 
Maximum stimulation was limited by either: 1) the comfort level of the subject, 2) a 
perceived change in the quality of the percept or 3) if the maximum safety limit for 
delivering electricity to tissue was reached [36]. The safety limit for injecting charge into 
the tissue was determined by measuring the maximum cathodic voltage excursion (with a 
limit of -0.6V) across the electrode and ground during stimulation [37-39]. Stimulation 
parameters varied depending on the objective of the experimental session. Pulse 
amplitude, frequency, and train duration ranged from 1-100 µA, 1-320 Hz, and 0.2-60 
sec, respectively. Pulse width and interphase interval were held fixed at 200 µs and 100 
µs. 
In Subject 1, stimulation experiments were focused on a subset of electrodes to 
investigate the subject’s ability to detect and discriminate single and multiple sensory 
percepts and the effects of modulating stimulation frequency on sensory percepts. Using 
a custom-built software interface, Subject 1 was allowed to control the amplitude, i.e., the 
level of current per pulse (1-100 µA in steps of 1 µA), to determine the threshold or 
minimum level needed for detection using a frequency of 200 Hz and train duration of 
0.2 sec (sessions 1-8, postimplant days 5-26). Additionally, Subject 1 was allowed to 





pressing down on a pressure sensor mounted on the manipulandum with a finger from the 
intact hand (sessions 4-8, postimplant days 14-26). The amplitudes for these sessions 
were set at the previously determined 200 Hz threshold level, and pulses were delivered 
continuously for up to 60 sec. 
In Subject 2, the first six stimulation sessions (postimplant days 6-25) were 
focused on investigating the thresholds and percepts evoked by delivering stimulation to 
individual electrodes across the entire array at a constant frequency of 200 Hz and train 
duration of 0.2 sec. The last two sessions (postimplant days 26 and 27) were focused on 
investigating the threshold and percepts evoked by lower frequency stimulation (20 Hz) 
using a train duration of 2 sec. Subject 2 was allowed to control when stimulation was 
delivered, but the experimenter controlled the amplitude (1-100 µA in steps of 1-5 µA) 
and pulse train duration (0.2 or 2 sec). 
Both subjects indicated the location, size, and quality of the percept on anterior 
and posterior images of a hand. The subjects could choose the quality of the percept from 
a list (tingle, pressure, vibration, hot, cold) or they could define the quality using their 
own words. Subject 1 made these indications by marking on a sheet of paper, while 
subject 2 marked digitally using a mouse. When a percept was faint or the subject was 
unsure of the sensation, they could repeat stimulation until they were sure the percept was 
electrically evoked (as opposed to a phantom limb sensation). 
In order to investigate to what extent the percepts remained stable over 
consecutive stimulation sessions, all of the electrodes that evoked a percept during each 
stimulation session when the entire array was stimulated at 200 Hz were analysed 





localized anatomical region of the phantom hand, defined as one of the following: 
anterior or posterior of a particular finger, the palm, or the back of the hand. If a portion 
of an evoked percept was located on the border differentiating two anatomical locations 
(e.g., over the metacarpophalangeal joint), the percept was considered within the location 
where the majority of the sensation occurred; however, if the size of the percept spread 
beyond the border then the percept was not considered stable. 
 
7.4 Results 
7.4.1 Device performance 
 For Subject 1, the mean in vivo impedance for working electrodes (measured at 1 
kHz) over the 29-day implant was 222 ± 133 kΩ (mean ± std, n=7 sessions). Likely due 
to mechanical failure of the lead wires, the number of working electrodes (defined as 
electrodes with impedance < 500 kΩ) dropped from 96 to 20 by the end of week two, and 
then to four by the end of week four. In Subject 2, the percutaneous connector was 
sutured to the skin to minimize strain applied to the wires. The mean electrode impedance 
for working electrodes over the 31-day implant for this subject was 143 ± 76 kΩ (mean ± 
std, n=13 sessions), and the number of working electrodes was 87 ± 5 (mean ± std). 
 
7.4.2 Neural recordings and decoding phantom finger movements 
 Neural recordings were made while the subjects were asked to make volitional 
flexion, extension or abduction movements of their phantom fingers. Several electrodes 
recorded action potentials over the course of the study (Figure 7.1(c-d)). In Subject 1, an 





maximum of 20 electrodes recording action potentials on postimplant day three (Figure 
7.1(e). In Subject 2, an average of 22 ± 7 electrodes recorded action potentials for the 13 
recording sessions with a maximum of 40 electrodes recording action potentials on 
postimplant day seven (Figure 7.1(f)). The mean SNR of these action potentials for all 
sessions was 5 ± 2 (Figure 7.1(e)) and 5 ± 3 (Figure 7.1(f)). 
Subjects were cued to make the movements by a computer cursor or by 
movement of virtual robotic fingers (Figure 7.2(a-b)). The intent to flex or extend 
individual phantom digits produced spatiotemporal neural firing patterns that were visible 
in the high-pass filtered data (Figure 7.2(c-d)). The patterns of neural activity varied 
across electrodes and movement types. Some electrodes recorded action potentials that 
were correlated with a single movement type (Figure 7.2(c), flexion, electrode 44) or 
movement of a single digit (Figure 7.2(d), thumb, electrode 88), whereas other electrodes 
recorded action potentials that correlated with multiple different fingers and movement 
types (Figure 7.2(d), electrodes 13 & 44).  
7.4.2.1 Multiple DOF movements could be decoded offline. Predicted finger 
positions showed high correlations (R = 0.9) with the instruction variables for the best 2 
DOF in Subject 1 and best 4 DOF in Subject 2 (Figure 7.2(e-f)). Prediction accuracy 
decreased as the number of predicted movements or DOF increased (Figure 7.2(g-h)), but 
trended toward an asymptote of R≈0.5 at 13 DOF for Subject 2 (Figure 7.2(h)). To 
validate the decode results, the electrode order was randomly shuffled between the 
training and testing sets, and the firing rate data was decoded again. Using this shuffled 
data, the prediction accuracy dropped to R=0.14 for 13 DOF (Subject 2). For Subject 2, 





movements (8 DOF) was R=0.62 ± 0.07 (the five finger extension movements were 
added on postimplantation day 13 and could not be included in this analysis). Decoding 
data overtime for Subject 1 were not analyzed as impedances on most electrodes went out 
of specification and the electrophysiological recordings were lost on postimplant day 10. 
7.4.2.2 Multiple DOF movements could be decoded online. Data recorded from 
the median nerve were decoded online for middle and index phantom finger flexion and 
the subject was able to move the cursor to targets specific to each finger individually with 
a median time to trial completion of 9 ± 6 sec (16 trials; 5 electrodes). Data recorded 
from the ulnar nerve were decoded online for thumb and little phantom finger flexions, 
and the subject was able to independently and proportionally control each of the virtual 
robotic fingers with a median time to trial completion of 2 ± 5 sec (79 trials, 4 
electrodes). For both subjects, online decodes were successful in obtaining 2 DOF control 
(Figure 7.2(i-j)). 
 
7.4.3 Evoked sensory percepts Subject 1: median nerve stimulation 
 Over the course of the study, microstimulation on 17 electrodes evoked sensory 
percepts approximately located in an expected median nerve distribution (Figure 7.3(a)). 
The mean threshold across all microstimulation sessions for evoking sensory percepts 
was 27 ± 20 µA (mean ± std) (Figure 3(e)). 
In addition to the standard threshold detection experiments, stimulation sessions 
were performed where the subject was cued that a trial began, but did not know whether 
stimulation was delivered via either of two electrodes, both electrodes simultaneously, or 





different experimental sessions on postimplantation days 13, 19, and 26. Electrodes with 
different interelectrode distances were chosen, and suprathreshold stimulation amplitudes 
were used (Day 13: electrodes 16 and 19, 1200 µm distance, 19 µA and 25 µA 
thresholds; Day 19: electrodes 19 and 20, 400 µm distance, 47 µA and 18 µA thresholds; 
Day 26: electrodes 20 and 46, 1442 µm distance, 18 µA and 10 µA thresholds). For each 
trial, the subject had to record the size, location and intensity of the evoked percept. If no 
percept was evoked, the subject reported that he felt nothing. Across all three 
experimental sessions, Subject 1 correctly detected any-stimulation (stimulation on either 
electrode individually or both electrodes simultaneously) versus no-stimulation with 98% 
accuracy (58 out of 59 total trials; day 13 = 19 out of 19 trials, day 19 = 20 out of 20 
trials, and day 26 = 19 out of 20 trials). Across all three experimental sessions, Subject 1 
correctly discriminated between spatially distinct percepts evoked by microstimulation on 
the two electrodes individually (n = 5 for each electrode per session) with 87% accuracy 
(26 out of 30 total trials; day 13 = 9 out of 10 trials, day 19 = 8 out of 10 trials, and day 
26 = 9 out of 10 trials). Spatial discrimination was accurately reported with electrodes 
only separated by 400 µm (day 19) (Figure 7.3(c)). Subject 1 was also able to 
discriminate between simple patterns of stimulation, i.e., stimulation via either electrode 
individually versus simultaneous stimulation via both electrodes, with 84% accuracy (38 
out of 45 total trials; day 13 = 11 out of 14 trials, day 19 = 13 out of 15 trials, and day 26 
= 14 out of 16 trials). 
The quality of the evoked percept depended on stimulation parameters. High 
frequencies (100 – 320 Hz) evoked an ‘electric shock’ like quality for this volunteer, and 





more physiological percepts (e.g., pressure) some of the time. Subject 1 was allowed to 
self-modulate the stimulation frequency from 1 – 100 Hz by pushing down on the 
manipulandum pressure sensor with his intact hand with stimulation being delivered via 
two electrodes at 30 µA (postimplant day 14). He noted:  
(1) “As I’m pressing that down there [on the manipulandum pressure 
sensor] on that intensity and moving the finger a little bit…this [the 
sensory percept] stayed on that finger as I was moving it.” 
(2) “As they speed up [the stimulation frequency increasing from 1 to 100 
Hz] I can feel more of the finger. … It applies pressure on the index 
and this finger [the tip of the ring finger on his intact hand].” 
(3) Question from the experimenter: “Could you use this stimulation to 
recreate touch?” 
Answer from Subject 1: “Definitely…The more you press it [subject 
pressed on manipulandum pressure sensor changing the frequency 
from 1 to 100 Hz] you can sense it [the phantom finger] more. … And 
you’ll get the sense of touch, ‘cause that’s what you did for me.” 
 
 
7.4.4 Evoked sensory percepts Subject 2: ulnar nerve stimulation 
 Single electrode stimulation over the course of the study evoked sensory percepts 
approximately located in the normal ulnar nerve distribution with a mean of 81 electrodes 
that evoked percepts when all 96 electrodes were stimulated in Subject 2 (Figure 7.3(b)). 
Five of the total eight stimulation sessions (postimplant days 10-25) resulted in a 
complete mapping across the array at fixed parameters of 200 Hz, 0.2 ms durations, 200 
µs pulse widths, and amplitudes that varied from 1-100 µA. The first stimulation session 
(postimplant day 6) resulted in an incomplete mapping of the array where maximum 
stimulation was not delivered to all 96 electrodes. The last two sessions (postimplant days 
26 and 27) were mapped using a different frequency (20 Hz). These three stimulation 





evoked percepts across all five sessions. Out of these 61 electrodes, 18 electrodes 
produced percepts that were considered stable within a defined region of the phantom 
hand for two consecutive sessions (separated by 1-3 days). A total of eight electrodes 
evoked stable percepts for three consecutive sessions, four electrodes evoked stable 
percepts for four consecutive sessions, and three electrodes evoked stable percepts across 
all five stimulation sessions. Figure 7.3(d) shows examples of percepts evoked by two 
different electrodes over time. One of the electrodes (electrode 63) evoked a stable 
percept across all five sessions. The other electrode (electrode 88) was stable for two 
consecutive sessions. The quality of stimulation-evoked percepts in this subject combined 
across all five sessions included: 76 ‘tingle’ percepts; 7 ‘pressure’ percepts; and 216 
‘vibration’ percepts. For the last two stimulation sessions where the array was mapped at 
20 Hz, a total of 76 electrodes evoked percepts on both days, with 17 electrodes evoking 
stable percepts. The percept quality evoked during these sessions included: 21 ‘tingle’ 
percepts; 19 ‘pressure’ or ‘hair brush’ percepts; 17 ‘vibration’ percepts; and 96 ‘cold’ or 
‘air brush’ percepts. The subject noted that the ‘tingle’ and ‘vibration’ percepts evoked 
during each session were of a ‘painful’ quality. Across all stimulation sessions, the mean 
threshold for evoking a sensory percept was 12 ± 11 µA (mean ± std) (Figure 7.3(f)). 
 
7.4.5 Poststimulation evoked phantom limb sensations 
 Subjects each differentiated between phantom limb sensations (the normal 
feelings from their phantom hand) and phantom limb pains (percepts that were 
considered uncomfortable). Subjects reported an increase in the occurrence of phantom 





electrical stimulation. At times, the poststimulation sensations included percepts such as 
‘pressure’ or ‘hair brushing on the skin.’ Subject 2 noted the feeling of the nonpainful 
poststimulation percepts in her phantom limb sensation diary: 
“I’ve had the kind of fluttering or breath-on-the-skin-or-hair-pressure that 
I had often in the lab session today. (Located in the web area between my 
PIF [phantom index finger] and PMF [phantom middle finger].) It’s as if 
now that the sensation has been awakened, it keeps registering, regardless 
of context …” 
 
 At other times, the subjects reported an increased occurrence of poststimulation 
evoked phantom limb sensations that were painful, and the quality of such percepts 
included: ‘electric shock,’ ‘stinging,’ or ‘tingling.’ For each subject, percepts (duration 
≈1-2 sec) began after the first day of stimulation, and had peak occurrences of 10/hr for 
subject 1 and 2-9/hr for Subject 2. By 30 days postexplantation of the electrode array, 




 In 2003, a human volunteer had a high-electrode count microelectrode array 
implanted in his median nerve for 96 days [28, 40]. The array implanted in the 2003 
study had the microelectrodes arranged in a flat plane parallel to the base of the array, 
limiting the cross-sectional access to the nerve, and only 20 of the electrodes were wired 
for electrophysiological use. Therefore the full potential of a 96-electrode array could not 
be investigated. Furthermore, no containment system was used to protect the implanted 
array. Most importantly, this study was performed in a subject with an intact arm, so that 





amputation using a bidirectional neural interface for controlling an artificial limb could 
not be addressed. 
 
7.5.1 Device performance 
 The impedances of all working electrodes remained stable for the duration of the 
study. In Subject 1, the impedances for the majority of the electrodes went out of 
specification at the end of the first week; however, four electrodes remained viable for 
the duration of the implant. Suturing the percutaneous connector to the skin may have 
reduced the chance of wire breakage in Subject 2. However, a robust percutaneous 
connector or a telemetry system will be needed before applications using high electrode 
count arrays achieve clinical utility. Work is underway to develop wireless versions of 
the electrode arrays described in this report [41]. The generation of microelectrode arrays 
used in this study have maximum electrode shank lengths of 1.5 mm, which limits the 
cross-sectional access to the outer region of the relatively large human peripheral nerves 
that are greater than 3 mm in diameter. Longer electrodes and/or multiple arrays are 
needed to expand electrophysiological access across the entire diameter of the nerves. A 
more robust containment system, an anchoring system, or a more compliant 
microelectrode array design may be required to achieve the very long functional lifetimes 
necessary for clinical applications. Additionally, not addressed in this study is the 
technological challenge of performing near simultaneous electrophysiological recordings 







7.5.2 Neural recordings and decoding independent and proportional 
phantom finger movements 
 The number of electrodes that recorded action potentials over time was relatively 
stable for Subject 2, providing evidence that the devices remained intrafascicularly 
implanted for the duration of the study. Both subjects were given dexamethasone and 
minocycline doses in order to potentially increase the quality of action potential 
recordings over time [31, 32]. Additional control studies are needed to investigate 
whether administration of these drugs can improve neural signal longevity. Previously 
published studies have used the rodent model. 
 An important aspect of any decoded signal that could be used to control a 
prosthetic hand is that the signals can mediate proportional control. This was investigated 
in two ways: using the trajectory tracking described above, and by challenging the subject 
to move their phantom finger to various end positions between full extension and full 
flexion. For both subjects, the decoded neural activity patterns provided proportional 
control of finger position and importantly, such control was achieved during the first 
recording session with each subject. 
 The relationship between the central representation of motor control and the 
kinematics of movement is complex, with activity in single neural units correlated with 
the movements of multiple finger muscles [42, 43]. The central and peripheral nervous 
systems are set up to control the synergistic biomechanics of the human hand [44], while 
current high-DOF prosthetic hands do not implement mechanical synergies [21, 22]. 
Future work needs to develop efficient mapping of these synergistic neural signals onto 





7.5.3 Stimulation-evoked sensory percepts 
 The sensory feedback provided by the sensors distributed throughout the fingers 
and hand allow for the manipulation of complex objects in 3-D space. In this study, we 
explored the ability to evoke sensory percepts by injecting currents into the peripheral 
nerves via many of the electrodes in the implanted arrays. Translations of evoked 
percepts into more physiological percepts was achieved by varying the frequency and the 
duration of stimulation, i.e., the percept changed from an ‘electric shock-like tingle’ to 
pressure. The stability of the stimulation-evoked percepts was assessed, and the results 
indicate that implantations of microelectrode arrays into the peripheral nerves of 
amputees could provide the sensory feedback that would enable dexterous manipulation 
of complex objects with future generations of prosthetic hands. Future studies are 
warranted to investigate the stimulation parameters that evoke other sensations, such as 
proprioception, as well as, long duration stimulation to evoke long-lasting sensations.  
 
7.5.4 Poststimulation evoked sensory percepts 
 The subjects experienced poststimulation percepts that occasionally had the 
uncomfortable or painful qualities of the percepts evoked by some electrical stimulation. 
Importantly, neither of the subjects experienced these quality of percepts prior to 
participating in the study. Future work may focus on optimizing stimulation parameters 
to produce only physiologically relevant and comfortable sensory percepts, and needs to 








 Here we describe the first implantation of high-count microelectrode arrays into 
human peripheral nerves in subjects with forearm amputations. Electrodes recorded 
neural activity patterns from the residual nerves that were volitionally generated by the 
intention to flex, extend or abduct individual digits in the subject’s missing hand. Up to 
thirteen movement types could be decoded and proportional control of all digits on a 
virtual prosthetic hand was achieved. Stimulation of up to 96 electrodes, either one-at-a-
time or simultaneously, evoked multiple percepts that were widely spatially distributed 
across the phantom hands. The relatively large number of channels of motor and sensory 
information provided by the microelectrode arrays indicate that such arrays can serve as a 
neural interface for controlling high-DOF prosthetic limbs. Patients outfitted with a 
highly dexterous prosthetic limb controlled through a bidirectional peripheral nerve 
interface might begin to think of the prosthesis not as a piece of hardware attached to 
their amputated arm, but rather, as an integral extension of themselves. 
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Figure 7.1. Neural signals recorded using USEAs implanted into human median and 
ulnar nerves. Panels (a), (c) and (e) show data from Subject 1; and panels (b), (d), and (f) 
show data from Subject 2. (a-b) Photographs of intrafascicular USEA implantation into 
the median and ulnar peripheral nerves. The device-nerve interfaces were contained 
within an organic nerve wrap (clear material surrounding the implant) and secured with 
vascular clips (3-5 clips are seen in each photo) to minimize movement of the device and 
allow containment of the reference wires proximal to the arrays. (c-d) Action potentials 
(APs) were recorded on individual electrodes for the duration of the study in both 
subjects, providing electrophysiological validation that the devices remained 
intrafascicular throughout the study. (e-f) Median signal-to-noise (SNR) for all APs 
recorded on all electrodes across the duration of the study. The number below each 






Figure 7.2. Decoding volitional phantom finger movements from peripheral nerve action 
potentials. Panels (a), (c), (e), (g) and (i) show data from Subject 1; and (b), (d), (f), (h) 
and (j) show data from Subject 2. (a-b) Experimental setup showing each subject 
volitionally controlling either a computer controlled display (Subject 1) or the digit of a 
virtual hand (Subject 2). During the examples shown, the neural information 
corresponding to the phantom movement was decoded in real-time and used to control 
the virtual movement. (c-d) High-pass filtered, common-average referenced neural 
recordings (solid blue line) made by three electrodes during phantom finger movements 
for Subject 1 (Postimplant day 3) and Subject 2 (Postimplant day 24). Superimposed is 
the instructed finger movement (dashed black line). APs can be seen in the high-pass 
filtered data extending above and below the noise floor during the instruction period. 
Sorted AP waveforms are shown on the far right for each electrode. (e-f) Kalman filter 
predictions for the best two DOF for Subject 1 and the best four DOF for Subject 2. 
Prediction accuracies of 0.9 were achieved using multiunit firing rates calculated from 
unsorted spike events on 55 electrodes and 18 electrodes, respectively. (g-h) Kalman 
filter performance for all combinations of available DOF using the same electrodes as in 
(e-f). Red horizontal lines and blue boxes represent the median and interquartile ranges, 
respectively. (i-j) Kalman filter performance during real-time decode sessions for each 
subject. Boxes represent trial-by-trial target locations and the traces represent the Kalman 
filter predictions for the intended finger movement. To complete a trial, predicted 
movements must enter the same color box for a specified hold duration (3000 (i) and 300 
(j) ms). Only a subset of trials for each subject are shown. Asterisks highlight verbally-













Figure 7.3. Electrical stimulation evokes spatially distinct and stable sensory percepts. 
Panels (a), (c) and (e) show data from Subject 1; and (b), (d), and (f) show data from 
Subject 2. (a-b) Results from intrafascicular stimulation of human median and ulnar 
nerves show evoked sensations in the phantom hand that follow the expected spatial 
distributions for each nerve. The percepts evoked outside of the expected distributions 
did not repeat location on subsequent stimulations and may have been phantom 
sensations occurring at the same time as stimulation. (c) Single electrode stimulation 
(electrode 19 at 47µA; electrode 20 at 15µA) produced discrete sensory percepts, and 
when the same electrodes were stimulated simultaneously the two discrete percepts could 
be perceived simultaneously (Subject 1, median implant). The interelectrode distance in 
this example was 400 µm. (d) Examples of percepts that were evoked by two different 
electrodes with one percept that was considered stable across all five sessions (electrode 
63; top row of hands) and another that was stable for two consecutive sessions (electrode 
88; bottom row of hands). Marked locations were felt simultaneously (Subject 2). (e-f) 
Sensory percept thresholds over the duration of the experimental period for both subjects. 
For subject 1, only a subset of electrodes were stimulated each session. For subject 2, 
except on postimplant day 6, all 96 electrodes were stimulated each session. The number 
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 As neuromodulation goals grow in complexity, restoration of voluntary and 
autonomic functions will require multifaceted devices that can record and decode neural 
activity then send a corresponding electrical stimulation to evoke the desired 
physiological outcome(s). Such devices will likely be more complicated that the devices 
commonly used in the clinic today. For example, deep brain stimulators deliver constant 
electrical stimulation via large electrodes (> 1 mm) to the patient, achieving one clinical 
goal at all times. 
 As we continue to strive to restore normal physiological function using neural 
electrodes, we must aim to recapitulate what our nervous system does so well: send and 
receive signals to and from different neural pathways in a selective manner to achieve 
higher degrees of functionality. Taking these ideas one step further, we can begin to 
design devices that can detect multiple different neural signals associated with different 
stimuli, and then such devices can simultaneously drive excitation or inhibition of these 
different pathways. An example that demonstrates this idea would be a spinal cord 
injured person with a Utah Array-based pudendal neuroprosthesis that could detect and 
control all three different pathways in this nerve: urination, defecation and reflex 
erection.  
 Another branch of research in neuromodulation is the regrowth of injured nerves. 
In models of nerve growth today, such as injured peripheral nerves, this type of growth 
takes time. We also know from fundamental neurophysiology studies those neurons that 
‘fire together wire together,’ meaning that neural activity drives the formation and 
strengthening of neural connections.1,2 Therefore, we can begin to postulate that 





to achieve restoration of injured neural connections. Indeed, researchers are working on 
methods to promote axonal regeneration3 and even combinations of nerve growth factors 
and electrical stimulation.4 However, one confound for neural regeneration methods is 
targeting the regenerating fibers to appropriate targets, a problem that has yet to be 
resolved. 
Neuromodulation may also act as a temporary therapy to increase functional 
recovery following nerve injury. New research is uncovering better functional recovery 
following spinal cord or peripheral nerve injury when neuromodulation is used 
immediately following nerve injury. In these cases, the neuromodulation methods may 
include the delivery of surface stimulation5,6 and/or spinal cord stimulation7 for acute 
periods of rehabilitation time following nerve injury.  
The future of neuromodulation is here and exciting new research is demonstrating 
improved functionality in patients with nerve injury or disease. As mentioned in the 
preface, it will be essential for neural engineers and physicians to continue to bridge the 
gap and strengthen the relationship between research and clinical medicine, especially as 
we embark on the development of highly sophisticated neural modulation devices. 
 
8.2 Neural electrodes 
 In this section, we first discuss the future of Utah Array technologies and three 
major topics are addressed: wireless arrays, arrays for larger peripheral nerves, and longer 
duration peripheral nerve implant studies. The end of this section then discusses the 
future of neural electrodes and the emerging techniques in neural stimulation, including 





 In order to unfold the potential of multielectrode neural interfaces, these devices 
must become wireless: fully packaged and hermetically sealed. There can be no question 
that one of the current limitations of high electrode count devices stems from the 
requirement of a percutaneous connector. This is especially true once these devices are 
implanted into the peripheral nervous system, where the convenience of the skull as an 
attachment site, free from joint movements, is no longer an option. The human studies we 
carried out in amputees were limited by one-month duration implants, due to having the 
required percutaneous connector attached to the skin, which negated their ability to use 
an elbow-joint prosthesis. In order to fully uncover the potential of USEA devices, they 
must be implanted and electrophysiologically monitored for years in human studies. It is 
our hope that the initial studies we carried out in amputees helps to motivate neural 
engineers to push their ongoing efforts in developing wireless technologies,8 for without 
this feature, the clinical usefulness of high-electrode count devices will be limited.  
 Devices that can be implanted in larger peripheral nerves will also dictate the 
future of Utah Array technologies. The studies carried out in Chapter 7 utilized USEAs 
with electrode lengths from 0.5 to 1.0 mm. However, the human ulnar and median nerves 
are > 1 mm diameter (4-6 mm diameters were observed during our preliminary 
dissections in human cadavers), and thus, we were only able to achieve intrafascicular 
implantation into the portion of the nerve adjacent to the array. As we developed higher 
electrode density devices with shorter length electrodes for smaller neuronal structures, 
future work is needed to develop arrays with longer electrodes for larger neuronal 
structures.  





for chronic USEA implants extends to only 7 months.10 In order to translate USEA 
applications to human studies, more data are needed to assess the effects of these devices 
after years of implantation. The importance of conducting these studies in animals will be 
to investigate whether the current devices are sufficient for such long durations, so that 
modifications can be made to these devices before their long-term implantation into 
humans (see biocompatibility section below). Therefore, the next steps for peripheral 
nerve Utah Arrays is to investigate longer duration implants and extend what is known 
about nerve degeneration and regeneration following 1-7 month implants.10-12 
 The work presented in this dissertation was focused on neuromodulation via 
electrical stimulation of the nervous system, but many new nerve stimulation methods are 
being developed, including magnetic,13,14 infrared,15 and optical stimulation.16 These 
neuromodulation techniques may surpass electrical stimulation in their ability to provide 
safe stimulation of neural tissue as well as highly selective stimulation of neural circuits. 
For example, multiwaveguide arrays have been developed for light delivery to multiple 
locations and depths in the cortex,17 similar to the Utah Array technologies for delivery of 
electrical stimulation. The combination of optogenetics—whereby specific neural 
networks are targeted for activation (via transgenic manipulation of select neurons)—
with multiwaveguide arrays provides an exciting example of combining new 
neuromodulation techniques and electrodes for functional restoration after nerve injury.  
 
8.3 Increasing the lifetime of indwelling Utah Arrays  
 Combination devices may include any number of drugs or surface modifications 





activated. One example is cardiac pacemakers that deliver dexamethasone to decrease the 
fibrotic encapsulation of the device, which can effectively remove it from the distances 
needed to provide clinically useful electrical stimulation. Such combinations of devices 
and drugs have become commonplace in the clinic, from antibiotic containing sutures to 
vascular stents with anticoagulation modifications.   
 Future Utah Array technologies will likely benefit by incorporating some of these 
strategies, which may help increase the lifetime of these devices and/or the number of 
viable neurons surrounding the devices. In our chronic rat and human studies, we 
systemically administered dexamethasone and minocycline. However, local slow release 
of dexamethasone is more effective at attenuating the inflammatory response and 
reducing neural loss.18 Thus, the next generation Utah Arrays may see enhanced 
effectiveness for long duration (months to years) indwelling devices if surface chemical 
modifications can be used to provide local delivery of drugs. Another strategy for 
increasing the effectiveness of these devices may be hydrogel matrix coatings, which 
have been shown to decrease cell loss surrounding neural probe-type cortical electrode 
arrays.19 
 One factor that is unique to nerve cuff and USEA-type interfaces is that the nerve 
and electrodes are wrapped with a containment system. New theories are emerging that 
postulated the inhibition of normal flow of molecules and cells at the device-tissue 
interface may lead to supra-physiological concentration of immune cells and signaling 
molecules, augmenting the chronic foreign body response.19 Thus, decreasing the surface 
area or utilizing hydrogel matrices may improve the long-term functioning of Utah 





 To this end, we tested a novel organic nerve wrap containment system in our rat 
studies, a system that was already FDA approved for use as a neuroprotective wrap or 
conduit in people with injured or severed nerves, respectively. In contrast to the systems 
previously used to contain USEAs (silicone or gortex-based wraps10,20), this wrap 
consisted of decellularized intestinal submucosa of the pig.21 By the nature of such 
material, cells and signaling molecules would be able to diffuse through the material, and 
therefore, supraphysiological concentrations of immune cells and molecules would not 
accumulated at the wrap-tissue interface.22 In addition, using this organic nerve wrap 
would directly translate to human studies, as the material was nonimmunogenic, FDA 
approved, and could be explanted after semichronic time periods (< 2 months). The 
results of both our rat and human studies support the use of this material as a containment 
system for Utah Arrays implanted for up to two months. Future studies are now 
warranted to investigate the use of such wraps to contain arrays in actively behaving 
animals for many months or even years postimplantation.  
 
8.4 Final remarks 
 Utah Array technologies were being used worldwide prior to the work presented 
in this dissertation; however, applications were only available for medium-sized 
peripheral nerve animal studies. As a consequence of this work, we have designed an 
array that can be implanted in smaller nervous system structures, and validated the use of 
such high-density devices for up to two-month time periods. We have also expanded the 
potential clinical applications for Utah Array-based prostheses as an interface for neural 





next generation prosthetic limbs in humans. We hope this work will continue to open 
doors in basic research and clinical applications that utilize Utah Array-based neural 
interfaces for the restoration of function in people who have suffered from nerve injury or 
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